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Asthma is a chronic disease affecting families in the United States; especially 
pediatric patients aged 5-18.  In Pittsfield, Massachusetts the local prevalence of asthma 
is 14.4% versus 12.1% statewide and 8.4% nationally.  These patients miss school days 
thus causing parental workday loss.   In 2016, 14.4 million missed school days occurred 
due to asthma (Alexander et al., 2016).  Unexpected clinic visits, as well as emergency 
room visits due to asthma, can contribute to rising healthcare costs both locally and 
nationally.  Unexpected asthma visits are a leading reason for visits to this author’s clinic.  
Asthma is treated with inhaled medications through a metered dose inhaler.  
Proper use of this device is imperative for patients to achieve the best asthma control.  
vii 
Research has demonstrated that a lack of proper education and teaching of how to use an 
inhaler results in less than optimal outcomes.  Furthermore, a review of the evidence 
indicated that most patients do not correctly utilize an inhaler, confirming that this leads 
to decreased medicine effectiveness and poor patient outcomes.  At the author’s clinic, 
verbal inhaler technique education is provided but was not measured for effectiveness. 
The Evidence-Based Practice process guided the Doctor of Nursing scholarly 
project.  This project was solidly based on existing evidence to support improved 
outcomes in the asthma population.  Therefore, the question arose, in pediatric patients 
with asthma, how does the addition of hands-on inhaler education compared to only 
verbal inhaler education affect inhaler technique, appropriate utilization of medications, 
clinic exacerbation visits, ER utilization, school attendance, and parent work attendance 
over a 3-month period of time? 
Based on the evidence, the fundamental component of the scholarly project was to 
provide education to healthcare professionals so that they knew proper inhaler use and 
how to teach inhaler technique to patients.  Following training of healthcare 
professionals, a protocol to consistently educate patients on correct inhaler technique was 
initiated.  Planned outcomes for this project were improved inhaler technique and 
tightened asthma control.  Outcomes that were planned but were unable to be measured 
were asthma exacerbation visits to both clinic and emergency room and missed school 
and parental work days. To evaluate these outcomes properly, ongoing quality 
improvement methods will be used. Sustainability of the Breathe In-Breathe-Out…Now 
What program will be contingent upon addressing lessons learned during the three 
months protocol implementation (Summer-Fall of 2018). 
viii 
Keywords: Evidence-Based Practice Improvement, EBP, Inhaler Technique, Pediatric 
Asthma, Asthma Control, School Absence, Parental Work Absence, Emergency Room 
Utilization 
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Chapter 1:  Development of the Clinical Question and Problem Identification 
Background and Significance of the Clinical Issue   
Asthma is a chronic disease affecting families in the United States; especially 
pediatric patients: 868,000 of these visits were for asthma (CDC, 2018).  Exacerbations 
of asthma resulted in 200,000 hospitalizations and 14.4 million school absences in 2016 
(Alexander et al., 2016).  An average of 4.1 missed school days occurs with each episode 
of asthma exacerbation (Kouba et al., 2012).  The total economic impact of missed days 
from school, parental work days and total medical costs related to asthma can be close to 
56 billion dollars per year (Alexander et al., 2016).  Care expenditure for an uncontrolled 
case of asthma is more than double that of a controlled asthmatic patient’s care (Price et 
al., 2013).  Asthma affects all ages, race and socioeconomic levels in the United States. 
 The Northeast region of the United States has one of the highest incidences of 
asthma, with Massachusetts being the highest in the area (Massachusetts Department of 
Public Health Asthma Prevention and Control Program, 2009).  The Massachusetts 
Environmental Public Health Tracking system tracks asthma data from all in-state public, 
private and charter schools.  From this tracking system, the prevalence rate of asthma has 
increased from 11.5% in 2010 to 12.1% for the 2016-2017 school year (Massachusetts 
Environmental Public Health Tracking, 2018). 
 This Scholarly Project took place at Community Health Programs-Berkshire 
Pediatric Associates (CHP-BPA) in Pittsfield, Massachusetts.  One of ten locations 
within the federally qualified health center, this office provided pediatric primary health 
care to all patients.  Pittsfield is in Berkshire County, which is the westernmost and 
second most rural county of Massachusetts.  Our clinic is not able to accurately report full 
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asthma information due to an electronic medical record (EMR) that does not have a 
sophisticated reporting module.  However, one can examine Berkshire County and 
Pittsfield’s asthma prevalence.  The county’s asthma prevalence is slightly lower than the 
state, with 10.4% in 2010, rising to 12.2% in 2017 (Massachusetts Environmental Public 
Health Tracking, 2018).  The rise across the seven years was three times as high in 
Berkshire County as it was in the Commonwealth of Massachusetts (1.8% increase 
compared to 0.6% increase) (Massachusetts Environmental Public Health Tracking, 
2017).  Figures AA1-3 in Appendix A display the asthma prevalence rates. 
 Providers at CHP-BPA care for 45% of the pediatric population in Pittsfield and 
surrounding areas.  The rise in asthma prevalence in the city from 2010-2017 was 11.8% 
to 14.4%; with an increase as high as 16.8% in 2016.  Both the prevalence rate and the 
rise across the seven years (2.6%) are higher than those for both the county and the state 
(Massachusetts Environmental Public Health Tracking, 2018).  These data indicate that 
this population requires further assessment and possible intervention to reduce the 
prevalence and mitigate the additional rise in asthma cases.  Figure AA3 in Appendix A 
displays these graphics. 
Development of the Clinical Question and Problem 
 As a chronic lung disease, patients respond differently to the treatment and the 
condition of asthma itself.  Some may only require infrequent therapy for their asthma, 
while other patients may progressively require increased medications as well as further 
patient care, such as hospitalization.  When an asthma exacerbation occurs, swelling and 
constriction of the lung musculature follow.  Symptoms can include coughing and 
wheezing.  More severe symptoms can lead to increased difficulty with breathing and 
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even death.  With these exacerbations, additional provider visits occur; often in the 
emergency department.  One exacerbation office visit-or emergency department visit 
equates to uncontrolled asthma.  Uncontrolled asthma occurs when current treatment 
(education or medication) does not stop asthma symptoms (Alexander et al., 2016; Kouba 
et al., 2012). 
 Uncontrolled asthma is not an unusual occurrence for the pediatric population in 
this country.  In Massachusetts, almost 47% of the population had poorly controlled 
asthma (Massachusetts Department of Public Health Asthma Prevention and Control 
Program, 2009).  In 2015, a retrospective chart review took place to evaluate the causal 
factors of uncontrolled asthma. These factors included poor metered dose inhaler (MDI) 
technique, poor compliance with treatment, exposures to environmental triggers, and co-
morbid conditions.  Only 2.8% of the children had treatment-resistant asthma (deGroot et 
al., 2015).   
 Uncontrolled asthma leads to increased emergency room usage.  In 2012, 
Massachusetts had 73.08 per 1,000 age-adjusted emergency room visits.  Berkshire 
County had 86.41 per 1,000 age-adjusted asthma-related emergency room visits and had 
the fifth highest asthmatic emergency visit rate in the state.  Pittsfield, Massachusetts has 
an even higher age-adjusted asthmatic emergency room rate of 121.15 per 1,000 visits 
further supporting the need for assessment and intervention (Massachusetts Department 
of Public Health Asthma Prevention and Control Program, 2009; Massachusetts 
Environmental Public Health Tracking, 2018).  Additional costs for asthmatic emergency 
room visits or hospitalizations can be incurred since Berkshire County does not have a 
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Pediatric Intensive Care Unit (PICU).  Critically ill children must be transported to 
Baystate Medical Center in Springfield, Massachusetts. 
 Uncontrolled asthma also leads to decreased school attendance and parental work 
attendance.  14.4 million school absences occurred nationally in 2016.  An average of 4.1 
school days is missed with each asthma exacerbation (Alexander et al., 2016; Kouba et 
al., 2012), which also impacts parental work days lost.  41.1% of asthmatic 
Massachusetts school students missed at least one day of school in 2010 (Mass.gov, 
2018).  Nighttime symptoms often occur.  With only 1-3 nighttime awakenings due to 
symptoms, asthmatic children are nearly four times more likely to miss school compared 
to their counterparts.  Uncontrolled asthma is also seen in children with learning 
difficulties and lower standardized testing scores.  Nearly 30% of parents with children 
who have uncontrolled asthma reported lost work days due to asthma exacerbations 
(Schmier et al., 2006).  Pittsfield’s school district has a yearly tuition amount reported for 
students.  These amounts are $12,928 for elementary; $12,939 for middle school; and 
$13,035 for high school students (Pittsfield public schools FY 2018 tuition rates, 2018).  
One day missed from school then equates to 71-72 dollars per day just in tuition funds.   
 The healthcare dollar burden in the United States translates into 200,000 
hospitalizations and 868,000 ER visits (Alexander et al., 2016; CDC.gov, 2015 
Emergency Department Summary Tables, 2015).  The Asthma Prevention and Control 
Program in Massachusetts estimates of those children with asthma, 66.2% had 
uncontrolled asthma as of 2010.  The program states 2010 is the most up to date 
information due to small sample sizes with current sampling measures (Mass.gov, 2018).  
With uncontrolled asthma, healthcare expenditure per case is more than double the cost 
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as compared to a patient with controlled asthma (Price et al., 2012). The cost of inpatient 
hospitalized asthma care increased from 57 million dollars in 2002 to 104 million dollars 
in 2013 with public insurance (Medicaid, Medicare, and other state programs) the 
expected payers of these costs (Mass.gov, 2018). 
 Mortality due to uncontrolled asthma remains a threat in the pediatric population.  
Death is preventable in almost every case of asthma if correct diagnosis, management, 
and treatment at home occur.  Between 1990 and 2006, 1,708 deaths occurred due to 
asthma.  This number represents a 63.8% mortality rate decrease over these years.  In 
2006, 45 deaths took place between the ages of 0-24 in Massachusetts and 219 deaths 
nationally in 2015 (CDC, 2018; Mass.gov, 2018). 
 Inhaled medications are the primary forms of treatment for asthma.  A metered-
dose inhaler (MDI) is utilized to administer these medications.  The MDI is the preferred 
method of medication delivery with asthma.  Inhaled medication is delivered directly to 
the lungs, thus, requiring a lower dosage, more rapid onset of action, and decreased 
systemic medication amounts (Capanoglu et al., 2015; Manriquez, Acuna, Munoz & 
Reyes, 2015; Pedersen, Dubos, & Crompton, 2010).  Bronchodilators, or rescue 
medications (i.e., pro-air, Ventolin) are fast-acting medications that quickly relieve 
inflammation in the lung airways to alleviate symptoms- wheeze, cough and improved 
ability to breathe.  Inhaled corticosteroids are controller medications (i.e., Flovent, q-var).  
As the name implies, the function of corticosteroids is to aid in decreasing inflammation 
in the lung airways to reduce asthma symptoms- and to reduce the need for rescue 
bronchodilator use.   
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Most patients who utilize an MDI are unable to do so effectively (Burkhart, 
Rayens, & Bowman, 2005; Carpenter et al., 2015; Janssen, Spoelstra, & Brueren, 2003; 
Kamps, VanEwjik, Roorda, & Brand, 2000); however, most patients and families assume 
their technique is correct (Alexander et al., 2016; Burkhart et al., 2005; Capanoglu et al., 
2015; Carpenter et al., 2015; Foland et al., 2002; Kamps et al., 2000; Sleath et al., 2012).  
Dependent upon the particle size of the inhaled medications, a large amount of the 
particles can naturally deposit in both the oral pharynx and esophagus.  With incorrect 
inhaler technique, the amount of this deposition can increase.  This increased deposition 
is especially true in children due to smaller airways.  As patients’ asthma control 
decreases, prescription costs increase due to either added on oral medications or step up 
therapy with inhaled medications (Price et al., 2012).  Therefore, it is imperative to both 
teach this population how to utilize an inhaler properly and to have return demonstration 
from the patient (Pedersen et al., 2010). 
Both pediatricians (MDs), as well as nurse practitioners and physician assistants 
(NPs and PAs), provide pediatric based care to most children in the United States.  
However, these providers are not always trained in correct inhaler technique or asthma 
education.  In multiple studies, healthcare providers neither teach inhaler technique to 
patients nor know how to teach inhaler technique (Amirav, Goren, Kravitz, & Pawlowski, 
1994; Duerden & Price, 2001; Jones, Holstege, Riekse, White, & Berquist, 1995; Sleath 
et al., 2012 Reznik, Ylie-Rosett, 2014).   
 Since joining the clinic in August 2017, I have had several conversations with 
both providers and nursing staff regarding current asthma care standards.  Currently, the 
nurses and providers teach patients and their families inhaler technique verbally, 
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however, no hands-on demonstration or return method occurs.  Consequently, the clinic 
does not know if patients can properly perform proper inhaler technique.  Therefore, the 
question arises, in pediatric patients with asthma (P), how does the addition of hands-on 
inhaler education (I) compared to only verbal inhaler education (C) affect inhaler 
technique (O1), appropriate utilization of medications (O2), follow up clinic visits for 
exacerbations (O3), ER utilization (O4), school attendance (O4), and parent work 
attendance (O5) over a 3 month period of time? 
Selection of EBP Model and Theoretical Model 
 Clinical scholar model.  Evidenced-based practice melds research, clinical 
practice, and patient preferences into one entity.  The Clinical Scholar Model was 
developed to initiate clinical questions, the spirit of inquiry and to initiate the education 
of healthcare team members in the evidence-based practice process.  A hallmark of the 
Clinical Scholar Model is providing mentorship to others in evidenced-based practice 
(Dang et al., 2015).  The author of the model believed that point of care nurses could both 
perform and utilize research at the patient care level.  Therefore, nurses and other team 
members became part of quality improvement at the unit level.  Not only does the team 
learn how research and evidence-based practice (EBP) evolve together, but also how to 
utilize EBP in the healthcare setting.  With EBP, healthcare teams can move practice 
forwards, rather than remaining stagnant in “how care has always been performed.”  
Sustainability of EBP is a hallmark of the model.  EBP begins with a spirit of inquiry 
then to critiquing and synthesizing the evidence and then placing the evidence into 
clinical practice by applying the evidence into the care setting and evaluating generated 
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outcomes (Dang et al., 2015).  Dissemination of the outcomes to other healthcare 
members and teams is an expected endpoint of the process.   
 The spirit of inquiry is the starting point of an EBP project.  The clinical 
significance of the problem (how to improve inhaler technique and asthma outcomes for 
pediatric patients) is discovered and discussed.  Then, the clinical scholar analyzes the 
available evidence- both external and internal.  The external evidence involves database 
literature search and then a thorough critique and synthesis of the literature.  Internal 
evidence requires a comprehensive review of the clinic’s direct care daily processes: 
chart reviews, quality, and risk analysis, as well as a review from provider/nursing as 
well as patient/family perspectives of the clinical issue.  A written proposal for action is 
created, and if required, internal review board (IRB) permission obtained (Dang et al., 
2015).  Adherence to the EBP process in a scholarly project is both ethically and morally 
necessary.  By adhering to EBP standards, the healthcare provider can make sure that 
patients and families are not harmed by erroneous information, and justice for the patient 
is realized. 
 The Clinical Scholar Model then requires a thorough review of the proposal in 
action as well as outcomes from the EBP project.  Quality measures allow for continuous 
feedback regarding both outcomes and sustainability of the EBP project in the clinic.  
EBP scholarly projects are only ethical to do it they are worth doing; in other words, the 
previous critical appraisal piece is crucial.  If the evidence supports a change in practice, 
it would be ethically negligent to not implement an improved patient care process 
(O’Mathuna, 2015).  Dissemination of the project outcomes then occurs to contribute 
towards improved nursing practice.  Dissemination is also an ethical process.  If the 
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scholarly project has outcomes that will improve patients’ lives, then it is imperative to 
disseminate the information.  Likewise, if the project does not have similar outcomes as 
noted in the evidence or any adverse effects upon patients, then the healthcare world must 
also be notified of these occurrences (O’Mathuna, 2015).  A schematic for the Clinical 
Scholar EBP Model can be found in Figure AA4 in Appendix A. 
 Functional mastery of health ownership model.  The Functional Mastery of 
Health Ownership Model (FMHO) is a new model aiding the advanced practice nurse 
(APRN) to empower the patient and family to own their health.  FMHO consists of 4 
foundational influences: 1- the patient perception of health, 2- self-efficacy, 3- social 
resources, and 4- the personal perception of mastery (Donnelley, 2018).  Wellness is not 
merely the absence of disease, but also involves the holistic self: physical, psychological 
and social wellness (WHO, 2017).  The FMHO also allows for the patient and parents to 
make decisions regarding their care and to gain the responsibility required to achieve 
wellness (Donnelley, 2018).  At each point in the model, supports are present to empower 
the patient to learn how to care for their self.  Thus, the concept of ownership is born.  As 
the patient and parents receive essential tools to aid him/her in health decision, he/she can 
learn responsibility, mastery as well as obtain improved self-image and self-efficacy 
skills; all of which are attributes of ownership of health (Nickels-Nelson, 2018).  Self-
efficacy is the crux of the model; with self-efficacy, the patient or parent has the 
confidence to perform their health care and are physically able to carry the care plan out.  
Quality of life measurement is also crucial.  The model supports using quality of life 
measures that document patient and family beliefs of their quality of life over the past 
two weeks (Donnelley, 2018). 
11 
Ultimately, the patient moves to the final stage of personal perception of mastery- 
how he or she views his or her ability to own one’s health.  This pivotal point leads the 
patient either to or away from a state of wellness.  How the patient views themselves, as 
well as his or her diagnosis and treatment, will either allow for ownership of disease and 
ultimate wellness or hamper the progression towards wellness.  This self-identity 
contributes to the wholeness or holistic view the person holds of self (Karnilowicz, 
2010).   
 FMHO starts by examining the patient’s perception of his or her health.  These 
perceptions, such as symptoms and quality of life measures, provides the foundation of 
how the patient and family regarding disease and its treatment (Laforest et al., 2009).  
The second foundational point in FMHO is self-efficacy.  The patient and family will 
learn responsibility as well as self-management skills to continue in a state of wellness 
with their current diagnosis.  Knowing that he or she can self-manage his or her disease 
allows for self-efficacy to occur.  Social resource utilization is the third step in the model. 
Further education as well as having responsibility for his or her care becomes 
emphasized.  The patient and family learn what resources are available to them for self-
managed care; transportation, social networks, and social programs are just a few 
examples.  Personal perception of mastery is the final checkpoint in the FMHO.  The 
patient and family duo have received all the tools necessary to empower ownership of 
health and wellness.  This empowerment leads to the expected belief that he or she will 
continue to be successful with matters of healthcare.  Persons who believe that they are 
capable of being successful with their health will often have continued engagement with 
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the medical team as well as seek further knowledge about their condition (Laforest et al., 
2009).   
 Empowering patients and families is an expected outcome of the FMHO.  An 
ethical imperative in this model is to empower the patient and to respect their wants and 
needs.  As healthcare providers, the end goal is to improve outcomes.  “The principle of 
empowerment is reinforced by that of social responsibility, and the principle of respect 
should be seen as including respect for true personal autonomy where it does not involve 
harm to others” (Tannahill, 2008, p. 387).  Theory helps to guide healthcare interventions 
and allows for proposed health outcomes to be realized.  As Tannahill (2008) continues 
to note, theory should cover the entire range of ethical principles in healthcare and not 
just the concept of beneficence.   Theory should help guide the evidenced-based process 
in asking the clinical questions and critiquing the evidence to then put into practice.  
Then, theory should help answer the question, what effects would an intervention as 
proposed be likely to have on health (equity) and what reason do we have to believe that 
it would help empower people?” (Tannahill, 2008, p. 388).  Theory helps to guide the 
clinician to examine potential harms in the proposed interventions and allows the 
guidance to steer patients and families away from these harms (Tannahill, 2008).  A 
schematic of FHMO is found in Figure AA5 in Appendix A. 
Systematic Search for Evidence Process and Results 
 CINAHL, PubMed, Psych Info, ScholarWorks, and Virginia Henderson databases 
were utilized to conduct the systematic search of the literature.  MeSh terms and search 
terms comprised in the PICOT question included: pediatric, asthma, inhaler technique, 
nebulizers and vaporizers, school abs*, and emergency room utilization.  Limiting 
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elements for the search included ages five to eighteen, peer-reviewed, and the English 
language.  A yield of 1,334 articles which met the above search criteria was retrieved. 
 Of the above 1,334 articles, 1,304 were excluded.  The exclusions causations 
included: 74 duplicate citations and 1,229 of the articles did not meet project needs and 
outcome goals (inhaler technique, school, emergency room utilization and asthma 
control) or the population (pediatric aged 5-18).  Two articles were located through 
references noted in the keeper studies.  Figure 6 in Appendix A denotes the Literature 
search process. 
 The hierarchy of evidence classifies each article into six categories; from the 
highest levels of evidence to the lowest.  These six categories are level I: systematic 
reviews, level II: Randomized Controlled Trials; Level III: Controlled Cohort Studies; 
Level IV: Uncontrolled Cohort Studies; Level V: Case studies, Qualitative and 
Descriptive Studies, EBP Implementation and QI project; and Level VI: Expert Opinion.  
Utilizing evidence which falls in the higher levels of evidence equates to using 
knowledge which most likely will relate to current day practice and will allow for reliable 
healthcare outcomes in practice (O’Mathuna & Fineout, 2015).  Table AB2 in Appendix 
B shows the hierarchy of evidence.  Once the hierarchy of evidence is noted the critical 
analysis can begin. 
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Chapter 2:  Critical Appraisal of Evidence; Model of EPB & EPIP Plan: Part 1 
Rapid Critical Appraisal 
There are four phases of critical appraisal once the beforementioned literature 
search is completed.  Critical appraisal is required to determine how worthy each study is 
to the clinical question.  Each article is assessed for the following: the level of evidence, 
the study’s validity, the reliability of outcomes and any noted biases; and its applicability 
to practice.  The final step of Critical Appraisal is the evaluation and synthesis of the 
evidence for the project (Fineout-Overholt, Melnyk, Stillwell, & Williamson, 2010). 
Two forms facilitate rapid critical appraisal, the Generalized Appraisal Overview 
(GAO) and the Rapid Critical Appraisal Checklist (RCAC).  The GAO and RCAC 
provide for a streamlined process to review each article for the purpose, data collection, 
outcome measures, validity, the reliability of outcomes, and any noted bias.  The RCAC 
further analyzes how each study could be applied within a practice setting.  After 
completing the GAO and RCAC on each of the studies found in the systematic search, 31 
keeper studies were identified.  A keeper study is a well-performed study that can help 
answer my clinical question (Fineout-Overholt et al., 2010; Fineout-Overholt, 2015). 
 Ethics of critical appraisal.  The primary purpose of performing a critical 
appraisal of the evidence in a scholarly project is to make sure the evidence being utilized 
is valid, reliable, non-biased and applicable to the project at hand; to provide better 
outcomes for patients.  Above all, the number one requirement for healthcare providers is 
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not to cause harm to a patient; emotionally, spiritually or physically.  This concept 
encompasses both beneficence and nonmaleficence with beneficence being the concept of 
bringing goodness to a patient and nonmaleficence being not causing harm to a patient 
(O’Mathuna, 2015).  Thus, it is essential to review all evidence minding these two 
concepts, mainly when working with pediatric and adolescent patients.  These patients 
are not at the age of majority so are not able to make full decisions by themselves.  Their 
parents and guardians put their trust in the healthcare provider.  With the pediatric 
population, not only is the provider caring for the child but also caring for the family unit.  
The provider must consider the entire family’s beliefs and values, not just the patient’s.  
The family expects that the healthcare provider will offer the best care for their child; 
care that will not cause harm to them.  The families trust that the healthcare provider will 
give the child the “latest data and technology” that is available to produce the best 
outcomes (Palmer, 2009). 
 Therefore, as a healthcare provider, it is mandatory that critical analysis of the 
literature and evidence be carried out in the manner described in the previous section.  As 
O’Mathuna noted, if the EBP process is not entirely carried out in all steps, “poorly 
designed research studies and EBP project will waste valuable resources. . . and may lead 
to practice that is neither effective nor beneficent” (O’Mathuna, 2015, p 520).  To not 
partake in the full critical appraisal process would lead to non-ethical practice.  To 
include any research in an evidence-based scholarly project that was poorly performed, 
filled with bias, or had content which could potentially harm a patient would also be 
unethical practice (O’Mathuna, 2015).  Tannahill (2008) also noted that randomized 
controlled studies are not the only studies necessary for an evidenced-based scholarly 
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project.  The scholar must employ the studies that consisted of the best research process 
implemented in the best manner for the situation.  Other forms of research, controlled 
studies, descriptive, quasi-experimental, may provide better information for different 
situations (Tannahill, 2008).  It is therefore imperative for the evidenced-based scholar to 
perform a complete literature search and review of all the available evidence. 
Evaluation 
After critically appraising the evidence, I compiled evidence and synthesis tables 
for this Scholarly Project.  All 31 of the keeper studies (plus one DNP scholarly project 
and one nursing master’s thesis) had an average study time of 3 months.  Four of the 
studies utilized interprofessional and intraprofessional providers during study 
implementation.  All the studies noted with both verbal and hands-on patient inhaler 
education along with a hands-on display of inhaler technique, inhaler technique improved 
as well as asthma control.  The evidence did not show a robust decrease in school or work 
absences or decreased emergency room visits.  The evidence and synthesis tables for this 
scholarly project are found in Appendix B. 
Synthesis 
Patient and provider metered dose inhaler technique.  The mainstay of asthma 
treatment includes the use of inhaled medications through MDIs.  Inhaled medications 
provide increased symptom control with a decrease in residual side effects.  There are 
eight steps required for correct inhaler use: 1- Remove the cap of the inhaler; 2- Shake 
the inhaler and insert into spacer; 3- Exhale breath; 4- Place mouthpiece in mouth and 
close lips around; 5- Press down on inhaler canister once; 6- Inhale slow and deeply and 
hold breath for 10 seconds; 7- Breathe out gently; 8- wait 30 seconds before next 
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dose/puff (Alexander et al., 2016; Bourne, 1996; Deerojanawong, Sakolnakorn, Prapphal, 
Hanrutakorn & Sritippayawan, 2009; Gillette, Rockich-Winston, Kuhn, Flesher & 
Shepherd, 2016; Morin, 2012). 
 Parents, as well as pediatric and adolescent patients, viewed their ability to use an 
inhaler correctly higher than their actual skills (Alexander et al., 2016; Burkhart et al., 
2005; Gillette et al., 2016; Janssen et al., 2003; Kamps et al., 2000).  When patients were 
asked how confident they were in utilizing an MDI, over 75% of the patients stated they 
had complete confidence.  However, both completely confident and not completely 
confident MDI users missed the same amount of inhaler steps, 1.5-1.8 steps, out of 8 
steps (Alexander et al., 2016; Gillette et al., 2016).  Rates from 12-92% of patients 
misusing their inhalers were recorded in the studies both in and out of the United States 
(Alexander et al., 2016; Burkhart et al., 2005; Chen et al., 2002; Deerojanawong et al., 
2009; Duerden & Price, 2001; Foland et al., 2002; Gillette et al., 2016; Janssen et al., 
2003; Kamps et al., 2000; Levy et al., 2013; Minai, Martin, & Cohn, 2004; Manriquez et 
al., 2015; Sleath et al., 2012; Walia et al., 2006; Zivkovic, Radic, Cerovic, & 
Vukasinovic, 2008).  The inhaler technique steps most often missed include removing the 
cap from the inhaler, shaking the inhaler, exhaling prior to actuation of the device, 
placing the inhaler in the mouth between the lips, inhaling and holding breath for 10 
seconds, and waiting 30 seconds before next dose (Bourne, 1996; Burkhart et al., 2005; 
Capanoglu et al., 2015; Carpenter et al., 2015; Chen et al., 2002; Deerojanawong et al., 
2009; Foland et al., 2002; Gillette et al., 2016; Kamps et al., 2000; Janssen et al., 2003; 
Manriquez et al., 2015; Morin, 2012; Pedersen et al., 2010; Reznik et al., 2014; Sleath et 
al., 2012; Turkeli, Yilmaz, & Yuksel, 2016; Walia et al., 2006). 
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 Healthcare providers also do not know how to properly use an inhaler (Duerden & 
Price, 2001; Jones et al., 1995; Reznik et al., 2014; Sleath et al., 2012).  The most 
recently published national asthma guidelines (2007) also have recommendations for 
providers to demonstrate correct MDI technique to asthmatic children at all clinic visits 
(Expert Panel Report 3, 2007).   Resident physicians with presumed knowledge of inhaler 
technique performed 3.7 correct inhaler steps (Amirav et al., 1994).  Only 15% of nurses 
and 28% of physicians could accurately show a patient how to use the MDI device 
(Duerden et al., 2001).  A train the trainer approach has been recommended in the 
literature.  Various means of healthcare provider education has been suggested, including 
one-one sessions, webinar, video, and classroom-based methods.  Even a single one-on-
one inhaler technique session can improve a healthcare provider’s inhaler technique 
knowledge (Price et al., 2012).   
 MDI technique education.  Educational programs have been shown to improve 
inhaler technique (Alexander et al., 2016; Amirav et al.; 1995; Bourne 1996; Burkhart et 
al., 2005; Capanoglu et al., 2015; Deerojanawong et al., 2009; Expert Report Panel 3, 
2007; Foland et al., 2002; Gillette et al., 2016; Janssen et al., 2003; Kamps et al., 2000; 
Levy et al., 2013; Minai et al., 2004; Morin, 2012; Sleath et al., 2012; Zivkovic et al., 
2008).  Evidence has shown verbal training alone does not elicit the same outcomes as 
verbal and hands-on MDI training with return demonstration.  By utilizing verbal and 
hands-on education with patient demonstration, improved inhaler technique occurs 
(Alexander et al., 2016; Amriav et al., 1995; Bourne, 1996; Burkhart et al., 2005; Foland 
et al., 2002; Gillette et al., 2016; Janssen et al., 2003; Kamps et al., 2000; Levy et al., 
2013; Minai et al., 2005; Morin, 2012; Munzenberger et al., 2007; Pedersen et al., 2010; 
18 
Sleath et al., 2012; Walia et al., 2006; Zivkovic et al., 2008).  Pediatric inhaler technique 
scores increased 1.1 to 3.9 steps patients after verbal and hands-on education with return 
demonstration inhaler technique training (Carpenter et al., 2015, Carpenter et al., 2016, 
Gillette et al., 2016; Morin, 2012; Turkeli et al., 2016).  Over time, the correct inhaler 
technique decreases due to lack of education and reinforcement of technique.  With 
correct inhaler technique at one visit, can eventually begin to have an incorrect technique 
in the future; therefore, it is imperative to continue with technique training at each visit 
(Manriquez et al., 2015; Pedersen et al., 2010).  Capanoglu et al. (2007), Munzenberger 
et al. (2007), and Kamps et al. (2000) noted patients retained the correct inhaler technique 
after three hands-on and verbal inhaler technique educational sessions.  In 2007, younger 
and older children’s inhaler technique were evaluated 2-3 months after one intensive 
inhaler education program.  60% of the children had decreased inhaler technique 
measurements after those months (Jones et al., 1995).  Therefore, the evidence states 
inhaler technique training is to be performed at every patient encounter. 
Only 60% of primary care pediatric providers performed any asthma medication 
education during visits.  Training regarding daily management, including an explanation 
of asthma action plans, occurred only 20% of the time.  The pediatric patients were only 
addressed and asked about their thoughts regarding asthma diagnosis and treatment 6% of 
the time (Sleath et al., 2012).  Chen et al. (2002) noted families only sought asthma care 
services in the event of an exacerbation.  Otherwise, asthma care is not administered 
routinely in the primary care office.  The evidenced-based guidelines for asthma care 
suggest asthma follow up in the office every six months (Expert Panel Report, 2007).  
Without receiving routine asthmatic care, approximately 22% of patient in one study had 
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4 or more asthma exacerbations, 40% of children missed school (Chen et al., 2002).  
Barriers to provider MDI education include lack of time during appointments, patients 
not bringing MDIs to appointments, sample MDIs not available in the clinic, providers 
themselves not knowing inhaler technique or how to assess on the checklist, and 
patient/family disinterest (Chen et al., 2002; Reznik et al., 2013).   
Verbal and hands-on MDI education interventions were studied from a minimum 
of one month to a maximum of three years.  Most of these studies were conducted up to 
three months.  Only three studies continued evaluations after their trials.  These studies 
included Minai et al. (2004) (continuation of Foland et al. (2002) study); Walia et al. 
(2006) (re-measurement in 3 months); and Levy et al. (2013) (3-year chart review).   
Outcome measures utilized.  Inhaler technique and asthma control outcome 
measurement tools were also utilized in the evidence.  These outcome measures included 
the asthma control test (ACT) (Carpenter et al., 2015; Carpenter et al., 2016; Expert Panel 
Review 3, 2007; Sleath et al., 2012): Quality of Life questionnaire (QOL) (Expert Panel 
Review 3, 2007); spirometry (Expert Panel Review 3, 2007; Foland et al., 2002; Levy et 
al., 2013; Minai et al., 2004; Zivkovic et al., 2008); Ashtma Action Plan (AAP); 
(Carpenter et al., 2015; Carpenter et al., 2016; Expert Panel Review 3, 2007; Foland et 
al., 2002; Minai et al., 2004; Rodriguez-Martinez et al., 2017); inhaler technique checklist 
(Alexander et al., 2016; Burkhart et al., 2005; Carpenter et al. 2015; Carpenter et al., 
2016; DeGroot et al., 2015; Expert Panel 3, 2007; Foland et al., 2002; Janssen et al., 
2003; Kamps et al., 2002; Levy et al., 2013; Minai et al., 2004; Rodriguez-Martinez et 
al., 2017; Sleath et al., 2012; Walia et al., 2006; Zivkovic et al., 2008). 
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The ACT and QOL assessment are both validated patient completed 
questionnaires for the pediatric and adolescent age group.  The ACT was developed for 
children as young as age 4.  A score of less than 19 on the ACT indicates decreased 
asthma control over the past month.  The ACT is comprised of 4 sections: 1-child 
response to questions regarding asthma control; 2-activity limitations; 3- nighttime 
symptoms of asthma; and 4- parental perceptions of daytime and nighttime symptoms 
(Deschildre et al., 2014).  With improved inhaler technique, the ACT measurement 
increased from 18.6 to 20.3 (Carpenter et al., 2016).  
 The pediatric QOL questionnaire contains 28 patient answered questions.  These 
questions measure the patient’s beliefs towards how asthma has affected their lives over 
the past week.  Questions include how “bothered” their lives are due to asthma as well as 
how “often” asthma symptoms occur over the past week.  The questionnaire further 
measures how asthma has emotionally affected the children over the past week.  The 
QOL questionnaire was developed for specific age groups: 4-7 years; 8-11 years; and 12-
16 years (Everhart, Smyth, Santuzzi, & Fiese, 2010).  The FMHO model is based upon 
self-efficacy; and measurement of quality of life scores over a two-week time frame is 
vital (Donnelley, 2018).   
 The inhaler use checklist allows for an objective evaluation measurement of 
inhaler technique by any provider.  This checklist is the only validated tool available for 
these purposes (Boccuti, Celano, Geller, & Philips, 1996).  The checklist is comprised of 
8 scoring areas.  All areas receive either a score of 0 or 1; with 0 being not performed 
correctly and one being scored correctly (Boccuti et al., 1996).  Spirometry also is an 
objective measurement metric to measure asthma control.  However, FEV1 measurement 
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did not change with improved inhaler technique.  The authors commented since the study 
was only conducted for one-month FEV1 measurement could improve with a longer 
intervention time (Minai et al., 2004).   
 Improved asthma outcomes.  With improved inhaler technique, an improvement 
in asthma knowledge, control, and self-efficacy occur (Alexander et al., 2016; Burkhart et 
al., 2005; Carpenter et al., 2015; Carpenter et al., 2016; DeGroot et al., 2015; Foland et 
al., 2002; Gillette et al., 2016; Janssen et al., 2003; Kamps et al., 2002; Levy et al., 2013; 
Minai et al., 2004; Sleath et al., 2012; Walia et al., 2006; Zivkovic et al., 2008).  Faulty 
inhaler technique correlates with reduced asthma control.  With education, improvement 
in both inhaler technique and asthma control occur (Levy et al., 2013).  Parental and 
patient asthma knowledge increases as asthma control increases.  Compliance with 
asthma care and self-efficacy improve.  Fear of asthma decreases, allowing the patient to 
have improved quality of life (Carpenter et al., 2015; Zivkovic et al., 2008).   
  Improved asthma control also led to decreased missed school days, and parental 
lost productivity days.  Adolescents with controlled asthma reported less missed days of 
school (3.5% controlled asthma vs. 34% uncontrolled asthma missing class) as well as 
decreased tardiness from school or having to leave early due to asthma exacerbations 
(1.8% controlled vs. 28% uncontrolled).  School children also reported an increased 
ability to concentrate in school with improved asthma control.  Parents of children with 
uncontrolled asthma reported increased work absences due to asthma exacerbations 




 Through the review of the composed evidence and synthesis tables; improved 
MDI technique is positively correlated to both verbal and hands-on education in the 
healthcare office.  As seen in the evidence, most patients and families deem their inhaler 
technique is correct.  However, upon MDI technique evaluation, only 25-58% of patients 
had correct MDI technique.  Since inhaled medications act upon the small pulmonary 
airways in the lungs, correct inhaler technique is mandatory for effective asthma control 
and exacerbation relief to occur.  If the patient only receives verbal training, the 
percentages of improved MDI technique are less than those patients who received both 
verbal and hands-on inhaler technique training.  Therefore, for correct MDI inhaler 
technique, both verbal and hands-on training with re-demonstration is required at every 
encounter.  To ensure patient education is performed, it will be a requirement for the 
practice to have an audit system in place to monitor IT teaching and recording. 
Healthcare providers do not automatically know how to use an MDI correctly.  
Providers must also receive inhaler teaching.  In the evidence, providers were not able to 
provide correct inhaler education to patients without first being taught themselves.  
Guidelines recommend that all asthmatic patients received MDI technique education at 
every asthma visit.  As shown in the evidence, only 20% of providers and nurses perform 
MDI technique education. 
 Improved asthma outcomes do not only involve correct MDI technique.  Evidence 
has shown with improved MDI technique there is a correlation between increased asthma 
knowledge and asthma control.  Evidence has also shown with improved asthma control 
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and knowledge; medication compliance increases as well.  Patients can have a decreased 
fear of asthma and have an increase in self-efficacy. 
The cycle of emergent asthma care must be broken to improve asthma outcomes.  
Any acute care asthma visit (office or ER) is equivalent to treatment failure.  This failure 
is accountable to not following self-management care; such as non-adherence to daily 
medications as well as not adhering to treatment schedules such as having (or not having) 
a written asthma plan and maintaining regular asthma chronic care visits in the office.  
After these acute visits, patients and families often discontinue chronic medications or do 
not fill ordered prescriptions.  As well, primary care chronic management continues to 
not take place (Ducharme et al., 2010).  Therefore, primary care offices must help 
patients and families take ownership of their chronic asthmatic care. 
Objective validated outcome metrics are available and have been utilized to aid 
with MDI technique measurement.  The inhaler use checklist allows for all providers to 
have one validated metric to streamline the evaluation process and allow for similarity in 
the testing of MDI technique.  The ACT and pediatric QOL, enable the patients to be 
evaluated with the same measure of metrics.  Patient and family can be part of the 
asthmatic care plan.  The AAP provides for the patient and family to have a roadmap of 
asthma management at home. 
 Improved MDI technique in the pediatric and adolescent patients require new 
processes for education and must be put into practice.  All healthcare providers in the 
office will first have their own MDI technique evaluated followed by verbal and hands-
on training for any steps that were incorrect.  The providers must be given educational 
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sessions regarding how to evaluate and educate patients and families on how to correctly 
use an MDI.   
 At every office visit encounter, asthmatic patients must have their MDI technique 
evaluated and receive verbal and hands-on education.  Asthma control is to be evaluated 
to aid the patient and family.  Inhaler technique must be evaluated using the inhaler 
technique checklist and ongoing asthma control measured by the ACT and QOL scales.  
The AAP must be updated at least every six months and as needed to allow for 
individualized care planning to reduce asthma exacerbations.  
EPIP operationalized through EBP Model and Theoretical Model 
 The Clinical Scholar Model was chosen for this Scholarly Project since the clinic 
staff had never had an EBP project initiated in the office.  I had to both teach all staff and 
providers the EBP methods as well as mentor the staff throughout the project.  This 
model allows the team to view the forward movement required in each step of the 
evidence-based process.  As well, since the staff was new to both the EBP method as well 
as an EBP project, mentorship would be required.  Thus, the Clinical Scholar Model was 
chosen.  A schematic for the model in practice is noted in Figure AA7 of Appendix A.   
“The FMHO allows for seamless care with the [child] who has asthma.  The 
wellness aspect of the FMHO is vital in that it allows the [child and family] to 
function in a world of wellness rather than a world of illness with asthma.  By 
focusing upon ownership of health rather than a state of illness, the [child and 
family] learn how to gain responsibility for their care.  The family learns how to 
own their asthma, meaning, they learn how to utilize the tools given to them by 
the health care team to appropriately care for their asthma symptoms.  The [child 
and family] learn how to be responsible for asthmatic care, by taking prescribed 
medications, learning their asthma triggers, and utilizing the beforementioned 
tools.  Mastery of their illness is obtained, and the [child] and family have the 
keys to own their health and live in a state of wellness” (Nickels-Nelson, 2018). 
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 Figure AA8 in Appendix A is the schematic for the operationalized FMHO 
theory in this project.   
Fully Operationalized Project Plan/Logic Model 
 A logic model was essential to planning and implementation of this Scholarly 
Project.  Logic models are project planning tools that define the assumptions, inputs, 
outputs, and outcomes of a project.  The logic model allows one to examine what 
thoughts led to the program design and desired outcomes.  Assumptions allow for the 
initial thoughts of what will occur throughout the implementation process.  Key inputs, 
such as resources of time, people, finances, and supplies are also planned into the project.  
Barriers and facilitators can also be quickly noted.  If the barriers appear to be too 
powerful to overcome, the new plans can be placed into motion so full implementation 
will not become a failure.  Planned outcomes from short term to long term is noted as 
well.  Outcomes, then, are the endpoint of the logic model.  A figure of the logic model is 




Table 2A: Operationalized P0lan of DNP Scholarly Project 
Assumptions for DNP Scholarly Project 
Staff will learn how to utilize, teach 
and train inhaler technique 
Patients will learn inhaler technique 
Decreased utilization of healthcare 
resources due to decreased asthma 
exacerbations 
Decreased school absenteeism  
Improved quality of life Patients will have improved asthma 
control 
Resources & Inputs 
People: 
• CHP-BPA nursing 
• CHP-BPA medical assistants 
• CHP-BPA providers 





• Financial Funding Request 
• Organizational support from 
CHP senior management 
Activities 
Patients will receive the following care at asthma visits: 
• Written, verbal & hands-on inhaler training from nursing 
• Validated tool assessments of asthma control and quality of life 
Outputs and Outcomes:  With the above activities the patient will have: 
• Improved inhaler technique 
• Improved quality of life 
• Decreased school absenteeism 
Impact 
• Improved state of health and ownership of health 
• Decreased health care costs 
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Chapter 3: Project Design and Methodology 
Project Design and Methodology Overview 
Setting/description of clinic.  Pediatrician Dr. Thomas Whitfield started 
Children’s Health Program in 1975 to provide both pediatric office and mobile care.  He 
noted several children presenting for kindergarten physicals yet had never been seen 
otherwise since early infanthood.  These children not only were lacking immunizations 
but also social skills.  Several children had unrecognized illnesses and developmental 
delays.  After 25 years of pediatric services, Children’s Health Program applied for 
designation to become a federally qualified health center (FQHC) due to Berkshire 
County’s need for improved health care in the adult community.  Community Health 
Programs (CHP) was born.  The stated mission of the CHP is to, “measurably improve 
the health of Berkshire County, Massachusetts” with a vision that “Berkshire County’s 
population will be the healthiest in Massachusetts” (Community Health Program, 2017). 
 In 2018, the FQHC now operated as one practice with ten locations; including 
internal and family medicine, obstetrical/gynecology care, pediatric medicine, and dental 
care.  After a recent Uniform Data System (UDS) review, 1 out of every 5 Berkshire 
County persons receives care at the FQHC. 
 Project design and methodology overview.  As was discussed in Chapter 2, this 
DNP scholarly project was fully developed upon the evidence-based process.  A full 
review of the literature along with a synthesis of the evidence allowed for the creation of 
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this asthma project.  All clinical members of CHP-BPA were involved in the project.  
These members included the medical assistants, nurses (both licensed practical nurses 
(LPN) and registered nurses (RN), and providers (nurse practitioners and physicians).  
The project director (PD) was Gina Nickels-Nelson. 
 The methodology for this project included hands-on along with verbal inhaler 
technique training at every asthmatic patient visit to the office.  Inhaler technique scores 
were obtained before any education being given and then recorded again post education.  
At each care visit, the patient and family also completed the asthma control test and 
quality of life questionnaires.  Each patient also was to receive a completed asthma action 
plan at each visit.  The implementation time for this project was three months, July-
October of 2018. 
Fully Operationalized Project 
 The inhaler technique education project was conducted at CHP-BPA from July 
through October 2018.  The project included both a pre-implementation phase and an 
implementation phase. 
 Pre-implementation phase.  During the pre-implementation phase, the staff at 
CHP-BPA received education regarding EBP.  As well, the project outline, expectations, 
and outcomes were discussed at length.  Since the basis of the project was inhaler 
technique, the expertise of a respiratory therapist was sought.  The head of the RT 
department at BMC was contacted, and I met with her along with our head nurse to 
discuss how to both use and teach inhaler technique.  This expertise was then brought 
back to the office, and all nursing staff had their inhaler technique evaluated.  The 
nursing staff learned how to teach and evaluate inhaler technique. 
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 As well, during the pre-implementation phase of the project, all tools were 
acquired for project implementation and completion.  These tools included: 
• Inhaler technique checklist 
• Emergency room/urgent care utilization questionnaire 
• Patient/Family reported school/work absenteeism questionnaire 
• Asthma Control Test (ACT) 
• Pediatric/Caregiver Quality of Life Questionnaire (QOL) 
• Asthma Action Plan (AAP) 
CHP also developed an introductory letter describing the new asthma program to 
families.  A take-home inhaler technique letter was also acquired from an online 
source that allowed for copying to occur. 
 Implementation phase.  All clinical staff of CHP-BPA was active within the 
project during the time of implementation.  At the onset of each day, the medical assistant 
was to evaluate their provider’s schedule and locate any patient aged five and older with 
an active diagnosis of asthma.  These patients were also to have had an MDI ordered as 
well.  Once located, the asthma packet (as described above) was given to the patient to be 
completed.  While the provider was with the patient, asthma control was to be assessed 
with the ACT and QOL forms; along with exam completion.  The provider would then 
complete the AAP.  The AAP is a written plan of care outlining asthma self-care 
measures and step-up treatments required for worsening symptoms.  The form is depicted 
as a traffic stop light: Green: no symptoms (daily actions needed); Yellow: start of 
symptoms or cold/allergy symptoms (daily actions plus new controller or rescue 
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medications and call to provider office); and Red: emergency care needed (daily actions 
plus emergency actions and immediate patient care required) (Booth, 2012). 
 Finally, the patient’s inhaler technique was evaluated.  With the use of a placebo 
inhaler and spacer in the office, the patient demonstrated their technique.  The total 
number of correct technique steps was noted on the inhaler technique checklist.  Then, 
the patient was given both verbal and hands-on education.  After this education, the 
patient again demonstrated their technique.  The total number of scores was noted again 
on the inhaler technique checklist.   
 The full implementation process and progress markers are found in tables AC1-2 
in Appendix C. 
Process indicators with lessons learned, barriers and solutions 
Stakeholders.  Determining stakeholders in any implementation project is key to 
project success.  Stakeholders can hold active as well as passive rolls and can be both 
facilitators as well as barriers to the implementation process.  All patients aged five and 
older with asthma had the opportunity to participate in this scholarly project.  If the 
patient was only on nebulized medications, then they were excluded since a nebulizer is a 
different form of medication delivery. 
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Table 3A: Stakeholder Analysis 
ACTIVE STAKEHOLDERS PASSIVE STAKEHOLDERS 
Pediatricians (6) Back office staff (3) 
Nurse Practitioners (3) Billing (1) 
Physician Assistant (1) Senior Management CHP (5) 
Registered Nurses (5) Senior management CHP (5) 
LPN (1) Practice Administrator CHP BPA (1) 
Medical Assistants (8)  
Front Desk (8)  
Senior management CHP (5)  
Dr. Lamm, CMO (1)  
Practice Administrator CHP BPA (1)  
Patients and Families  
  
Data collection.  Data collection, record keeping, and management were also 
essential components of the implementation plan and had to be planned before the project 
began.  With the recent merger to CHP, CHP-BPA had started to use a new electronic 
medical record (EMR). Unfortunately, the EMR was not capable of reporting vital 
information for many quality measures.  Thus, most of the data keeping was required to 
be kept in a binder as well as monitored through a quality improvement database, 
Azarahealthcare.   
Data collection during the implementation period was vital for both patient 
privacy as well as implementation success.  Each paper record was sent back to PD desk 
for evaluation.  Patients received a patient number that was devoid of any identifying 
data, such as name or social security number.  A master list linking the patient number 
and identifying patient information was kept in a locked drawer in the PD office.  In this 
manner, the evaluation of the implementation process was continued without sacrificing 
any HIPPA or privacy matters.  The Excel file was kept on PD’s personal computer 
devoid of any identifying information as mentioned above.  This personal computer 
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requires three personal identification markers to log in.  After all, forms were inputted 
into Excel; the forms were placed into HIPPA bins and taken for shredding per CHP 
policy. 
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Budgetary planning.  Since the office was utilizing all the current staff for this 
project, new staff acquisition was not a requirement.  As well, the clinic did not need to 
acquire any new office equipment.  The office already had computers, copy, fax, and 
label maker machines.  All providers had their stethoscopes and watches for assessments.   
 New costs that were needed to be considered for this project included the time for 
nursing staff in performing MDI technique education as well as this writer’s time in 
implementing the project as well as metric evaluation.  All employees of the office were 
already receiving their respective salaries.  There were not any new monies released for 
salary with this proposal; however, hours spent on each employee on the project were 
tabulated. These costs included medical assistant, nursing and provider care and time 
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with patients and families.  Dr. Lamm graciously extended 500 dollars towards the 
purchase of aerochambers for this project. 
 The MAs also had a planned 30-minute meeting with PD discussing their 
requirements for the asthma EPIP project.  MA time with patients was consistent with the 
delivering of asthma patient forms to both patients and PD.  A medical assistant’s salary 
is $15 per hour and the expected time per patient was 5 minutes. 
Nursing (licensed practical nurse (LPN) and registered nurse (RN)) also had 
meetings with PD to discuss their role in the Asthma project.  The evidenced-based 
process was also discussed.  Nursing also had a 30-minute session with PD measuring 
their inhaler technique and how to teach inhaler technique to patients and score the 
inhaler use checklist.  Each month, nursing and PD met to discuss the project and 
brainstorm any changes that were required.  Nursing spent on average ten minutes with 
each patient during an asthma visit to teach, measure and record patients inhaler use.  
Nursing salary is $30 per hour. 
Nurse Practitioners, Physician Assistant, and Physicians (MD/DOs) also had an 
initial meeting with PD to discuss the project and their roles for the Asthma project.  The 
evidenced-based process was also discussed to differentiate the EBP process from 
research.  The providers also had a planned 30-minute session with PD measuring their 
inhaler technique and how to teach inhaler technique to patients and score the inhaler use 
checklist; however, none of the providers except PD performed this task.  Therefore, this 
amount was not recorded in the budget.  Review of the ACT, QOL, and AAP was to be 
discussed.  Each month the providers and PD were to have a 30-minute meeting to 
discuss the project and brainstorm any changes that were to be required.  The providers 
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stated that time was a barrier for these meetings, so very brief 5-10-minute status update 
meetings occurred.  Providers had visits in length from 20-40 minutes depending on visit 
type (sick visit, prolonged sick visit or well care) in which asthma control was 
established, treatment plans were discussed with families, and the use of inhalers was 
encouraged.  PDs time for all data collection and analysis was also tallied; however, not 
paid out for this project.  Average Nurse Practitioner salary is $43 per hour, and the 
average MD salary is $85 per hour. 
Office supplies, such as paper, needed to be factored into the budget.  These paper 
supplies were vital since the EMR did not allow for the retrieval of metrics.   
 A projected budget expense of $16,156 was projected.  Once the full project was 
completed the real budget was decreased.  The actual budget spent on this project was 
$10.065.58.  Below is a table of the budget. 
  
36 
Table 3C: Actualized Budget for DNP Scholarly Project 
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MD $85/hour Training time with PD 
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meeting 
60 minutes 
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5) 
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  76.25 
Pens Filling out packet 
forms (patients) 
 $5.00 
Aerochambers 2 for placebo inhalers; 
remainder for patients 
not able to pay copay 
for spacer 
 $500.00 
Total   $659.78 
Grand Total   $10,065.60 
 
Revenue generation.  Patient billing revenue was performed for every aspect of 
the asthma inhaler technique program.  Billing was generated immediately with each 
patient encounter.  Since CHP-BPA is a federally qualified health center, all providers 
(both MD and NP) can bill at 100%.  The three main commercial health insurance 
companies seen at CHP-BPA were Blue Cross Massachusetts, Health New England, and 
Aetna.   
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On March 1, 2018, Massachusetts Medicaid formed Accountable Care 
Organizations (ACO) in Massachusetts.  These ACOs are arranged by county.  Each 
provider office in Massachusetts was given a choice to either join the ACO or not.  By 
joining the ACO, the payment structure changed from one of volume payment (payment 
per patient) to one of performance payment (payment for performance).  Thus, each 
enrollee’s visit is reimbursed at the same amount, regardless of medical complexity.  At 
the end of each year performance markers, such as asthma care outcomes, are monitored 
and evaluated.  Incentives are then given to high performing offices. 
Budget justification.  With the intended project outcomes, children would have 
fewer asthma exacerbations.  With fewer exacerbations, the clinic would be able to see 
other patients for urgent visits.  Thus, further revenue would be generated, and decreased 
use of urgent care and emergency room facilities may be realized.  With Berkshire county 
not having a pediatric tertiary hospital with PICU services, costs savings would also be 
evident through fever ground/air ambulance transports.  In the office, with this project, 
CHP-BPA would be able to justifiably bill at least a 99214 or 99215 based on asthma 
severity scoring, quality of life monitoring, inhaler technique teaching and patient visit.  
With the commercial insurers upcoding could realize: 
• From a 99213 to a 99214: increased reimbursement $37 
• From a 99214 to a 99215: increased reimbursement of $45 
• From a 99213 to a 99215: increased reimbursement of $81 
This return on investment (ROI) in asthma education could actualize a 5-14-dollar 
ROI per asthma education dollar spent (Berkshire Health Systems, 2015).  At the onset of 
the project, I sent each provider and nurse billing data that could be billed since enhanced 
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asthma teaching was being documented during visits.  These codes included MDI 
technique teaching (94664) as well as codes for patient questionnaires (ACT and QOL) 
(96160). 
An audit of billing was performed of the 119 project patients.  All the providers 
participating in the program submitted superbills after each patient visit.  These 119 
patients had a combined total of $16,034 gross billable income.  Several missed 
opportunities in billing were realized, including not capturing the modifier 25 coding 
with a well visit for asthma education as well as inhaler technique education coding.  A 
gross total of $19,983 could have been realized if these two billing measures were 
captured.  Finally, these 119 patients had a collective amount of other missed billing 
opportunities; they were seen for subsequent visits but did not have any asthma teaching 
or evaluation performed.  If they had received this evaluation, then another $3,074 could 
have been realized in gross billing.  A total of $7,023 missed revenue was realized. 
 Separate from billable income, as CHP-BPA implements improved asthma care 
with metrics in daily practice, reportable measures will now be captured within Athena 
EMR as well as Azarahealthcare.  CHP can then report these measured metrics to 
national quality programs, such as UDS and HRSA.  With these reportable metrics and an 
assumed improvement in asthma care and outcomes within the practice, CHP-BPA will 
collect increased revenue with quality measures.  As stated earlier, the ACO payment 
structure is now one of performance rather than volume-based payment.  Thus, with 
decreased ER utilization, hospitalization, improved medication compliance, and asthma 
severity, incentive payments would be available to CHP-BPA.  Since the ACO has just 
initiated in early 2018, these incentive payment structures are not yet available. 
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Lessons learned and barriers.  At the onset of the proposed program at CHP-
BPA, I had obtained buy-in from all clinical personnel at the office, except our lead 
physician.  As I look back upon the pre-implementation phase of this project, I spent too 
much time with our lead physician; attempting to win his favor for the project.  Instead, I 
should have focused more efforts upon the rest of the staff.  Ultimately, when it came 
time to implement; the entire team stated an initial refusal to move forward.  Even though 
all portions of the project had been discussed with each level of provider; all noted no 
recollection of having a role to play in the project.  I, therefore spent an extra week 
speaking with each member of the team individually.  After having discussions with 
individuals, the nursing staff became champions for this program.  A few of the MAs 
voluntarily participated in the program, but for most of the program I needed to give daily 
reminders to the staff.    
Change was another barrier to this project.  Before my arrival at the clinic last 
year; 3 MDs and 1 NP had retired.  The clinic, also facing financial difficulties, decided 
to merge with CHP.  This merger itself caused change.  I also created change when I 
arrived at the clinic; just by being a new provider to the practice.  As well, I arrived as a 
CHP NP, rather than a BPA NP.  This, along with my collaboration with the CMO as my 
industry mentor, has created an “us vs. them” work environment at times.   
The medical assistants and nurses also determine the flow of the days and what 
actions would and would not occur with the patient population.  On more than one 
occasion, one of the nurses interrupted a patient visit to tell me the nurses would not be 
performing any asthma care that day.  The MAs also carry this same power.  Many of the 
MAs would not locate their provider’s asthma patients for the day or initiate any asthma 
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packets for the program.  By not locating their patients, I was then required to spend my 
own time searching for upcoming asthmatic visits and preparing packets.  Since patients 
are scheduled as same-day visit, many of these patients were missed. 
The day before the start of my implementation; our practice manager announced 
her resignation.  This resignation also created continued change in the clinic.  After her 
departure was announced, the clinic had resignations of three front and back office 
personnel (medical records, billing, and reception) as well as one LPN.   
With our change to CHP, all patients are required to fill out both a two-page 
health history form as well as a ten-page patient registration form.  This form is only 
needed to be filled out once; however, we are still having patients arriving for care who 
have not been seen for over a year or who are new patients to the practice.  As well, at 
every annual physical, each child and teen must fill out a developmental or depression 
screening tool.  Before the asthma program, families were already upset with the amount 
of paperwork.  With the asthma program, patients were now given an additional six pages 
of forms to fill out.  Some families expressed extreme displeasure.  One father accused 
me of “killing a forest.”  I had one occasion where I walked into an exam room as an MA 
was telling the mother, “yeah, it is ridiculous how much she is expecting you to do for 
this.” 
Our current EMR is not adequate to perform EBP care for our patients.  At no 
time has a reporting module been present to allow for the chart review process to occur.  I 
am not able to obtain a list of patients fitting the demographic criteria for this project.  All 
data had to be searched for retrospectively, and hand entered into excel.  This process 
was very long and tedious.  With the EMR not being able to perform a simple search, 
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each day I must hand search for asthmatic patients fitting the criteria for the project.  The 
expectation at the onset of the project was for MAs and nurses to also watch the 
schedules and locate any newly added patients to the daily schedules fitting the criteria.  
However, this did not occur during the project.  Thus, a great many of missed 
opportunities occurred.  If the EMR had best care practices (i.e., IT protocol, ACT, AAP 
locaters) then possibly the staff may have noted these patients required the IT program.  
The current EMR does currently have a quality measure area and asthma control, and 
AAP is drop downs on this list.  However, this feature is not routinely utilized in the 
clinic. 
I had also planned on utilizing the Azarahealthcare database to help with patient 
location as well as asthma measures.  However, this database is only useful if the patient 
already has a diagnosis of asthma listed in their problem list.  The clinic had transitioned 
from one EMR system to another in 2017.  Patient charts are still not fully loaded with 
past or current histories.  Therefore, the database did not prove to be useful.  As well, 
several patients either had a resolved history of asthma (but the diagnosis was still present 
on their dashboard) or never had the diagnosis placed as active.   
The final barrier to this project was time.  In our current scheduling system, all 
MDs and one NP (myself) have 20 minutes to conduct a well-child physical; 30 minutes 
for a teenage physical.  The other NPs and PA have 30-40 minutes per well exam and 20-
30 minutes for sick care.  This allotted time does not allow for in-depth discussion of 
asthma; or for any other physical, mental or social care needs.  Therefore, most of the 
providers declined to participate fully in the program.  None of the physician providers 
would let the quality of life questionnaires be utilized for their patients.  Reasonings 
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included: “not supported by the AAP” (American Academy of Pediatrics);” too much 
patient paperwork” as well as “time.”  
The success of the program was the realization that our patient population does 
not know how to use an inhaler.  This success equates to this; we have much to do in the 
realm of education and care of our patients at CHP-BPA.  Now we have a roadmap to 
follow to lead to this success.  Another success occurred after implementation had 
finished.  Clinic staff were apprised of the results from this program.  The providers are 
now willing to move forward with an asthma medical home.  Two MAs routinely come 
to me now for the asthma packet when I have an asthmatic patient in the office.  Our 
patients also were provided spacers during the program.  Many patients had never had a 
spacer; or where not able to have two spacers (one for home and one for school).  Upon 
learning how to use their inhaler, they learned of the importance for the spacers. 
 Solutions.  Before initiating any new programs at CHP-BPA, I now know that I 
need to include the buy-in of every person in the clinic, and not to only focus on the lead 
physician.  I have learned of the power that is held by both the MAs and the nurses; thus, 
I need to have their input and buy-in before moving forward with any new initiative.   
 This past fall, CHP-BPA acquired a new practice manager.  He had already been a 
practice manager at a sister site within CHP.  Thus, he is knowledgeable of both business 
and personnel flows within the agency.  He is also very interested in hearing about this 
new asthma program and how the program can both positively affect our patients as well 
as the office financially. 
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 All of CHP is transitioning to another EMR in July 2019.  Even though this will 
be yet another change, I do feel that this EMR will be far superior to our current program.  
The new EMR will have built-in reporting capabilities.  Best practices are also a part of 
the program.  I am hopeful that the superior EMR will be a benefit to our asthmatic 
patients shortly.  We also will not need to rely upon the Azarahealthcare database once 
this EMR is in place. 
 Finally, one of the most significant barriers to this project was time itself.  After 
reviewing the outcomes of the project with the providers, all the providers are on board 
for improving asthmatic health care in our office.  We are moving forward to expand care 
in an asthma medical home environment.  Thus, we will have dedicated time every 
quarter to meet with our asthmatic patients. 
Evaluation of EBP model, theoretical model and logic model function within EPIP 
 All three models (Clinical Scholar EBP, Functional Mastery of Health Ownership 
and the Logic Model) were instrumental in the development, implementation, and 
evaluation of this DNP Scholarly Project. 
 The Clinical Scholar model allowed for the seamless implementation of the 
evidence-based process to become embedded in this project.  The reason for this choice 
was the mentorship piece of the model.  Before this project, CHP-BPA had not had an 
EBP quality improvement project take place.  While the providers were knowledgeable 
of EBP, the medical assistants and nurses were not.  Through mentorship, the staff 
learned of the importance of EBP and how to effectively implement into practice.   
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 The Functional Mastery of Health Ownership (FMHO) theory also guided this 
project.  Our patients not only learned how to use their inhaler correctly but learned of 
tools to keep their asthma in control.  By giving our patients and families these necessary 
tools, they learn self-efficacious behaviors that will hopefully lead to asthma control 
improvement.  I did find one new approach to care which will need to be a future 
consideration to this model.  We as health care providers cannot expect our patient to 
learn how to own their health unless we as providers learn how to own the care that we 
give to our patients.   
 The logic model was instrumental in the pre-implementation process.  I did find 
that it helped me to think of potential barriers, facilitators, and resources that would be 
required for this project.  However, I did not find it to be as useful once the 
implementation started.  Several barriers presented themselves, and I did not expect these 
to occur.  I could envision the logic model being re-formatted monthly for future projects 
to more smoothly guide the implementation process. 
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Chapter 4: Project Outcomes, Impact, and Results 
Over the past three chapters of this DNP Scholarly Project, I have followed the 
EBP process as it relates to my clinical problem of decreased knowledge of inhaler 
technique and asthma control.  I reviewed the available evidence to develop a best 
practice protocol to put into place at CHP-BPA.  Then, per the Clinical Scholar EBP 
Model, I mentored my team in the EBP process.  The Breathe In Breathe Out Inhaler 
Technique Education Program was put into practice at CHP-BPA.  Now, it is time to 
evaluate the outcomes.  Evaluating outcomes in an EBP best practice pilot project is 
essential.  The effectiveness of the plan needs to be assessed and then later disseminated 
to assure that patients continue to receive the best care that is evidence-based (Brewer & 
Wojner Alexandrov, 2015). 
Completion Outcomes, Data Collection, Measurement 
Demographics.  From July 5 through October 19, 2018, 312 asthmatic patients 
utilizing an MDI between the ages of 5 and 20 received care at CHP-BPA.  These 
patients had a combined total of 518 distinct patient encounters.  The age ranged from 5 
through 20 with a mean of 11 years.  One hundred thirty-six males, 175 females, and one 
transgender patient were seen during the project.  Seventeen insurance payers covered 
these patients; with Fallon Health ACO covering most of the patients followed by Blue 
Cross Blue Shield (BCBS) of Massachusetts.  The primary residence of most of the 
patients was Pittsfield; however, the entire Berkshire County had representation along 
with five towns in Eastern New York State.   
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Visit types and inhaler technique program.  Most encounter type visits were 
for sick care (187) followed by well care encounters (144).  Ninety-three of the visits 
were solely nursing visits (suture removal, immunizations, etc.).  Sixty-nine asthmatic 
specific visits (exacerbations as well as follow up care) were performed.   
Ten pediatric providers along with nursing staff provided care during the inhaler 
technique program.  Of these providers, one physician declined to perform the program.  
The remainder of the providers and nursing staff participated in the program.  One 
hundred nineteen patient visits received the inhaler technique asthma program.  Three 
hundred ninety-nine missed opportunities otherwise occurred.  The reasons for the missed 
opportunities included “no time,” missed chance, MA or nursing forgot; provider not yet 
in implementation; computer technical error; provider declining to participate, and patient 
unwillingness.  25% of the patients received the inhaler technique program of care, and 
75% of patients did not. 
 Provider inhaler technique scores.  At the onset of this program, the intent was 
to measure all providers as well as nursing staff with their inhaler technique knowledge.  
However, all pediatric providers stated they did not have time to teach their patients 
inhaler technique, thus did not wish to display their inhaler technique.  The nurses were 
all evaluated for inhaler technique before the program.  All nurses were able to perform 
the eight steps correctly before the program. 
Inhaler technique checklist demonstration scores.  Inhaler technique (IT) 
demonstration scores ranged from 0, meaning 0 correct IT steps, to 8, indicating eight 
correct IT steps out of 8 steps.  One hundred nineteen patients participated in IT 
education.  Inhaler technique was assessed by either nursing or Gina Nickels-Nelson 
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(PD) before any training.  Then, the patient received both hands on and verbal inhaler 
technique education; per the developed protocol that was based upon best practice from 
the reviewed evidence.  The patient’s inhaler technique score was then reassessed.  As 
was seen in the previously reviewed studies, patients improved their inhaler technique by 
at least one step after receiving both hands on and verbal inhaler technique education.   




Number of Steps 
Correct Before 
Education 
Number of Steps 
Correct After 
Education 
0 3 0 
1 1 0 
2 1 0 
3 1 0 
4 7 0 
5 17 0 
6 30 0 
7 34 3 
8 25 116 
 
Thirteen patients were seen on a subsequent visit within the project 3-month 
timeframe.  Each of these patients had a perfect score of 8 at their first visit; however, at 
subsequent visits, their score decreased to 5 correct steps.  These results indicate that 
inhaler technique must be reviewed and assessed at multiple visits; not just one time per 
year.  The same trends of decreasing inhaler technique were also noted in the reviewed 
studies.   
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Asthma control test (ACT).  Of the 119 patients who participated in the project, 
93 filled out an ACT questionnaire.  ACT scoring ranges from 0-27; with 0-18 
demonstrating poor asthma control and 19-27 demonstrating good asthma control.  The 
range of ACT scores were 3 to 27.  The mean ACT score at the first visit was 21.  At a 
second office visit, 17 patients completed an ACT, with a mean score of 17. 
Table 4B: ACT Scores at Visit 1 and Subsequent Visits 
ACT Score Number of Patients, 
Visit 1 
Number of Patients, 
Visit 2 
3 1  
7 1 1 
10 1 1 
14 2  
15 3  
16 2 2 
17 4  
18 12  
19 9 2 
20 11  
21 11 4 
22 15 2 
23 9  
24 10  
25 20 2 
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26 2  
27 7  
 
Mini pediatric and caregiver asthma quality of life questionnaires (QOL).  A 
total of 75 patients and 76 caregivers completed the asthma QOL questionnaires at the 
onset of the office visit.  Four out of ten providers declined to utilize this questionnaire.  
The pediatric questionnaire has three sections: asthma symptoms; emotional symptoms; 
and activity limitations.  All scoring is completed by a Likert scoring system as follows, 
with lower scores being representative of increased concerns: 
• “How bothered have you been during the last week” with symptoms 
o 1: extremely bothered 
o 2: very bothered 
o 3: quite bothered 
o 4: somewhat bothered 
o 5: bothered a bit 
o 6: hardly bothered at all 
o 7: not bothered 
• “How often during the last week did you” regarding emotions towards asthma: 
o 1: all of the time 
o 2: most of the time 
o 3: quite often 
o 4: some of the time 
o 5: once in a while 
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o 6: hardly any of the time 
o 7: none of the time 
• “How bothered have you been in the last week” generalized 
symptoms/sleeping/activities 
o 1: extremely bothered 
o 2: very bothered 
o 3: quite bothered 
o 4: somewhat bothered 
o 5: bothered a bit 
o 6: hardly bothered at all 
o 7: not bothered 
The caregiver asthma quality of life questionnaire measured caregiver reviews of 
activity limitations and emotional aspects of their child’s asthma.  This questionnaire is 
also scored via Likert scoring with lower scores being representative of increased 
caregiver concern: 
• 1: all of the time 
• 2: most of the time 
• 3: quite often 
• 4: some of the time 
• 5: once in a while 
• 6: hardly any of the time 
• 7: none of the time 
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QOL scores for both patient and caregivers were tallied, and a mean score was derived; 
with a lower score being representative of concern or decreased performance due to 
asthma. 
Table 4C: Patient Reported QOL Scores 
QOL Score Patient Visit 1 Patient Visit, 
Subsequent 
1 0  
2 0  
3 2  
4 6 1 
5 8 2 
6 36 1 
7 23 2 
 
Table 4D: Caregiver Reported QOL Scores 
QOL Score Patient Visit 1 Patient Visit, 
Subsequent 
1 0  
2 2  
3 2  
4 4 1 
5 8 2 
6 27 2 
7 33  
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 Even though written responses were not expected on the caregiver QOL 
questionnaire, some parents left written responses regarding their child’s asthma. 
• “I am very upset that she has asthma.” 
• “I don’t get mad at him not his fault.” 
• “Inhalers, neb machine are being used too much, Flovent also.” 
• “If I can’t get out of my black mold apartment won’t be able to control his 
asthma.” 
• “I feel hurt because I want her to be ok.”                                                                                                                                                                                                                                                                                                                                                                                                                                                                    
Asthma action plan (AAP).  An AAP allows for the patient to have a written plan of 
care at home, school and elsewhere for their asthma.  The AAP is written either by 
nursing and reviewed by the provider or provider written and then given to the patient.  
All 312 patient charts were reviewed for the presence of an AAP. 
Table 4E: AAP Presence in Patient Charts 
Presence of AAP in 
Chart 






Yes 289 191 
No 22 120 
 
Healthcare utilization and absenteeism.  Only three patients reported an ER visit in 
the past year; 2 of the patients each reporting two visits each.  After the chart review, 37 
ER visits were noted.  Likewise, self-reported urgent care visits were collected, and 
families stated that they did not attend any urgent care visits.  However, three patients 
had an urgent care visit at BMC.  Self-reported missed school days were also recorded.  
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Twenty-eight missed school days were noted.  Self-reported missed workdays were also 
noted.  Five parental missed workdays were recorded; as well as the loss of one job.  All 
the above metrics were verbally asked and written down on the inhaler technique 
checklist form.  Several families did answer with “don’t know” or “unsure” regarding 
missed school days. 
Analysis, Project Results, and Impact 
Demographics.  Demographically, the patient ages were all similar to the body of 
evidence.  In Pittsfield Massachusetts, the asthma prevalence is noted to be 14.4% as 
compared to state prevalence at 12.1% (Massachusetts Environmental Public Health 
Tracking, 2017).  As I reviewed the residences of our patients, our geographic range also 
mimicked reported data; a predominance of our patients resides in Pittsfield.  This 
predominance could be due to geography since CHP-BPA is in Pittsfield.   
Patients receiving protocol at practice.  As I had reviewed the body of 
evidence, I had not noted any mention of patients not receiving the protocol in the 
studies.  However, not all of our providers participated in the program, and 75% of our 
patients did not receive the inhaler technique educational program.  Morin, a DNP 
candidate in 2012, also conducted a DNP scholarly project regarding inhaler technique 
training in Pittsfield, Massachusetts.  His program took place at a private pediatric 
practice.  At the onset of his program, there were two providers (a pediatrician and a 
nurse practitioner) and Morin.  As noted in his scholarly project; he completed nearly 
90% more inhaler technique teaching visits as compared to his physician counterpart.  
The nurse practitioner at the practice had resigned just before his implementation (Morin, 
2012). 
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Barriers reported by CHP-BPA providers to the project included lack of time as 
well as the lack of components of the program being endorsed by the American Academy 
of Pediatrics.  The clinic staff also reported time as being a significant barrier.  Upon 
further evaluation, the other significant obstacles included the staff forgetting to include 
the patient into the IT education protocol; and the medical assistants’ not searching their 
provider schedules for asthma protocol patients.  The barrier of time was noted in the 
literature (Chen et al., 2002) but the other obstacles I found during the implementation 
were not found in the literature. 
Provider and nursing IT scores.  None of the CHP-BPA providers performed 
initial IT scoring.  All providers, except PD, noted that they did not have the time to teach 
their patient's inhaler technique during the patient encounter.  Before the nurses 
participated in the IT program, their technique was evaluated.  All our nurses were able to 
complete all eight steps of inhaler technique without an error.  This perfect scoring goes 
against the evidence.  In the evidence noted, most of the providers and nurses do not 
know how to perform, evaluate or teach IT (Amirav et al.,1994; Duerden & Price, 2001; 
Jones et al., 1995; Sleath et al., 2012; Reznik &Ylie-Rosett, 2014).   
Patient inhaler technique.  Our patients did not immediately have full 
knowledge of how to utilize an inhaler correctly.  As well, over half of the patients have 
either never utilized an aerochamber or did not use one at all.  The body of evidence 
noted at least a one to two step improvement in IT post hands-on and verbal education 
(Alexander et al., 2016; Burkhart et al., 2005; Foland et al., 2002; Janssen et al., 2003; 
Kamps et al., 2000; Levy et al., 2013; Minai et al., 2005; Sleath et al., 2012; Walia et al., 
2006; Zivkovic et al., 2008).  Our program also noted this improvement; with five 
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children having an increase of eight inhaler technique steps.  Once the patients received 
an educational session, almost every patient had nearly perfect technique.  However, 13 
of these patients had return visits with IT performed, and again missed at least three IT 
steps.  In previous IT studies, retention of IT was noted to drop after only one educational 
session; therefore, it was recommended for several sessions to occur (Capanoglu et al., 
2015; Jones et al., 1995; Kamps et al., 2000; Manriquez et al., 2015).  Unfortunately, 
only 25% of the patients received one inhaler technique evaluation and teaching session.  
To improve our patients’ overall asthmatic health; our office always needs to implement 
the best practice asthmatic care for all patients; not just when the time allows for it to 
occur. 
Asthma control and quality of life.  The evidence also noted with improved IT 
an improvement in asthma control and quality of life was also observed (Alexander et al., 
2016; Burkhart et al., 2005; Carpenter et al., 2015; Carpenter et al., 2016; DeGroot et al., 
2015; Foland et al., 2002; Janssen et al., 2003; Kamps et al., 2002; Levy et al., 2013; 
Minai et al., 2004; Sleath et al., 2012; Walia et al., 2006; Zivkovic et al., 2008).  
Currently, I am not able to definitively show this same correlation.  This is because I had 
several missed occurrences for repeat IT program visits.  As well, this program only 
covered the months from July until the end of October.  My program did not have the 
same repeat of visits as was noted in the body of evidence.  A recommendation would be 
to continue to monitor these patients over an extended period to evaluate their asthma 
control and the quality of life. 
Twenty-six patients reported an ACT of less than 19.  A score of less than 19 
indicates poor asthma control.  Only two times was this score notated and acted upon by 
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the provider.  Further education of the provider staff needs to occur regarding the use of 
this screening tool and how to incorporate it into patient care.  
In the measurement of quality of life, only24% of the patients were given an 
opportunity to participate in the questionnaire.  Further observation and analysis would 
be warranted for this group of patients.  As well, further provider education must occur.  
Again, a few parents noted, “I am scared of my child’s asthma,” and this was not 
discussed by the provider or the family during the visit. 
Asthma action plan.  The asthma action plan is a written at home treatment plan 
that allows for a family to be self-efficacious with their asthma treatments; but also know 
when to call for help or guidance.  Only seven percent of the patients before the program 
had a written asthma action plan.  After receiving IT education; 38% of the patients had a 
scanned asthma action plan present in the EMR.  One of the nurses responded by stating, 
“Well, I do them all of the time, but I don’t scan them (the action plans) into the chart.”  
Most of the providers in the office rely on the nurses to complete these plans for our 
patients. 
Healthcare utilization and absenteeism.  Finally, both missed school days and 
parental work days were not accurately reported during this program.  As I compared ER 
and urgent care visits; the families’ self-reporting numbers were much lower as compared 
to the recorded visits.  I am concerned that the self-reporting for school and work is also 
low.  As well, this was a verbal question asked by several different nursing staff members 
and providers.  This amount of people could have led to the reports that were obtained.  
In the future, a checklist system could be considered for families to mark when their child 
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is out of school.  A partnership with the Pittsfield Public Schools could occur to tabulate 
these numbers.  
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Chapter 5: Project Sustainability Discussion, Conclusions, and Dissemination 
Discussion 
Discussion of Project Results 
 Out of ten pediatric providers, only one provider was 100% vested in the 
program.  One provider declined to participate at all, and one other provider would only 
allow well patients to participate.  The remaining providers were actively enrolled in the 
program.  However, nearly 200 patients were not included in the education program.  
This number was mostly attributed to the missed opportunities of either the providers 
declining to participate or the remainder of the medical/nursing team missing 
opportunities for patient engagement.  None of the providers except for myself would 
personally teach their patients how to use the inhaler.  Our nurses all had 100% correct 
inhaler technique.   
Only 25% of the asthmatic patients seen between July and October of 2018 
received any recorded asthma teaching.  Only 49% of these patients knew how to 
perform at least seven out of eight inhaler steps correctly.  Through the educational 
program, 100% of the patients could correctly use an inhaler at the end of one training 
session.  As was noted, upon a second visit, 69% of the patients receiving a second 
screening, again had incorrect inhaler technique.  These values mimic the evidence noting 
that inhaler technique must be a recurrent educational focus at future patient visits.  
Inhaler technique and asthma education cannot remain once a year visit type focus.   
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Twenty-six patients scored an 18 or lower on the asthma control test.  Only two 
times was it recorded in the patient’s record that this score was discussed.  A score of 18 
or less denotes poor asthma control.  As well, the quality of life scores was not often 
viewed by the providers.  The two most significant reasons for this were: 1- most of the 
physicians declined to utilize this questionnaire, and 2- since the copyright for this 
questionnaire would not allow for scanning into the EMR all the questionnaires came 
directly back to me.  After my day was over and the patients had left the office, I noted 
the low scores on the quality of life.   
This project will have a long-lasting impact on our patients at CHP-BPA.  As I 
worked with the patients, several noted: “that no one has ever personally shown us how 
to use the inhaler.”  Other parents noted that they “were scared about their child’s asthma, 
but now had a sense that they could talk to our office about their concerns.  Many patients 
had never used a spacer in the past.  Through the generosity of Dr. Lamm, 50 spacers 
were purchased for this program.  Patients who were not able to afford a spacer due to the 
co-pay were now able to have a spacer.  As well, several patients were able to have a 
spacer both at home as well as at school.  I was gone from the office for two weeks 
during the implementation project.  The spacers were kept in an unlocked drawer in my 
desk.  Upon my return after each week, the number of spacers in the drawer drastically 
decreased.  Even though the providers did not fully participate in the program, the 
providers realized the importance of the spacers.   
 Our patients were able to learn how to use their inhalers!  Before education, 50 
percent of the patients missed three or more steps of inhaler technique.  However, after 
education, all patient had seven to eight correct inhaler steps.  For these patients, we 
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fulfilled the ability to teach our patients how to use their inhalers!  If this teaching can 
move forward to all our patients, the impact on our practice would be phenomenal. 
 Impact of project results.  Two patients were seen at CHP-BPA throughout the 
implementation of the project.  Each of these patients was seen more than once in the 
office.  However, each patient had a different trajectory of results. 
 Patient “I” had three appointments between July and October.  At all three 
appointments, she received both inhaler technique training as well as the opportunity to 
complete ACT and QOL questionnaires.  She had a full discussion of her asthma as well 
as completion of an asthma action plan for school.  One of her appointments was for a 
well visit; the others were for asthma follow up.  At each visit, “I’s” inhaler technique 
improved by one step to eventually having all eight steps correct.  At a subsequent visit 
after the scholarly project was completed, she again demonstrated her technique and was 
immediately able to note that she completed a step incorrectly and verbalized why it was 
done incorrectly.  She did not require any emergency room or urgent care visits during 
the time of the program.  She and her mother completed both ACT and QOL 
questionnaires at all three visits.  Her ACT scores started at 17, increased to 19 and then 
decreased to 16.  Both she and her mother’s QOL scores increased from five to six.  
When asked why she thought her ACT scores decreased, she responded by saying that 
she could now tell when she was not feeling well due to her asthma and not be able to be 
in gym or sports with her friends due to her asthma.  Her mother noted, “she now has the 
tools that she needs to be able to be on top of her asthma.  We now know when we need 
to call for help.” 
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 Patient “M” had eight visits between July and October of 2018, but only received 
the inhaler technique educational program twice.  He did not receive the program the 
other six times due to either the provider declining the program during the patient visit or 
the medical assistant or nursing forgetting to include him into the project.  His inhaler 
technique decreased in correct steps between the recorded visits one and two.  He was 
seen two times in the emergency room for his asthma in this period, and his ACT scores 
decreased from a 24 to a 10.  His reported QOL scores decreased from seven to six; 
caregiver scores decreased from seven to four 
 These two cases show the impact of this inhaler technique education program.  As 
was seen in the evidence backing this best practice quality initiative program at CHP-
BPA- this program increases the correct number of steps of inhaler technique and 
increases asthma control as well as the quality of life.  Only 25% of our patients received 
this program at our office.  The impact that could have been seen if all 312 patients 
received the program could have been enormous. 
Discussion of Project Sustainability Plans and Implementation 
After careful consideration of the above EBP implementation project data 
analysis, the next step in the evidence-based process is formalizing a sustainability plan.  
It is ethically required to continue to provide the best, evidence-based care, to the patient 
population (O’Mathuna, 2015). 
Asthma medical home.  CHP-BPA must move past the current care model of 
only assessing asthma one time per year or at asthma exacerbation visits.  With the clinic 
currently being in a state of change, this is an opportune time to implement a new care 
protocol for all caregivers.  The project has also had the same outcomes as did the body 
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of evidence; thus, proving that this project is commendable and needed for our patients.  
Repeat encounters with continued emphasis on inhaler technique are required to hone 
proper technique and to have improved asthma control.  For our patient to own their 
asthmatic health; they must be given the required tools to learn about their asthma.  The 
patients, therefore, must be seen more than once a year or for emergency visits.   
While performing the inhaler technique at every patient encounter is 
recommended in the body of evidence; this model of patient care was not accepted by 
most of the providers and staff at CHP-BPA.  One of the most significant barriers noted 
by all providers, including me, was the required time.  At a well visit, we are only given 
20 minutes for ages five to eleven- and thirty-minutes ages twelve and older.  This time 
does include not only the asthma education but also all other wellness aspects of the 
child’s life as well as any other questions the family may have.  A sick visit is only 
scheduled for 20 minutes.  The sick visit intends to only focus on the concern at hand; not 
including an additional asthma educational segment. 
Both the American Academy of Pediatrics (AAP) and the National Association of 
Pediatric Nurse Practitioners (NAPNAP) have separate special interest groups (SIGs) 
regarding asthma.  Each of these organizations bases their asthma education on the 
National Asthma Education and Prevention Program (NAEPP) 2007 Expert Panel 
Asthma guidelines.   
The American Academy of Pediatrics (AAP) along with the American Asthma 
Network (AAN) developed Medical Home Chapter Champions Program on Asthma 
(MHCCPA) in 2008.  Since that time, the AAP has sought at least one pediatrician per 
chapter to be a champion for this program.  In an informational website to members of 
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the AAP, the AAP has addressed the same barriers to care that was noted in this scholarly 
project.  For the biggest concern, time, the AAP noted the following: 
“Chronic care management visits are a great way to incorporate the six Guidelines 
Implementation Panel (GIP) priority messages from the National Heart, Lung, and 
Blood Institute (NHLBI) guidelines for optimal asthma care. In a non-acute visit, 
asthma control and allergen/irritant exposures can be assessed, asthma severity 
and medications adjusted, spirometry obtained (if indicated) and the child's 
asthma plan and school medication authorization forms can be completed. For 
providers who see many patients with asthma, grouping such visits into a single 
clinic day can streamline care flow and enhance staff familiarity with needed 
forms and procedures. These visits can be scheduled in longer time slots and 
coded for time spent in care. By asking your patient to schedule their asthma 
management visit with you before they leave, they are more l0ikely to return, and 
you can better predict your workflow” (Planning Care for Children with Asthma 
in your Medical Home: Addressing Common Concerns of Primary Care 
Providers, AAP 2014).   
 The AAP recommends asthma visits to the clinic every two to six weeks for 
uncontrolled asthma and every three to six months for controlled asthma.  At every 
patient encounter, the AAP also recommends the following;   
• Discussion of the Asthma Action Plan (AAP) 
• Discussion of asthma medications; how to take and their role in asthma care 
• How to use a spacer and an inhaler 
• Patient to know their asthma triggers; how to self- monitor their care (Key points 
for asthma guide implementation, AAP, 2013). 
While viewing the NAPNAP asthma SIG website as a non-paying member, 
NAPNAP does not have the same explicit guidelines found on their website.  The only 
inhaler technique information provided is regarding school nurses and asthma care at 
school. 
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 Sustainability plan:  asthma medical home at CHP-BPA.  A new proposal at 
CHP-BPA will be the formulation of asthma medical home care.  As noted above, with 
all the ongoing change at CHP-BPA, this is an opportune time to implement a new care 
model.  Even though the evidence supports inhaler technique evaluation at every care 
visit, time does not allow for this teaching to feasibly occur.  Upon discussion within the 
clinic, the providers are agreeable to an implementation of quarterly asthma care 
appointments at the clinic. 
Each asthmatic patient would be seen four times each calendar year; with one 
visit being their yearly well visit appointment.  At each of these appointments, the patient 
would demonstrate their inhaler technique and then have education given to them 
regarding any technique steps missed.  The patient would then return demonstration.  The 
patient and family would also complete the ACT and QOL questionnaires.  The provider 
would have time to review the questionnaires with the families.  Medication management 
would also be discussed.  Asthma action plans would be formulated.  These visits would 
be scheduled for 40 minutes; to allow for provider time to fully assess their asthma status.   
The social and psychological factors of asthma would also be assessed.  A link 
between the school and our office should be established.  Since the asthma medical home 
program would now be solely an office-based program and not have any affiliation with a 
teaching university; an IRB would not be required.  I would meet with the school nurses 
to discuss how we could establish a care team- continuing the work as demonstrated by 
Carpenter and partners (2015, 2016) with school-based nursing inhaler technique 
training.  As well, a system to monitor school absences due to asthma could also be 
established rather than an immediate recall system as was used in this scholarly project. 
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The evaluation of both patients, as well as patient/caregiver, views life with 
asthma is very important.  As I saw with a few patients, even though they had an ACT of 
27 with near perfect inhaler technique; some patients rated their quality of life as poor.  
To improve both asthma as well as ownership of their health- we must address the social 
side of asthma. 
Fallon Health Care, the ACO for Berkshire County, has a respiratory therapist.  
As well, the Berkshire Collaborative, which is a Fallon service, consists of an RN case 
manager, social worker as well as a community health worker.  We could certainly 
consider having an asthma clinic on a select day in the office.  We would have the Fallon 
workers present to assist with our Fallon ACO patients.  We could certainly also reach 
out to the other carriers, such as Blue Cross Blue Shield, to inquire if they would be 
willing to have case managers on site to assist their patients. 
Electronic medical record (EMR) at CHP-BPA.  As has been mentioned in the 
previous chapters of this project, the current EMR at CHP is not a sophisticated product.  
No one can run reliable reports.  Practices are not able to determine which patients have a 
diagnosis of asthma or even which patients coming to the practice currently have an 
asthma diagnosis.  The agency is in the process of implementing a new EMR.  The EMR 
will be in place as of July 2019.  This new EMR will have an enhanced reporting feature.  
As well, the day to day functionality of the system should prove useful to both the 
clinician as well as senior management.  Encounters will be documented as a point and 
click rather than a free texted field.  This will enhance reporting capabilities.  As well, 
best practices are a function of the EMR.  Therefore, providers will have access to asthma 
best practices.  Since we are still in the process of having the EMR configured for CHP, I 
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am hopeful that we will be able to have the ACT as a capturable questionnaire in the 
system.  We are also hopeful that asthma action plans will also be easy to format within 
the system. 
Implications of EPIP results to the community/organization, patients, health-care, 
nursing and advance practice nursing 
 The impact of this inhaler technique project along with asthma education and 
allowing families to learn how to own their health will be far-reaching.  At a subsequent 
appointment, one of the mothers of my patients wrote this email to me regarding the 
program: 
“[My daughter] has been struggling with her asthma for several years.  Ending up 
on several courses of steroid treatments a year.  Her asthma seemed to act up more 
in the winter’s months and with any sports activity.  Missing days of school, ER 
visits and multiple doctor office visits, as well as interfering with her sports. 
[My daughter] began seeing Gina Nelson, NP approximately 6 months ago and 
we began the asthma treatment program with her.  Gina switched [my daughter’s] 
inhalers from Flovent to Qvar and added a nightly pill on singulair.  We started a 
new plan as to when to take her inhalers, for example 20 min before sports.  [My 
daughter] did step by step training with Gina on how to properly use the inhalers 
and chambers. 
Since the new treatment plan started [my daughter] asthma symptoms have 
significantly improved.  She hasn’t needed any courses of steroids, has used the 
rescue inhaler very few times and isn’t experiencing interruption with her sports 
like she used to. 




 This is only one patient account that I received during this project.  However, I 
was told by many parents during the time that this was the first time that their child was 
given guidance on how to use an inhaler.  Several parents wrote on their quality of life 
forms that they were fearful of their child’s asthma.  These comments do not support the 
notion that our patients’ asthma is under control.  This program is needed and essential 
for this community. 
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 Pittsfield, Massachusetts has an asthma incidence of 14.4% which is nearly 
double the incidence of the nation.  We also have the fifth highest ER rate for asthma in 
the state.  Over this past week, CHP has written a press release about this asthma project.  
We are hopeful that the efforts that we are going to be engaging in at our practice will 
help to decrease the consequences of asthma.  
  The concept of owning one’s health with asthma is to allocate to the child and 
family all the tools that are necessary for the child to function at their greatest physical 
and emotional extent without an asthma exacerbation.  The children and adolescents 
would be allowed to live lives without the fear of asthma.  Rather than only treating 
asthma during exacerbations and keeping the child and family in an ill state, we need to 
start focusing on how to keep the child or adolescent in a well or healthy state, without 
exacerbations of their asthma.  For advanced practice nurses- this is our mission.  We 
practice as holistic wellness providers.  We need to maintain this state of wellness and 
ownership at the forefront of our minds.  The American Academy of Pediatrics has a very 
well laid out plan of care for an asthma medical home.  Their plan is physician led.  We 
as advanced practice nurses through our practice academies need to also lead the charge 
for our patients.   
 A knowledge gap was found with the implementation of this evidence-based 
program.  The current evidence states for inhaler technique demonstration and education 
to occur at every patient encounter.  However, as was noted in this program, this care is 
not feasible in a pediatric office with each provider seeing a patient every 20-30 minutes.  
I believe that a nursing scientist or PhD will need to come alongside me to discuss the 
sustainability plan that is recommended for our office.  We would need to work together 
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to discover how quarterly asthma teaching visits would impact upon the asthma outcomes 
detailed in this paper.  Would the patients and families require fewer or greater visits in 
order to achieve the outcomes? 
 Another knowledge gap involves the new FMHO model and pediatric ownership 
of asthmatic health.  I plan to work with Maria Donnelley in the future regarding how 
families and patients can learn to manage and own their asthmatic health.  We will need 
to discover if this ownership of asthmatic health would impact their lives further into the 
future.  Asthma is a progressive disease and can impact a patient’s respiratory and cardiac 
health far into the future.  Further, if a patient could learn how to own their asthmatic 
health, could they also then learn how to own other chronic health issues in the future? 
Key Lessons Learned from EPIP Implementation 
Many key lessons were learned during this process.  First and foremost, all the 
providers and nurses deeply care for our patients at CHP-BPA.  However, we need to 
change the way we are currently practicing on both a business as well as healthcare level 
at this time. 
CHP-BPA has been operating in a state of change since I joined in 2017.  The 
practice has merged from being an independent practice for over 40 years to an owned 
practice.  Furthermore, the clinic went from independent practice to a federally qualified 
health center overnight.  These are major changes to any practice.  Change needs to be 
looked at as an opportunity; not an obstacle.   
This past fall, CHP hired a new practice manager for CHP-BPA.  He was hired 
from within CHP, so he is knowledgeable of CHP practice environment as well as 
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processes.  He has already attempted to work with the staff at all levels to help us to 
embrace the changes and to move forward.  He is actively involved in the EMR 
transformation as well as daily practice.  I am very hopeful that his presence will allow 
CHP-BPA to evolve into a new revitalized practice. 
I was not aware of the power that both our medical assistants as well as nurses 
held in the practice until the time of the project.  Again, if we as a practice expect 
changes to occur, then we must all work as a team.  We must all collaborate together; 
however, if a care model needs to be implemented then all team members must work 
together. 
All providers are in favor currently for an asthma medical home.  The processes 
laid out in the sustainability section have been agreed upon by the providers.  With the 
upcoming EMR changes, we are in the process of incorporating the new asthma changes 
into the practice. 
The total amount of expenses for this scholarly project was $10,065.58.  The 
actualized gross billing for this project was $16,034.  If all billing were captured, a profit 
from those three months of $5,968.42 would be realized.  However, CHP-BPA providers 
did not bill to their full extent during the project.  At the start of the project, I emailed all 
nursing and all providers to make them aware of the additional billing that we would be 
able to justifiably utilize due to the increased education and assessments being done at 
these visits, including the use of a modifier 25 with well visits.  As I reviewed our gross 
billing documentation, neither the providers nor nursing fully billed to the greatest extent.  
If we had done so, we would have realized a gross billing of $19,983.  If all billing were 
captured, a profit of $9,917.42 would have been realized; an increase of $3,949. 
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Only 119 patients out of 312 patients were a part of the educational program.  
These patients totaled a net of 518 separate billable encounters.  Three hundred eighty-
two visits occurred without the asthma educational program.  Counting for only the 27-
dollar gross billing reimbursement for inhaler technique education, this billable amount 
would have captured a gross billing of $10,314.  This amount would have been seen in 
only three months.  Only considering these 312 patients, over a 1-year period of time 
with four visits each $33,696 would be gross billed just for inhaler technique education; 
not counting for additional billing coding. 
CHP-BPA also has the opportunity for performance reimbursement with the 
asthmatic population.  By maintaining a decreased ratio of quick acting to controller 
inhaled medications, written and documented asthma action plans as well as keeping 
patients out of the emergency rooms- CHP can receive incentive payments for these 
actions.  Through the existence of an asthma medical home, all these incentive markers 
would be met. 
Conclusions 
 The Breathe in Breathe out Inhaler Technique program at CHP-BPA is a best 
practice evidence-based project at CHP-BPA.  Major Bourne, in 1996, wrote her master’s 
in nursing thesis on inhaler technique.  She found that pediatric patients did not use 
inhalers correctly.  Twenty-three years later, we are finding that patients still do not know 
how to use an inhaler correctly.  By incorporating an inhaler education program, we 
found the same outcomes as did the thirty-one scholarly authors found with inhaler 
technique.  With inhaler technique hands-on and verbal education, patients can correctly 
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utilize an inhaler.  It is now time for providers to break the cycle of incorrect inhaler 
technique. 
I also found that our patients do not have as high of a quality of life with their 
asthma as was thought at the start of this project.  We must continue with this best 
practice program to help our patients learn how to both own their health and to own their 
asthma so they can have fewer asthma exacerbations.  With this program, we will meet 
CHP’s mission statement: “measurably improve the health of Berkshire County, 
Massachusetts” with a vision that “Berkshire County’s population will be the healthiest in 
Massachusetts” (Community Health Program, 2017). 
Recommendations for Dissemination 
 I submitted an abstract for the background and significance, initial literature 
search and proposed implementation plan to Doctors of Nursing Practice 2018 
conference.  My abstract was accepted for a poster presentation.  I presented at the 11th 
Annual Doctors of Nursing Practice conference in Palm Springs in September of 2018. 
 An accompanying concept analysis regarding ownership of adolescent asthmatic 
health was also written last year.  I submitted this manuscript to Nursing Forum, and it 
was accepted for publication in December of 2018.  The published manuscript is entitled: 
“Ownership of Adolescent Asthma Health:  A Concept Analysis. 
 I submitted an abstract to Sigma Theta Tau for their 45th Biennial Convention in 
Washington DC for a podium presentation of this DNP Scholarly Project.  My abstract 
was accepted, and I plan to present in November of 2019.  After presenting at Sigma 
Theta Tau, I will prepare a manuscript for publication of this Scholarly Project. 
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Figure AA6: Literature Search Flowchart Schematic 
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Figure AA8: FMHO Model in Practice 
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Logic Model for DNP Scholarly Project 
 
Figure AA9: Logic Model Schematic
1: Gillette et al. (2016); 2: Rodriguez-Martinez et al. (2017);  3: Alexander et al. (2016); 4: Amirav et al. (1994); 5: Burkhart et al. (2000); 6: Carpenter et al. (2015); 7: 
Kamps et al. (2000); 8: Zivkovic et al. (2008); 9: Bourne (1996); 10: Capanoglu et al. (2015); 11: Carpenter et al. (2016); 12: Chen et al. (2002); 13: Foland et al. (2002); 
14: Janssen et al. (2003); 15: Jones et al. (1995); 16: Levy et al. (2013); 17: Minai et al. (2004); 18: Munzenberger et al. (2007); 19: Sleath et al. (2011); 20: Turkeli et al. 
(2016); 21: Deerojanawong et al. (2009); 22: Walia et al. (2006); 23: Schmier et al. (2007); 24: Manriquez et al. (2015); 25: Reznik et al. (2013); 26: deGroot et al. 
(2014); 27: Duerden, et al. (2001); 28: Pedersen et al. (2010); 29: Price et al. (2013); 30: Morin, 2012 
AC: asthma control; ACT: asthma control test;  AE: asthma education; AQLQ: asthma quality of life questionnaire; AS: asthma severity; AV: after video; BV: before 
video; CC: completely confident; DV: dependent variable; DX: diagnosis; FEV1: forced expiratory volume 1 second;  ER: emergency room; FVC: forced vital 
capacity; GINA: global initiative for asthma; GT: good inhaler technique; HOH: hard of hearing; ICS: inhaled corticosteroid; IMPACT: Improving the Management 
of Patients Asthma and COPD Treatment; IT: inhaler technique; IV: independent variable; MDI: metered dose inhaler; NC: no change; NCC: not completely confident; 
NS: no significance; Obs: observational; PACT: pediatric asthma clinic trial; PE: physical exam; PIF: peak inspiratory flow; PFT: pulmonary function test;  pop: 
population; PP: parental perception RCT: randomized controlled study; RT: respiratory therapist; RTC: return to clinic; SE: self-efficacy; VT: verbal inhaler training; 
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Not enough to ask if know how to use 
inhaler, CC still missed steps 
 
Limits: only 2 centers, had to miss step IT 
to qualify, Hawthorne effect 
 
 
1: Gillette et al. (2016); 2: Rodriguez-Martinez et al. (2017);  3: Alexander et al. (2016); 4: Amirav et al. (1994); 5: Burkhart et al. (2000); 6: Carpenter et al. (2015); 7: 
Kamps et al. (2000); 8: Zivkovic et al. (2008); 9: Bourne (1996); 10: Capanoglu et al. (2015); 11: Carpenter et al. (2016); 12: Chen et al. (2002); 13: Foland et al. (2002); 
14: Janssen et al. (2003); 15: Jones et al. (1995); 16: Levy et al. (2013); 17: Minai et al. (2004); 18: Munzenberger et al. (2007); 19: Sleath et al. (2011); 20: Turkeli et al. 
(2016); 21: Deerojanawong et al. (2009); 22: Walia et al. (2006); 23: Schmier et al. (2007); 24: Manriquez et al. (2015); 25: Reznik et al. (2013); 26: deGroot et al. 
(2014); 27: Duerden, et al. (2001); 28: Pedersen et al. (2010); 29: Price et al. (2013); 30: Morin, 2012 
AC: asthma control; ACT: asthma control test;  AE: asthma education; AQLQ: asthma quality of life questionnaire; AS: asthma severity; AV: after video; BV: before 
video; CC: completely confident; DV: dependent variable; DX: diagnosis; FEV1: forced expiratory volume 1 second;  ER: emergency room; FVC: forced vital 
capacity; GINA: global initiative for asthma; GT: good inhaler technique; HOH: hard of hearing; ICS: inhaled corticosteroid; IMPACT: Improving the Management 
of Patients Asthma and COPD Treatment; IT: inhaler technique; IV: independent variable; MDI: metered dose inhaler; NC: no change; NCC: not completely confident; 
NS: no significance; Obs: observational; PACT: pediatric asthma clinic trial; PE: physical exam; PIF: peak inspiratory flow; PFT: pulmonary function test;  pop: 
population; PP: parental perception RCT: randomized controlled study; RT: respiratory therapist; RTC: return to clinic; SE: self-efficacy; VT: verbal inhaler training; 
























Appraisal of Worth to Practice 
Strength of the Evidence (i.e., level of 





































-shake and hold 





IT. CC boys more 
likely miss/girls 
p=0.04 








































MDI: 3.7/7 correct 
13/25 theory correct 
Post test: 6.3/7 IT 
18/25 theory 
Healthcare providers receiving 1:1 
education have improved IT and AK as 
compared to those who do not receive 
1: Gillette et al. (2016); 2: Rodriguez-Martinez et al. (2017);  3: Alexander et al. (2016); 4: Amirav et al. (1994); 5: Burkhart et al. (2000); 6: Carpenter et al. (2015); 7: 
Kamps et al. (2000); 8: Zivkovic et al. (2008); 9: Bourne (1996); 10: Capanoglu et al. (2015); 11: Carpenter et al. (2016); 12: Chen et al. (2002); 13: Foland et al. (2002); 
14: Janssen et al. (2003); 15: Jones et al. (1995); 16: Levy et al. (2013); 17: Minai et al. (2004); 18: Munzenberger et al. (2007); 19: Sleath et al. (2011); 20: Turkeli et al. 
(2016); 21: Deerojanawong et al. (2009); 22: Walia et al. (2006); 23: Schmier et al. (2007); 24: Manriquez et al. (2015); 25: Reznik et al. (2013); 26: deGroot et al. 
(2014); 27: Duerden, et al. (2001); 28: Pedersen et al. (2010); 29: Price et al. (2013); 30: Morin, 2012 
AC: asthma control; ACT: asthma control test;  AE: asthma education; AQLQ: asthma quality of life questionnaire; AS: asthma severity; AV: after video; BV: before 
video; CC: completely confident; DV: dependent variable; DX: diagnosis; FEV1: forced expiratory volume 1 second;  ER: emergency room; FVC: forced vital 
capacity; GINA: global initiative for asthma; GT: good inhaler technique; HOH: hard of hearing; ICS: inhaled corticosteroid; IMPACT: Improving the Management 
of Patients Asthma and COPD Treatment; IT: inhaler technique; IV: independent variable; MDI: metered dose inhaler; NC: no change; NCC: not completely confident; 
NS: no significance; Obs: observational; PACT: pediatric asthma clinic trial; PE: physical exam; PIF: peak inspiratory flow; PFT: pulmonary function test;  pop: 
population; PP: parental perception RCT: randomized controlled study; RT: respiratory therapist; RTC: return to clinic; SE: self-efficacy; VT: verbal inhaler training; 
























Appraisal of Worth to Practice 
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18 (33%) 2nd 
year 










than control group 
per figures” 
(no data numerically 
represented; able to 
view figures) 
1: Gillette et al. (2016); 2: Rodriguez-Martinez et al. (2017);  3: Alexander et al. (2016); 4: Amirav et al. (1994); 5: Burkhart et al. (2000); 6: Carpenter et al. (2015); 7: 
Kamps et al. (2000); 8: Zivkovic et al. (2008); 9: Bourne (1996); 10: Capanoglu et al. (2015); 11: Carpenter et al. (2016); 12: Chen et al. (2002); 13: Foland et al. (2002); 
14: Janssen et al. (2003); 15: Jones et al. (1995); 16: Levy et al. (2013); 17: Minai et al. (2004); 18: Munzenberger et al. (2007); 19: Sleath et al. (2011); 20: Turkeli et al. 
(2016); 21: Deerojanawong et al. (2009); 22: Walia et al. (2006); 23: Schmier et al. (2007); 24: Manriquez et al. (2015); 25: Reznik et al. (2013); 26: deGroot et al. 
(2014); 27: Duerden, et al. (2001); 28: Pedersen et al. (2010); 29: Price et al. (2013); 30: Morin, 2012 
AC: asthma control; ACT: asthma control test;  AE: asthma education; AQLQ: asthma quality of life questionnaire; AS: asthma severity; AV: after video; BV: before 
video; CC: completely confident; DV: dependent variable; DX: diagnosis; FEV1: forced expiratory volume 1 second;  ER: emergency room; FVC: forced vital 
capacity; GINA: global initiative for asthma; GT: good inhaler technique; HOH: hard of hearing; ICS: inhaled corticosteroid; IMPACT: Improving the Management 
of Patients Asthma and COPD Treatment; IT: inhaler technique; IV: independent variable; MDI: metered dose inhaler; NC: no change; NCC: not completely confident; 
NS: no significance; Obs: observational; PACT: pediatric asthma clinic trial; PE: physical exam; PIF: peak inspiratory flow; PFT: pulmonary function test;  pop: 
population; PP: parental perception RCT: randomized controlled study; RT: respiratory therapist; RTC: return to clinic; SE: self-efficacy; VT: verbal inhaler training; 
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Asthma dx of at 
least 4.6 years 
 
36 brought 
MDI to each 
visit/ 6 did not.  
If did not bring 
to at least 2 of 3 
visits- not 



































Not holding breath: 
56% 
Not waiting 1 minute 
between puffs 50% 
Inadequate shaking 
42% 
Not inhaling correct: 
42% 






for shake,inhale and 
hold breath;  
Education along with demonstration ↑ IT 
Weaknesses: small study size; mostly 
white suburb homes 
6/42 (1/7) of children forgot medication- 
so not part of IT calculation 
States that it is a RCT- however 
randomization/control is not evident. I 
would label this more quasi experimental 
Level IV 
Continue to show importance of education 
given each visit to improve IT/ correct 
mis-steps of IT 
Statement of NHLBI guidelines: 
• Verbal and written guidelines 
• Demonstrate each step 
• Patient demonstrates 
• Assess each visit 
• Provide feedback 
1: Gillette et al. (2016); 2: Rodriguez-Martinez et al. (2017);  3: Alexander et al. (2016); 4: Amirav et al. (1994); 5: Burkhart et al. (2000); 6: Carpenter et al. (2015); 7: 
Kamps et al. (2000); 8: Zivkovic et al. (2008); 9: Bourne (1996); 10: Capanoglu et al. (2015); 11: Carpenter et al. (2016); 12: Chen et al. (2002); 13: Foland et al. (2002); 
14: Janssen et al. (2003); 15: Jones et al. (1995); 16: Levy et al. (2013); 17: Minai et al. (2004); 18: Munzenberger et al. (2007); 19: Sleath et al. (2011); 20: Turkeli et al. 
(2016); 21: Deerojanawong et al. (2009); 22: Walia et al. (2006); 23: Schmier et al. (2007); 24: Manriquez et al. (2015); 25: Reznik et al. (2013); 26: deGroot et al. 
(2014); 27: Duerden, et al. (2001); 28: Pedersen et al. (2010); 29: Price et al. (2013); 30: Morin, 2012 
AC: asthma control; ACT: asthma control test;  AE: asthma education; AQLQ: asthma quality of life questionnaire; AS: asthma severity; AV: after video; BV: before 
video; CC: completely confident; DV: dependent variable; DX: diagnosis; FEV1: forced expiratory volume 1 second;  ER: emergency room; FVC: forced vital 
capacity; GINA: global initiative for asthma; GT: good inhaler technique; HOH: hard of hearing; ICS: inhaled corticosteroid; IMPACT: Improving the Management 
of Patients Asthma and COPD Treatment; IT: inhaler technique; IV: independent variable; MDI: metered dose inhaler; NC: no change; NCC: not completely confident; 
NS: no significance; Obs: observational; PACT: pediatric asthma clinic trial; PE: physical exam; PIF: peak inspiratory flow; PFT: pulmonary function test;  pop: 
population; PP: parental perception RCT: randomized controlled study; RT: respiratory therapist; RTC: return to clinic; SE: self-efficacy; VT: verbal inhaler training; 
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Remaining IT steps 
not use McNemar 
since 100% correct 
all steps post assess 
Parental/patient 
thoughts on use 
inhaler higher than 
actual use 
Carpenter, 





videos ↑ IT 
immediately 
& 1 month  
Video ↑ 
confidence IT 
& ↑ AC at 1 
month 
 















































control group mean 
∆:  0.03 






Brief use of videos during a visit can have 
↑ IT; however this effect does not last 
IT SE did not improve with one video 
AC did not improve with one video 
Weaknesses: 
Lost study funding- could only enroll 
91/100 families 
 
1: Gillette et al. (2016); 2: Rodriguez-Martinez et al. (2017);  3: Alexander et al. (2016); 4: Amirav et al. (1994); 5: Burkhart et al. (2000); 6: Carpenter et al. (2015); 7: 
Kamps et al. (2000); 8: Zivkovic et al. (2008); 9: Bourne (1996); 10: Capanoglu et al. (2015); 11: Carpenter et al. (2016); 12: Chen et al. (2002); 13: Foland et al. (2002); 
14: Janssen et al. (2003); 15: Jones et al. (1995); 16: Levy et al. (2013); 17: Minai et al. (2004); 18: Munzenberger et al. (2007); 19: Sleath et al. (2011); 20: Turkeli et al. 
(2016); 21: Deerojanawong et al. (2009); 22: Walia et al. (2006); 23: Schmier et al. (2007); 24: Manriquez et al. (2015); 25: Reznik et al. (2013); 26: deGroot et al. 
(2014); 27: Duerden, et al. (2001); 28: Pedersen et al. (2010); 29: Price et al. (2013); 30: Morin, 2012 
AC: asthma control; ACT: asthma control test;  AE: asthma education; AQLQ: asthma quality of life questionnaire; AS: asthma severity; AV: after video; BV: before 
video; CC: completely confident; DV: dependent variable; DX: diagnosis; FEV1: forced expiratory volume 1 second;  ER: emergency room; FVC: forced vital 
capacity; GINA: global initiative for asthma; GT: good inhaler technique; HOH: hard of hearing; ICS: inhaled corticosteroid; IMPACT: Improving the Management 
of Patients Asthma and COPD Treatment; IT: inhaler technique; IV: independent variable; MDI: metered dose inhaler; NC: no change; NCC: not completely confident; 
NS: no significance; Obs: observational; PACT: pediatric asthma clinic trial; PE: physical exam; PIF: peak inspiratory flow; PFT: pulmonary function test;  pop: 
population; PP: parental perception RCT: randomized controlled study; RT: respiratory therapist; RTC: return to clinic; SE: self-efficacy; VT: verbal inhaler training; 
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8 families lost 











1 month f/u IT 
control mean ∆: 
0.32 







Control ∆: 0.10 







Control ∆: 1.20 
IV ∆: 1.93 
Only 42% of subjects using MDI 
controller medication- this could have 
lessened the AC impact 
 
Self efficacy scale used at time of study 
had not been reported in the literature 
 
Video could be effective use of time and 
energy in clinic- able to set up and have 
family view/ demonstrate IT/ view video 
again if needed.  Would need to 
investigate if able to obtain the video used 
in this study.  Using new video could alter 
the evidence (i.e. making our own video) 
1: Gillette et al. (2016); 2: Rodriguez-Martinez et al. (2017);  3: Alexander et al. (2016); 4: Amirav et al. (1994); 5: Burkhart et al. (2000); 6: Carpenter et al. (2015); 7: 
Kamps et al. (2000); 8: Zivkovic et al. (2008); 9: Bourne (1996); 10: Capanoglu et al. (2015); 11: Carpenter et al. (2016); 12: Chen et al. (2002); 13: Foland et al. (2002); 
14: Janssen et al. (2003); 15: Jones et al. (1995); 16: Levy et al. (2013); 17: Minai et al. (2004); 18: Munzenberger et al. (2007); 19: Sleath et al. (2011); 20: Turkeli et al. 
(2016); 21: Deerojanawong et al. (2009); 22: Walia et al. (2006); 23: Schmier et al. (2007); 24: Manriquez et al. (2015); 25: Reznik et al. (2013); 26: deGroot et al. 
(2014); 27: Duerden, et al. (2001); 28: Pedersen et al. (2010); 29: Price et al. (2013); 30: Morin, 2012 
AC: asthma control; ACT: asthma control test;  AE: asthma education; AQLQ: asthma quality of life questionnaire; AS: asthma severity; AV: after video; BV: before 
video; CC: completely confident; DV: dependent variable; DX: diagnosis; FEV1: forced expiratory volume 1 second;  ER: emergency room; FVC: forced vital 
capacity; GINA: global initiative for asthma; GT: good inhaler technique; HOH: hard of hearing; ICS: inhaled corticosteroid; IMPACT: Improving the Management 
of Patients Asthma and COPD Treatment; IT: inhaler technique; IV: independent variable; MDI: metered dose inhaler; NC: no change; NCC: not completely confident; 
NS: no significance; Obs: observational; PACT: pediatric asthma clinic trial; PE: physical exam; PIF: peak inspiratory flow; PFT: pulmonary function test;  pop: 
population; PP: parental perception RCT: randomized controlled study; RT: respiratory therapist; RTC: return to clinic; SE: self-efficacy; VT: verbal inhaler training; 
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 IT ed 















-parents ?? on 
instructions 
-did parents feel 
child did good 
IT 
















hypothesis on IT 
instruction could 






Initial- 58% correct 
IT/ 97% perceived 
correct IT 
control: 
93% correct  IT 
p<0.0006 
pharm ed  
79% correct IT 
MD/RN ed: 
39% correct IT 
P<0.0014 
?? data: 
-Pharm ed: IT 
displayed and 
Single short instruction re: IT rarely 
successful 
Patients whom received ↑ personalized 
education with repeated education and 
demonstration had ↑ IT 
Just verbal education ↓ IT 
Weaknesses: 
Intervention group and control groups 
were not equal (did not discuss why or if 
power analysis was done) 
Some bias noted in discussion: authors 
stated none of children from 
disadvantaged background so most likely 
no compliance issues- that may not 
equate- disadvantaged can have good 
compliance and visa versa 
1: Gillette et al. (2016); 2: Rodriguez-Martinez et al. (2017);  3: Alexander et al. (2016); 4: Amirav et al. (1994); 5: Burkhart et al. (2000); 6: Carpenter et al. (2015); 7: 
Kamps et al. (2000); 8: Zivkovic et al. (2008); 9: Bourne (1996); 10: Capanoglu et al. (2015); 11: Carpenter et al. (2016); 12: Chen et al. (2002); 13: Foland et al. (2002); 
14: Janssen et al. (2003); 15: Jones et al. (1995); 16: Levy et al. (2013); 17: Minai et al. (2004); 18: Munzenberger et al. (2007); 19: Sleath et al. (2011); 20: Turkeli et al. 
(2016); 21: Deerojanawong et al. (2009); 22: Walia et al. (2006); 23: Schmier et al. (2007); 24: Manriquez et al. (2015); 25: Reznik et al. (2013); 26: deGroot et al. 
(2014); 27: Duerden, et al. (2001); 28: Pedersen et al. (2010); 29: Price et al. (2013); 30: Morin, 2012 
AC: asthma control; ACT: asthma control test;  AE: asthma education; AQLQ: asthma quality of life questionnaire; AS: asthma severity; AV: after video; BV: before 
video; CC: completely confident; DV: dependent variable; DX: diagnosis; FEV1: forced expiratory volume 1 second;  ER: emergency room; FVC: forced vital 
capacity; GINA: global initiative for asthma; GT: good inhaler technique; HOH: hard of hearing; ICS: inhaled corticosteroid; IMPACT: Improving the Management 
of Patients Asthma and COPD Treatment; IT: inhaler technique; IV: independent variable; MDI: metered dose inhaler; NC: no change; NCC: not completely confident; 
NS: no significance; Obs: observational; PACT: pediatric asthma clinic trial; PE: physical exam; PIF: peak inspiratory flow; PFT: pulmonary function test;  pop: 
population; PP: parental perception RCT: randomized controlled study; RT: respiratory therapist; RTC: return to clinic; SE: self-efficacy; VT: verbal inhaler training; 
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x2 over 4 
weeks 
-6 weeks later 





reviewed til correct 
IT (30 min) 
Missed IT steps: 
Not shaking 







longer than 5 minute 
(qualitative data- no 
stats given) 
No CI 













































































-LABA use ↑ 
8.7%/17.1% p<0.001 
Parental concern AS 
With education, video and demonstration- 
increase in IT, compliance, AK, ↓ fear,  
Those patients who received only regular 
education- no video or other specialized 
education did not show same effect 
Weaknesses 
Intervention group=231/ control 71- large 
difference 
 
My project: this study over a 12 month 
period of time whereas most studies much 
1: Gillette et al. (2016); 2: Rodriguez-Martinez et al. (2017);  3: Alexander et al. (2016); 4: Amirav et al. (1994); 5: Burkhart et al. (2000); 6: Carpenter et al. (2015); 7: 
Kamps et al. (2000); 8: Zivkovic et al. (2008); 9: Bourne (1996); 10: Capanoglu et al. (2015); 11: Carpenter et al. (2016); 12: Chen et al. (2002); 13: Foland et al. (2002); 
14: Janssen et al. (2003); 15: Jones et al. (1995); 16: Levy et al. (2013); 17: Minai et al. (2004); 18: Munzenberger et al. (2007); 19: Sleath et al. (2011); 20: Turkeli et al. 
(2016); 21: Deerojanawong et al. (2009); 22: Walia et al. (2006); 23: Schmier et al. (2007); 24: Manriquez et al. (2015); 25: Reznik et al. (2013); 26: deGroot et al. 
(2014); 27: Duerden, et al. (2001); 28: Pedersen et al. (2010); 29: Price et al. (2013); 30: Morin, 2012 
AC: asthma control; ACT: asthma control test;  AE: asthma education; AQLQ: asthma quality of life questionnaire; AS: asthma severity; AV: after video; BV: before 
video; CC: completely confident; DV: dependent variable; DX: diagnosis; FEV1: forced expiratory volume 1 second;  ER: emergency room; FVC: forced vital 
capacity; GINA: global initiative for asthma; GT: good inhaler technique; HOH: hard of hearing; ICS: inhaled corticosteroid; IMPACT: Improving the Management 
of Patients Asthma and COPD Treatment; IT: inhaler technique; IV: independent variable; MDI: metered dose inhaler; NC: no change; NCC: not completely confident; 
NS: no significance; Obs: observational; PACT: pediatric asthma clinic trial; PE: physical exam; PIF: peak inspiratory flow; PFT: pulmonary function test;  pop: 
population; PP: parental perception RCT: randomized controlled study; RT: respiratory therapist; RTC: return to clinic; SE: self-efficacy; VT: verbal inhaler training; 
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excluded due to 
above 








↓ concern asthmatic 
child: 72.6%-50.5% 
p<0.05 




















shorter duration.  As well, more into an 
asthma ed program- which practice 
working on- however project just IT.  
However, could possibly role my project 
into the bigger.  Must think about if by 
doing that would any change be due to the 
IT portion or to the full new education 
portion. 
1: Gillette et al. (2016); 2: Rodriguez-Martinez et al. (2017);  3: Alexander et al. (2016); 4: Amirav et al. (1994); 5: Burkhart et al. (2000); 6: Carpenter et al. (2015); 7: 
Kamps et al. (2000); 8: Zivkovic et al. (2008); 9: Bourne (1996); 10: Capanoglu et al. (2015); 11: Carpenter et al. (2016); 12: Chen et al. (2002); 13: Foland et al. (2002); 
14: Janssen et al. (2003); 15: Jones et al. (1995); 16: Levy et al. (2013); 17: Minai et al. (2004); 18: Munzenberger et al. (2007); 19: Sleath et al. (2011); 20: Turkeli et al. 
(2016); 21: Deerojanawong et al. (2009); 22: Walia et al. (2006); 23: Schmier et al. (2007); 24: Manriquez et al. (2015); 25: Reznik et al. (2013); 26: deGroot et al. 
(2014); 27: Duerden, et al. (2001); 28: Pedersen et al. (2010); 29: Price et al. (2013); 30: Morin, 2012 
AC: asthma control; ACT: asthma control test;  AE: asthma education; AQLQ: asthma quality of life questionnaire; AS: asthma severity; AV: after video; BV: before 
video; CC: completely confident; DV: dependent variable; DX: diagnosis; FEV1: forced expiratory volume 1 second;  ER: emergency room; FVC: forced vital 
capacity; GINA: global initiative for asthma; GT: good inhaler technique; HOH: hard of hearing; ICS: inhaled corticosteroid; IMPACT: Improving the Management 
of Patients Asthma and COPD Treatment; IT: inhaler technique; IV: independent variable; MDI: metered dose inhaler; NC: no change; NCC: not completely confident; 
NS: no significance; Obs: observational; PACT: pediatric asthma clinic trial; PE: physical exam; PIF: peak inspiratory flow; PFT: pulmonary function test;  pop: 
population; PP: parental perception RCT: randomized controlled study; RT: respiratory therapist; RTC: return to clinic; SE: self-efficacy; VT: verbal inhaler training; 
























Appraisal of Worth to Practice 
Strength of the Evidence (i.e., level of 
evidence + quality [study strengths and 
weaknesses]) 
RECOMMENDATIONS 
↓Fear of asthma: 
35.6%/7.8% p<0.01 
















1: Gillette et al. (2016); 2: Rodriguez-Martinez et al. (2017);  3: Alexander et al. (2016); 4: Amirav et al. (1994); 5: Burkhart et al. (2000); 6: Carpenter et al. (2015); 7: 
Kamps et al. (2000); 8: Zivkovic et al. (2008); 9: Bourne (1996); 10: Capanoglu et al. (2015); 11: Carpenter et al. (2016); 12: Chen et al. (2002); 13: Foland et al. (2002); 
14: Janssen et al. (2003); 15: Jones et al. (1995); 16: Levy et al. (2013); 17: Minai et al. (2004); 18: Munzenberger et al. (2007); 19: Sleath et al. (2011); 20: Turkeli et al. 
(2016); 21: Deerojanawong et al. (2009); 22: Walia et al. (2006); 23: Schmier et al. (2007); 24: Manriquez et al. (2015); 25: Reznik et al. (2013); 26: deGroot et al. 
(2014); 27: Duerden, et al. (2001); 28: Pedersen et al. (2010); 29: Price et al. (2013); 30: Morin, 2012 
AC: asthma control; ACT: asthma control test;  AE: asthma education; AQLQ: asthma quality of life questionnaire; AS: asthma severity; AV: after video; BV: before 
video; CC: completely confident; DV: dependent variable; DX: diagnosis; FEV1: forced expiratory volume 1 second;  ER: emergency room; FVC: forced vital 
capacity; GINA: global initiative for asthma; GT: good inhaler technique; HOH: hard of hearing; ICS: inhaled corticosteroid; IMPACT: Improving the Management 
of Patients Asthma and COPD Treatment; IT: inhaler technique; IV: independent variable; MDI: metered dose inhaler; NC: no change; NCC: not completely confident; 
NS: no significance; Obs: observational; PACT: pediatric asthma clinic trial; PE: physical exam; PIF: peak inspiratory flow; PFT: pulmonary function test;  pop: 
population; PP: parental perception RCT: randomized controlled study; RT: respiratory therapist; RTC: return to clinic; SE: self-efficacy; VT: verbal inhaler training; 
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improved IT post 
teaching. 
Slow inhalation step 
without 100% correct 
technique 
10% IT improvement 




Only 1 examiner for IT; author noted 
consistency; however potential bias 
Some patients used MDI morning prior to 
appt; could skew results (mainly PFT) 
Education patients for IT ↑ IT 
1: Gillette et al. (2016); 2: Rodriguez-Martinez et al. (2017);  3: Alexander et al. (2016); 4: Amirav et al. (1994); 5: Burkhart et al. (2000); 6: Carpenter et al. (2015); 7: 
Kamps et al. (2000); 8: Zivkovic et al. (2008); 9: Bourne (1996); 10: Capanoglu et al. (2015); 11: Carpenter et al. (2016); 12: Chen et al. (2002); 13: Foland et al. (2002); 
14: Janssen et al. (2003); 15: Jones et al. (1995); 16: Levy et al. (2013); 17: Minai et al. (2004); 18: Munzenberger et al. (2007); 19: Sleath et al. (2011); 20: Turkeli et al. 
(2016); 21: Deerojanawong et al. (2009); 22: Walia et al. (2006); 23: Schmier et al. (2007); 24: Manriquez et al. (2015); 25: Reznik et al. (2013); 26: deGroot et al. 
(2014); 27: Duerden, et al. (2001); 28: Pedersen et al. (2010); 29: Price et al. (2013); 30: Morin, 2012 
AC: asthma control; ACT: asthma control test;  AE: asthma education; AQLQ: asthma quality of life questionnaire; AS: asthma severity; AV: after video; BV: before 
video; CC: completely confident; DV: dependent variable; DX: diagnosis; FEV1: forced expiratory volume 1 second;  ER: emergency room; FVC: forced vital 
capacity; GINA: global initiative for asthma; GT: good inhaler technique; HOH: hard of hearing; ICS: inhaled corticosteroid; IMPACT: Improving the Management 
of Patients Asthma and COPD Treatment; IT: inhaler technique; IV: independent variable; MDI: metered dose inhaler; NC: no change; NCC: not completely confident; 
NS: no significance; Obs: observational; PACT: pediatric asthma clinic trial; PE: physical exam; PIF: peak inspiratory flow; PFT: pulmonary function test;  pop: 
population; PP: parental perception RCT: randomized controlled study; RT: respiratory therapist; RTC: return to clinic; SE: self-efficacy; VT: verbal inhaler training; 
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Asthma, f/u at 




only use rescue 
MDI 
IT 




?? ICS use, if no: 
















































-forget to take 51.3% 
-complicated 
technique 25.5% 
-feel well, don’t need 
15.4% 
-fear side effect 7.8% 
AC:adherence 
Correct IT and ↑ adherence equated to ↑ 
AC 
Incorrect IT: 42.2% 
Irregular use: 22.9% 
Education has to be repeated to maintain 
IT ; at least 3 times of teaching for IT to 
be correct 
IT should be evaluated before making 
therapy change- AC could ↓ with ↓ IT 
Weakness of study: parental report only 
on adherence- no other observable metric 
for adherence (stated by authors as well) 
 
What steps of IT missed most in study to 
look at in CHP-BPA 
F/U 3 months after intervention- one of 
few studies with follow up 
 
1: Gillette et al. (2016); 2: Rodriguez-Martinez et al. (2017);  3: Alexander et al. (2016); 4: Amirav et al. (1994); 5: Burkhart et al. (2000); 6: Carpenter et al. (2015); 7: 
Kamps et al. (2000); 8: Zivkovic et al. (2008); 9: Bourne (1996); 10: Capanoglu et al. (2015); 11: Carpenter et al. (2016); 12: Chen et al. (2002); 13: Foland et al. (2002); 
14: Janssen et al. (2003); 15: Jones et al. (1995); 16: Levy et al. (2013); 17: Minai et al. (2004); 18: Munzenberger et al. (2007); 19: Sleath et al. (2011); 20: Turkeli et al. 
(2016); 21: Deerojanawong et al. (2009); 22: Walia et al. (2006); 23: Schmier et al. (2007); 24: Manriquez et al. (2015); 25: Reznik et al. (2013); 26: deGroot et al. 
(2014); 27: Duerden, et al. (2001); 28: Pedersen et al. (2010); 29: Price et al. (2013); 30: Morin, 2012 
AC: asthma control; ACT: asthma control test;  AE: asthma education; AQLQ: asthma quality of life questionnaire; AS: asthma severity; AV: after video; BV: before 
video; CC: completely confident; DV: dependent variable; DX: diagnosis; FEV1: forced expiratory volume 1 second;  ER: emergency room; FVC: forced vital 
capacity; GINA: global initiative for asthma; GT: good inhaler technique; HOH: hard of hearing; ICS: inhaled corticosteroid; IMPACT: Improving the Management 
of Patients Asthma and COPD Treatment; IT: inhaler technique; IV: independent variable; MDI: metered dose inhaler; NC: no change; NCC: not completely confident; 
NS: no significance; Obs: observational; PACT: pediatric asthma clinic trial; PE: physical exam; PIF: peak inspiratory flow; PFT: pulmonary function test;  pop: 
population; PP: parental perception RCT: randomized controlled study; RT: respiratory therapist; RTC: return to clinic; SE: self-efficacy; VT: verbal inhaler training; 
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DPI: 52 (30) 
 
Correct IT: MDI 
68.1% vs DPI 34.6% 
p<0.001 
Missed steps: 
-hold breath 10 sec: 
24.4% 
- shake inhaler 21% 
 
Carpenter, 






















7 school RNs 























Mean steps correct: 
BV: 6.4 AV: 7.6 
P=0.03 
1 month f/u: 
100% accuracy 
p=0.01 
Video use as education did help to ↑ IT.  
Authors have not concluded if just the 
video or if combination of rapport with  
school RNs and video included 
 
Only a 5 minute video.  Dependent upon 
cost, this could easily be feasible within 
our practice 
1: Gillette et al. (2016); 2: Rodriguez-Martinez et al. (2017);  3: Alexander et al. (2016); 4: Amirav et al. (1994); 5: Burkhart et al. (2000); 6: Carpenter et al. (2015); 7: 
Kamps et al. (2000); 8: Zivkovic et al. (2008); 9: Bourne (1996); 10: Capanoglu et al. (2015); 11: Carpenter et al. (2016); 12: Chen et al. (2002); 13: Foland et al. (2002); 
14: Janssen et al. (2003); 15: Jones et al. (1995); 16: Levy et al. (2013); 17: Minai et al. (2004); 18: Munzenberger et al. (2007); 19: Sleath et al. (2011); 20: Turkeli et al. 
(2016); 21: Deerojanawong et al. (2009); 22: Walia et al. (2006); 23: Schmier et al. (2007); 24: Manriquez et al. (2015); 25: Reznik et al. (2013); 26: deGroot et al. 
(2014); 27: Duerden, et al. (2001); 28: Pedersen et al. (2010); 29: Price et al. (2013); 30: Morin, 2012 
AC: asthma control; ACT: asthma control test;  AE: asthma education; AQLQ: asthma quality of life questionnaire; AS: asthma severity; AV: after video; BV: before 
video; CC: completely confident; DV: dependent variable; DX: diagnosis; FEV1: forced expiratory volume 1 second;  ER: emergency room; FVC: forced vital 
capacity; GINA: global initiative for asthma; GT: good inhaler technique; HOH: hard of hearing; ICS: inhaled corticosteroid; IMPACT: Improving the Management 
of Patients Asthma and COPD Treatment; IT: inhaler technique; IV: independent variable; MDI: metered dose inhaler; NC: no change; NCC: not completely confident; 
NS: no significance; Obs: observational; PACT: pediatric asthma clinic trial; PE: physical exam; PIF: peak inspiratory flow; PFT: pulmonary function test;  pop: 
population; PP: parental perception RCT: randomized controlled study; RT: respiratory therapist; RTC: return to clinic; SE: self-efficacy; VT: verbal inhaler training; 
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Mean age 11.5 
Time 1 month 
Qual. 
Analysis  
MDI no spacer: 
Mean steps correct: 
BV: 4.5 AV: 7.2 
p<0.01 





96% chose avatar 
same gender 
70% same race 
Focus group: 
Overall: 
RNs thought feasible  
5 minutes to 
implement video 
with each child 
Children reacted well 
to positive vibe from 
video 
 
Praise given to the children- not just want 




Small sample size 
Authors noted that avatars not of different 
age groups- may make a difference 
Authors noted, as do I, that school nurses 
wanted to be part of study, could have 
more interest or buy in with their students 
than other school nurses or school 
programs 
 
As tech savvy as our population is- this 
would be an excellent avenue to look into.  
Short implementation time and high yield 
of results.  Would need to see how we 
would be able to acquire this video 
program 
1: Gillette et al. (2016); 2: Rodriguez-Martinez et al. (2017);  3: Alexander et al. (2016); 4: Amirav et al. (1994); 5: Burkhart et al. (2000); 6: Carpenter et al. (2015); 7: 
Kamps et al. (2000); 8: Zivkovic et al. (2008); 9: Bourne (1996); 10: Capanoglu et al. (2015); 11: Carpenter et al. (2016); 12: Chen et al. (2002); 13: Foland et al. (2002); 
14: Janssen et al. (2003); 15: Jones et al. (1995); 16: Levy et al. (2013); 17: Minai et al. (2004); 18: Munzenberger et al. (2007); 19: Sleath et al. (2011); 20: Turkeli et al. 
(2016); 21: Deerojanawong et al. (2009); 22: Walia et al. (2006); 23: Schmier et al. (2007); 24: Manriquez et al. (2015); 25: Reznik et al. (2013); 26: deGroot et al. 
(2014); 27: Duerden, et al. (2001); 28: Pedersen et al. (2010); 29: Price et al. (2013); 30: Morin, 2012 
AC: asthma control; ACT: asthma control test;  AE: asthma education; AQLQ: asthma quality of life questionnaire; AS: asthma severity; AV: after video; BV: before 
video; CC: completely confident; DV: dependent variable; DX: diagnosis; FEV1: forced expiratory volume 1 second;  ER: emergency room; FVC: forced vital 
capacity; GINA: global initiative for asthma; GT: good inhaler technique; HOH: hard of hearing; ICS: inhaled corticosteroid; IMPACT: Improving the Management 
of Patients Asthma and COPD Treatment; IT: inhaler technique; IV: independent variable; MDI: metered dose inhaler; NC: no change; NCC: not completely confident; 
NS: no significance; Obs: observational; PACT: pediatric asthma clinic trial; PE: physical exam; PIF: peak inspiratory flow; PFT: pulmonary function test;  pop: 
population; PP: parental perception RCT: randomized controlled study; RT: respiratory therapist; RTC: return to clinic; SE: self-efficacy; VT: verbal inhaler training; 
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½ of participants no 
follow up care 
Our population similar; lack of regular f/u 
care; only seeking care for exacerbation 
Participants decreased knowledge 
regarding asthma and asthma care; same 
as our clinic 
Similar barriers- lack of time and 
assumption patients know how to perform 
IT 
 
1: Gillette et al. (2016); 2: Rodriguez-Martinez et al. (2017);  3: Alexander et al. (2016); 4: Amirav et al. (1994); 5: Burkhart et al. (2000); 6: Carpenter et al. (2015); 7: 
Kamps et al. (2000); 8: Zivkovic et al. (2008); 9: Bourne (1996); 10: Capanoglu et al. (2015); 11: Carpenter et al. (2016); 12: Chen et al. (2002); 13: Foland et al. (2002); 
14: Janssen et al. (2003); 15: Jones et al. (1995); 16: Levy et al. (2013); 17: Minai et al. (2004); 18: Munzenberger et al. (2007); 19: Sleath et al. (2011); 20: Turkeli et al. 
(2016); 21: Deerojanawong et al. (2009); 22: Walia et al. (2006); 23: Schmier et al. (2007); 24: Manriquez et al. (2015); 25: Reznik et al. (2013); 26: deGroot et al. 
(2014); 27: Duerden, et al. (2001); 28: Pedersen et al. (2010); 29: Price et al. (2013); 30: Morin, 2012 
AC: asthma control; ACT: asthma control test;  AE: asthma education; AQLQ: asthma quality of life questionnaire; AS: asthma severity; AV: after video; BV: before 
video; CC: completely confident; DV: dependent variable; DX: diagnosis; FEV1: forced expiratory volume 1 second;  ER: emergency room; FVC: forced vital 
capacity; GINA: global initiative for asthma; GT: good inhaler technique; HOH: hard of hearing; ICS: inhaled corticosteroid; IMPACT: Improving the Management 
of Patients Asthma and COPD Treatment; IT: inhaler technique; IV: independent variable; MDI: metered dose inhaler; NC: no change; NCC: not completely confident; 
NS: no significance; Obs: observational; PACT: pediatric asthma clinic trial; PE: physical exam; PIF: peak inspiratory flow; PFT: pulmonary function test;  pop: 
population; PP: parental perception RCT: randomized controlled study; RT: respiratory therapist; RTC: return to clinic; SE: self-efficacy; VT: verbal inhaler training; 
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21% had ≥ 4 
asthma attack 
over 12 months 
















family ↑ IT 
 






















Age range 5-17 






Pre: 64 hospital 
















IT: pre/post eval 
of IT 
Pre: 3/26 (12%) 
perfect IT 
Steps correct 1st: 
• 1: 92% 

























Missed IT steps: 
1 single hand on and verbal coaching 
session improved IT in children 
Weaknesses: did not perform study with a 
spacer; in actuality have to consider if my 
patient population uses spacer at home 
Authors stated that FEV1, meds and AS 
measured each visit; but this data not 
given in article. 
Authors state that at time of publication- 
further study being performed to see when 
children lost any gains with IT. 
This study utilized the ability to allow 
children to come in on a walk in basis.  
This would also be a very interesting 
concept to explore if our clinic would be 
willing and able to allow this to occur 
(support personnel.  Possibly, could have 
1: Gillette et al. (2016); 2: Rodriguez-Martinez et al. (2017);  3: Alexander et al. (2016); 4: Amirav et al. (1994); 5: Burkhart et al. (2000); 6: Carpenter et al. (2015); 7: 
Kamps et al. (2000); 8: Zivkovic et al. (2008); 9: Bourne (1996); 10: Capanoglu et al. (2015); 11: Carpenter et al. (2016); 12: Chen et al. (2002); 13: Foland et al. (2002); 
14: Janssen et al. (2003); 15: Jones et al. (1995); 16: Levy et al. (2013); 17: Minai et al. (2004); 18: Munzenberger et al. (2007); 19: Sleath et al. (2011); 20: Turkeli et al. 
(2016); 21: Deerojanawong et al. (2009); 22: Walia et al. (2006); 23: Schmier et al. (2007); 24: Manriquez et al. (2015); 25: Reznik et al. (2013); 26: deGroot et al. 
(2014); 27: Duerden, et al. (2001); 28: Pedersen et al. (2010); 29: Price et al. (2013); 30: Morin, 2012 
AC: asthma control; ACT: asthma control test;  AE: asthma education; AQLQ: asthma quality of life questionnaire; AS: asthma severity; AV: after video; BV: before 
video; CC: completely confident; DV: dependent variable; DX: diagnosis; FEV1: forced expiratory volume 1 second;  ER: emergency room; FVC: forced vital 
capacity; GINA: global initiative for asthma; GT: good inhaler technique; HOH: hard of hearing; ICS: inhaled corticosteroid; IMPACT: Improving the Management 
of Patients Asthma and COPD Treatment; IT: inhaler technique; IV: independent variable; MDI: metered dose inhaler; NC: no change; NCC: not completely confident; 
NS: no significance; Obs: observational; PACT: pediatric asthma clinic trial; PE: physical exam; PIF: peak inspiratory flow; PFT: pulmonary function test;  pop: 
population; PP: parental perception RCT: randomized controlled study; RT: respiratory therapist; RTC: return to clinic; SE: self-efficacy; VT: verbal inhaler training; 
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hours on certain days of week where this 
could occur.) 
 
Statistical testing stated- only p values 
given.  Not given further statistics 
Janssen, et 















































failure to exhale 
Waiting 30 seconds 
next dose 
90% received some 
instruction at time of 
script; only 15% 
received repeated 
instruction 
Most children and parents consider their 
IT is adequate when in reality this 
generally is not the case.  This study 75% 
of children could not use correctly even 
though thought had good technique 
In questionnaire- most children received 
some form of education at time of MDI 
being prescribed- but did not receive 
education again.  In this study, again, 75% 
children poor IT 
The more education/instruction given the 
better the IT 
1: Gillette et al. (2016); 2: Rodriguez-Martinez et al. (2017);  3: Alexander et al. (2016); 4: Amirav et al. (1994); 5: Burkhart et al. (2000); 6: Carpenter et al. (2015); 7: 
Kamps et al. (2000); 8: Zivkovic et al. (2008); 9: Bourne (1996); 10: Capanoglu et al. (2015); 11: Carpenter et al. (2016); 12: Chen et al. (2002); 13: Foland et al. (2002); 
14: Janssen et al. (2003); 15: Jones et al. (1995); 16: Levy et al. (2013); 17: Minai et al. (2004); 18: Munzenberger et al. (2007); 19: Sleath et al. (2011); 20: Turkeli et al. 
(2016); 21: Deerojanawong et al. (2009); 22: Walia et al. (2006); 23: Schmier et al. (2007); 24: Manriquez et al. (2015); 25: Reznik et al. (2013); 26: deGroot et al. 
(2014); 27: Duerden, et al. (2001); 28: Pedersen et al. (2010); 29: Price et al. (2013); 30: Morin, 2012 
AC: asthma control; ACT: asthma control test;  AE: asthma education; AQLQ: asthma quality of life questionnaire; AS: asthma severity; AV: after video; BV: before 
video; CC: completely confident; DV: dependent variable; DX: diagnosis; FEV1: forced expiratory volume 1 second;  ER: emergency room; FVC: forced vital 
capacity; GINA: global initiative for asthma; GT: good inhaler technique; HOH: hard of hearing; ICS: inhaled corticosteroid; IMPACT: Improving the Management 
of Patients Asthma and COPD Treatment; IT: inhaler technique; IV: independent variable; MDI: metered dose inhaler; NC: no change; NCC: not completely confident; 
NS: no significance; Obs: observational; PACT: pediatric asthma clinic trial; PE: physical exam; PIF: peak inspiratory flow; PFT: pulmonary function test;  pop: 
population; PP: parental perception RCT: randomized controlled study; RT: respiratory therapist; RTC: return to clinic; SE: self-efficacy; VT: verbal inhaler training; 
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5 years use or more 
↑IT: p=0.008 
All children and 
parents scored IT as 
adequate even with 
75% missing steps 
Mann Whitney 
Age 0.577 
User duration 0.008 
Chi square: 
Sex 0.891 
Instructor (type of 
medical provider) 
0.590 
AC on IT p=0.014 
Age, type of instructor not have effect on 
IT 
AC and length of use of inhaler effects IT 
My practice- most patient state can use 
inhaler- but we are not currently eval IT. I 
would be very interested to incorporate 
this knowledge into my project as well 
 
1: Gillette et al. (2016); 2: Rodriguez-Martinez et al. (2017);  3: Alexander et al. (2016); 4: Amirav et al. (1994); 5: Burkhart et al. (2000); 6: Carpenter et al. (2015); 7: 
Kamps et al. (2000); 8: Zivkovic et al. (2008); 9: Bourne (1996); 10: Capanoglu et al. (2015); 11: Carpenter et al. (2016); 12: Chen et al. (2002); 13: Foland et al. (2002); 
14: Janssen et al. (2003); 15: Jones et al. (1995); 16: Levy et al. (2013); 17: Minai et al. (2004); 18: Munzenberger et al. (2007); 19: Sleath et al. (2011); 20: Turkeli et al. 
(2016); 21: Deerojanawong et al. (2009); 22: Walia et al. (2006); 23: Schmier et al. (2007); 24: Manriquez et al. (2015); 25: Reznik et al. (2013); 26: deGroot et al. 
(2014); 27: Duerden, et al. (2001); 28: Pedersen et al. (2010); 29: Price et al. (2013); 30: Morin, 2012 
AC: asthma control; ACT: asthma control test;  AE: asthma education; AQLQ: asthma quality of life questionnaire; AS: asthma severity; AV: after video; BV: before 
video; CC: completely confident; DV: dependent variable; DX: diagnosis; FEV1: forced expiratory volume 1 second;  ER: emergency room; FVC: forced vital 
capacity; GINA: global initiative for asthma; GT: good inhaler technique; HOH: hard of hearing; ICS: inhaled corticosteroid; IMPACT: Improving the Management 
of Patients Asthma and COPD Treatment; IT: inhaler technique; IV: independent variable; MDI: metered dose inhaler; NC: no change; NCC: not completely confident; 
NS: no significance; Obs: observational; PACT: pediatric asthma clinic trial; PE: physical exam; PIF: peak inspiratory flow; PFT: pulmonary function test;  pop: 
population; PP: parental perception RCT: randomized controlled study; RT: respiratory therapist; RTC: return to clinic; SE: self-efficacy; VT: verbal inhaler training; 
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(60 ER house 
staff; 50 ER 
attending; 75 
ED RN) 
N=100 ER pt 
asthma, MDI 3 
months 
Knowledge of 
IT: ability to 
demonstrate 
correct IT 











41% providers 5/6 
steps correct 




health care providers 
15% providers/17% 
patients estimate 
amount medication in 
canister 
90% providers knew 
about spacer 
28% describe spacer 
Provides & patients do not have correct IT 
greater than half the time 
No significant difference between types of 
health care providers IT knowledge 
Decrease spacer knowledge 
 




































IT 3 visits failed: 
58, 52, 38% incorrect 








Need to assess IT in order to order and 
continue with MDI treatment 
Spacer use ↑IT 
Used in-check dial for IT assess 
Weakness: no control group 
Since retrospective not able to ascertain if 
abiding by guidelines or if noncompliance 
issue 
1: Gillette et al. (2016); 2: Rodriguez-Martinez et al. (2017);  3: Alexander et al. (2016); 4: Amirav et al. (1994); 5: Burkhart et al. (2000); 6: Carpenter et al. (2015); 7: 
Kamps et al. (2000); 8: Zivkovic et al. (2008); 9: Bourne (1996); 10: Capanoglu et al. (2015); 11: Carpenter et al. (2016); 12: Chen et al. (2002); 13: Foland et al. (2002); 
14: Janssen et al. (2003); 15: Jones et al. (1995); 16: Levy et al. (2013); 17: Minai et al. (2004); 18: Munzenberger et al. (2007); 19: Sleath et al. (2011); 20: Turkeli et al. 
(2016); 21: Deerojanawong et al. (2009); 22: Walia et al. (2006); 23: Schmier et al. (2007); 24: Manriquez et al. (2015); 25: Reznik et al. (2013); 26: deGroot et al. 
(2014); 27: Duerden, et al. (2001); 28: Pedersen et al. (2010); 29: Price et al. (2013); 30: Morin, 2012 
AC: asthma control; ACT: asthma control test;  AE: asthma education; AQLQ: asthma quality of life questionnaire; AS: asthma severity; AV: after video; BV: before 
video; CC: completely confident; DV: dependent variable; DX: diagnosis; FEV1: forced expiratory volume 1 second;  ER: emergency room; FVC: forced vital 
capacity; GINA: global initiative for asthma; GT: good inhaler technique; HOH: hard of hearing; ICS: inhaled corticosteroid; IMPACT: Improving the Management 
of Patients Asthma and COPD Treatment; IT: inhaler technique; IV: independent variable; MDI: metered dose inhaler; NC: no change; NCC: not completely confident; 
NS: no significance; Obs: observational; PACT: pediatric asthma clinic trial; PE: physical exam; PIF: peak inspiratory flow; PFT: pulmonary function test;  pop: 
population; PP: parental perception RCT: randomized controlled study; RT: respiratory therapist; RTC: return to clinic; SE: self-efficacy; VT: verbal inhaler training; 
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-no AC review 
15 months 











-Incorrect IT 4x 
higher uncontrolled 




exacerbation: fail IT 
(68%) 
P=0.03 
Short course steroids: 
↓IT (67%), p<0.05 
OR 0.50-0.89 
Use of spacer:↑IT 
(68% vs 51%) 
p<0.0001 Chi square 
value 20.16 
 
Project: office has availability to in-check 
dial- 2nd study to utilize 
 
Very important to consider this study with 
project—several patients have less than 
desirable asthma control- we do not 
currently measure IT.  Again, another 
study noting improved AC with improved 
IT 
 
Several patients in practice have oral 
steroids at least once per year- do not 
routinely check IT 
1: Gillette et al. (2016); 2: Rodriguez-Martinez et al. (2017);  3: Alexander et al. (2016); 4: Amirav et al. (1994); 5: Burkhart et al. (2000); 6: Carpenter et al. (2015); 7: 
Kamps et al. (2000); 8: Zivkovic et al. (2008); 9: Bourne (1996); 10: Capanoglu et al. (2015); 11: Carpenter et al. (2016); 12: Chen et al. (2002); 13: Foland et al. (2002); 
14: Janssen et al. (2003); 15: Jones et al. (1995); 16: Levy et al. (2013); 17: Minai et al. (2004); 18: Munzenberger et al. (2007); 19: Sleath et al. (2011); 20: Turkeli et al. 
(2016); 21: Deerojanawong et al. (2009); 22: Walia et al. (2006); 23: Schmier et al. (2007); 24: Manriquez et al. (2015); 25: Reznik et al. (2013); 26: deGroot et al. 
(2014); 27: Duerden, et al. (2001); 28: Pedersen et al. (2010); 29: Price et al. (2013); 30: Morin, 2012 
AC: asthma control; ACT: asthma control test;  AE: asthma education; AQLQ: asthma quality of life questionnaire; AS: asthma severity; AV: after video; BV: before 
video; CC: completely confident; DV: dependent variable; DX: diagnosis; FEV1: forced expiratory volume 1 second;  ER: emergency room; FVC: forced vital 
capacity; GINA: global initiative for asthma; GT: good inhaler technique; HOH: hard of hearing; ICS: inhaled corticosteroid; IMPACT: Improving the Management 
of Patients Asthma and COPD Treatment; IT: inhaler technique; IV: independent variable; MDI: metered dose inhaler; NC: no change; NCC: not completely confident; 
NS: no significance; Obs: observational; PACT: pediatric asthma clinic trial; PE: physical exam; PIF: peak inspiratory flow; PFT: pulmonary function test;  pop: 
population; PP: parental perception RCT: randomized controlled study; RT: respiratory therapist; RTC: return to clinic; SE: self-efficacy; VT: verbal inhaler training; 
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IV: PACT to 
individualize tx 
IT 
































-IT correct: 53%/81% 
-PFT severity: 
2.4/2.1 











With repeated demonstration and 
education ↑IT 
FEV and PFT not affected; authors ? if 
would see improved PFT after further time 
Weaknesses: no control group 
Small number 
f/u was determined by AS- so some 
children received ↑ ed compared to others 
 
some of our patients would also receive ↑ 
ed than others; ? possibility of having 
individualized education 
1: Gillette et al. (2016); 2: Rodriguez-Martinez et al. (2017);  3: Alexander et al. (2016); 4: Amirav et al. (1994); 5: Burkhart et al. (2000); 6: Carpenter et al. (2015); 7: 
Kamps et al. (2000); 8: Zivkovic et al. (2008); 9: Bourne (1996); 10: Capanoglu et al. (2015); 11: Carpenter et al. (2016); 12: Chen et al. (2002); 13: Foland et al. (2002); 
14: Janssen et al. (2003); 15: Jones et al. (1995); 16: Levy et al. (2013); 17: Minai et al. (2004); 18: Munzenberger et al. (2007); 19: Sleath et al. (2011); 20: Turkeli et al. 
(2016); 21: Deerojanawong et al. (2009); 22: Walia et al. (2006); 23: Schmier et al. (2007); 24: Manriquez et al. (2015); 25: Reznik et al. (2013); 26: deGroot et al. 
(2014); 27: Duerden, et al. (2001); 28: Pedersen et al. (2010); 29: Price et al. (2013); 30: Morin, 2012 
AC: asthma control; ACT: asthma control test;  AE: asthma education; AQLQ: asthma quality of life questionnaire; AS: asthma severity; AV: after video; BV: before 
video; CC: completely confident; DV: dependent variable; DX: diagnosis; FEV1: forced expiratory volume 1 second;  ER: emergency room; FVC: forced vital 
capacity; GINA: global initiative for asthma; GT: good inhaler technique; HOH: hard of hearing; ICS: inhaled corticosteroid; IMPACT: Improving the Management 
of Patients Asthma and COPD Treatment; IT: inhaler technique; IV: independent variable; MDI: metered dose inhaler; NC: no change; NCC: not completely confident; 
NS: no significance; Obs: observational; PACT: pediatric asthma clinic trial; PE: physical exam; PIF: peak inspiratory flow; PFT: pulmonary function test;  pop: 
population; PP: parental perception RCT: randomized controlled study; RT: respiratory therapist; RTC: return to clinic; SE: self-efficacy; VT: verbal inhaler training; 
























Appraisal of Worth to Practice 
Strength of the Evidence (i.e., level of 







































Group 1: MDI 
only (24 pt) 
Group 2: MDI 
& Discus use 
(48 pt) 


















Group 1: mean 2.7 
months to f/u 
Group 2: mean 3.8 
months to f/u 
Group 2 older; 
asthma longer; ↑ time 
used MDI 
Group 1 ↑ spacer use 
Group 1 ↓ AS 
Overall ↓ IT to f/u 
appt: 60% ↓ IT 
Group 1: 12/24 
correct IT 
Group 2: 14/48 
correct IT 
Each component IT: 
Authors compared their results to Kamps- 
with Kamps study ↑ IT with visits- one 
thought ↑ younger children in this study 
with adult supervision; vs older children 
alone 
Author noted bias in groups- MD 
preference to treatment required open non 
randomized design- could have influenced 
outcomes 
Utilized an 8 item inhaler use checklist; 
authors noted if used a different checklist 
outcomes could have been different 
1: Gillette et al. (2016); 2: Rodriguez-Martinez et al. (2017);  3: Alexander et al. (2016); 4: Amirav et al. (1994); 5: Burkhart et al. (2000); 6: Carpenter et al. (2015); 7: 
Kamps et al. (2000); 8: Zivkovic et al. (2008); 9: Bourne (1996); 10: Capanoglu et al. (2015); 11: Carpenter et al. (2016); 12: Chen et al. (2002); 13: Foland et al. (2002); 
14: Janssen et al. (2003); 15: Jones et al. (1995); 16: Levy et al. (2013); 17: Minai et al. (2004); 18: Munzenberger et al. (2007); 19: Sleath et al. (2011); 20: Turkeli et al. 
(2016); 21: Deerojanawong et al. (2009); 22: Walia et al. (2006); 23: Schmier et al. (2007); 24: Manriquez et al. (2015); 25: Reznik et al. (2013); 26: deGroot et al. 
(2014); 27: Duerden, et al. (2001); 28: Pedersen et al. (2010); 29: Price et al. (2013); 30: Morin, 2012 
AC: asthma control; ACT: asthma control test;  AE: asthma education; AQLQ: asthma quality of life questionnaire; AS: asthma severity; AV: after video; BV: before 
video; CC: completely confident; DV: dependent variable; DX: diagnosis; FEV1: forced expiratory volume 1 second;  ER: emergency room; FVC: forced vital 
capacity; GINA: global initiative for asthma; GT: good inhaler technique; HOH: hard of hearing; ICS: inhaled corticosteroid; IMPACT: Improving the Management 
of Patients Asthma and COPD Treatment; IT: inhaler technique; IV: independent variable; MDI: metered dose inhaler; NC: no change; NCC: not completely confident; 
NS: no significance; Obs: observational; PACT: pediatric asthma clinic trial; PE: physical exam; PIF: peak inspiratory flow; PFT: pulmonary function test;  pop: 
population; PP: parental perception RCT: randomized controlled study; RT: respiratory therapist; RTC: return to clinic; SE: self-efficacy; VT: verbal inhaler training; 
























Appraisal of Worth to Practice 
Strength of the Evidence (i.e., level of 




between group 1 & 2 
Even with 1 intense 
education session, 
↓IT by next visit 
Hands on with verbal 
education 
recommended 




































































8.1% correct IT 
patient (pearson r 
0.20 p<0.001) 
 
Providers asked 5.4% 
MDI users/2.3% 
children w/missed 
steps IT to demo IT 
to them 
Provider demo IT: 
3.8% all MDI/ 2.3% 
poor IT children 
Shows use of inter/intra collaboration in 
order to increase IT both child/provider 
 
Provider needs to know how to utilize as 
well 
 
These results most likely very common in 
most clinics 
Self efficacy: ↑SE=↑behavior (use MDI, 
undertake behavior). Model use of MDI 
can ↑ SE 
 
1: Gillette et al. (2016); 2: Rodriguez-Martinez et al. (2017);  3: Alexander et al. (2016); 4: Amirav et al. (1994); 5: Burkhart et al. (2000); 6: Carpenter et al. (2015); 7: 
Kamps et al. (2000); 8: Zivkovic et al. (2008); 9: Bourne (1996); 10: Capanoglu et al. (2015); 11: Carpenter et al. (2016); 12: Chen et al. (2002); 13: Foland et al. (2002); 
14: Janssen et al. (2003); 15: Jones et al. (1995); 16: Levy et al. (2013); 17: Minai et al. (2004); 18: Munzenberger et al. (2007); 19: Sleath et al. (2011); 20: Turkeli et al. 
(2016); 21: Deerojanawong et al. (2009); 22: Walia et al. (2006); 23: Schmier et al. (2007); 24: Manriquez et al. (2015); 25: Reznik et al. (2013); 26: deGroot et al. 
(2014); 27: Duerden, et al. (2001); 28: Pedersen et al. (2010); 29: Price et al. (2013); 30: Morin, 2012 
AC: asthma control; ACT: asthma control test;  AE: asthma education; AQLQ: asthma quality of life questionnaire; AS: asthma severity; AV: after video; BV: before 
video; CC: completely confident; DV: dependent variable; DX: diagnosis; FEV1: forced expiratory volume 1 second;  ER: emergency room; FVC: forced vital 
capacity; GINA: global initiative for asthma; GT: good inhaler technique; HOH: hard of hearing; ICS: inhaled corticosteroid; IMPACT: Improving the Management 
of Patients Asthma and COPD Treatment; IT: inhaler technique; IV: independent variable; MDI: metered dose inhaler; NC: no change; NCC: not completely confident; 
NS: no significance; Obs: observational; PACT: pediatric asthma clinic trial; PE: physical exam; PIF: peak inspiratory flow; PFT: pulmonary function test;  pop: 
population; PP: parental perception RCT: randomized controlled study; RT: respiratory therapist; RTC: return to clinic; SE: self-efficacy; VT: verbal inhaler training; 
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ACQ (aka ACT) 
















asthma 21 months 
 Mean months MDI 
use 17.4  
IT: 
Before education: 
4.9 (1.3 SD)  
After education: 




4.3 (3.6 SD) 
After education: 
0.2 (O.7 SD)  
P<0.001 
Errors IT steps before 
education: 
Lack mouth rinsing 
78.9% 
Common missed IT steps as seen in other 
studies 
2 step improvement in IT with education 
(verbal, hands on redemonstrations)- one 
of few studies listing step increase with 
education 
 
Decreased asthma severity noted with 
inhaler technique education 
1: Gillette et al. (2016); 2: Rodriguez-Martinez et al. (2017);  3: Alexander et al. (2016); 4: Amirav et al. (1994); 5: Burkhart et al. (2000); 6: Carpenter et al. (2015); 7: 
Kamps et al. (2000); 8: Zivkovic et al. (2008); 9: Bourne (1996); 10: Capanoglu et al. (2015); 11: Carpenter et al. (2016); 12: Chen et al. (2002); 13: Foland et al. (2002); 
14: Janssen et al. (2003); 15: Jones et al. (1995); 16: Levy et al. (2013); 17: Minai et al. (2004); 18: Munzenberger et al. (2007); 19: Sleath et al. (2011); 20: Turkeli et al. 
(2016); 21: Deerojanawong et al. (2009); 22: Walia et al. (2006); 23: Schmier et al. (2007); 24: Manriquez et al. (2015); 25: Reznik et al. (2013); 26: deGroot et al. 
(2014); 27: Duerden, et al. (2001); 28: Pedersen et al. (2010); 29: Price et al. (2013); 30: Morin, 2012 
AC: asthma control; ACT: asthma control test;  AE: asthma education; AQLQ: asthma quality of life questionnaire; AS: asthma severity; AV: after video; BV: before 
video; CC: completely confident; DV: dependent variable; DX: diagnosis; FEV1: forced expiratory volume 1 second;  ER: emergency room; FVC: forced vital 
capacity; GINA: global initiative for asthma; GT: good inhaler technique; HOH: hard of hearing; ICS: inhaled corticosteroid; IMPACT: Improving the Management 
of Patients Asthma and COPD Treatment; IT: inhaler technique; IV: independent variable; MDI: metered dose inhaler; NC: no change; NCC: not completely confident; 
NS: no significance; Obs: observational; PACT: pediatric asthma clinic trial; PE: physical exam; PIF: peak inspiratory flow; PFT: pulmonary function test;  pop: 
population; PP: parental perception RCT: randomized controlled study; RT: respiratory therapist; RTC: return to clinic; SE: self-efficacy; VT: verbal inhaler training; 
























Appraisal of Worth to Practice 
Strength of the Evidence (i.e., level of 
evidence + quality [study strengths and 
weaknesses]) 
RECOMMENDATIONS 
Lack exhaling before 
inhalation (65.8%) 
Not shaking inhaler 
(60.5%) 
Most common errors 
IT steps after 
education: 
Not shaking inhaler 
Not exhaling before 
inhalation 
Lack rinsing mouth 










MDI use w/ 

























Factors correct IT: 
-MDI given by 
caregiver: 28% 
correct IT 
->age 10: 66% 
correct IT 
-first instruction 
trained HCP: 28% 
-frequency ITT: once 
33% 
Author noted bias: children selected 
mostly had controlled asthma within the 
clinic 
Combination of MDI with spacers and 
without spacers; those w/spacers had 
improved IT 
1: Gillette et al. (2016); 2: Rodriguez-Martinez et al. (2017);  3: Alexander et al. (2016); 4: Amirav et al. (1994); 5: Burkhart et al. (2000); 6: Carpenter et al. (2015); 7: 
Kamps et al. (2000); 8: Zivkovic et al. (2008); 9: Bourne (1996); 10: Capanoglu et al. (2015); 11: Carpenter et al. (2016); 12: Chen et al. (2002); 13: Foland et al. (2002); 
14: Janssen et al. (2003); 15: Jones et al. (1995); 16: Levy et al. (2013); 17: Minai et al. (2004); 18: Munzenberger et al. (2007); 19: Sleath et al. (2011); 20: Turkeli et al. 
(2016); 21: Deerojanawong et al. (2009); 22: Walia et al. (2006); 23: Schmier et al. (2007); 24: Manriquez et al. (2015); 25: Reznik et al. (2013); 26: deGroot et al. 
(2014); 27: Duerden, et al. (2001); 28: Pedersen et al. (2010); 29: Price et al. (2013); 30: Morin, 2012 
AC: asthma control; ACT: asthma control test;  AE: asthma education; AQLQ: asthma quality of life questionnaire; AS: asthma severity; AV: after video; BV: before 
video; CC: completely confident; DV: dependent variable; DX: diagnosis; FEV1: forced expiratory volume 1 second;  ER: emergency room; FVC: forced vital 
capacity; GINA: global initiative for asthma; GT: good inhaler technique; HOH: hard of hearing; ICS: inhaled corticosteroid; IMPACT: Improving the Management 
of Patients Asthma and COPD Treatment; IT: inhaler technique; IV: independent variable; MDI: metered dose inhaler; NC: no change; NCC: not completely confident; 
NS: no significance; Obs: observational; PACT: pediatric asthma clinic trial; PE: physical exam; PIF: peak inspiratory flow; PFT: pulmonary function test;  pop: 
population; PP: parental perception RCT: randomized controlled study; RT: respiratory therapist; RTC: return to clinic; SE: self-efficacy; VT: verbal inhaler training; 
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Most frequent error: 
inhalation error 













































































-duration spacer use 
0.013 
-MD assess AC 
0.909 
1 mis-step 7% 
Miss all 4.2% 
This clinic had excellent results in regards 
to relatively good IT among patients. 
Clinic also had set program of frequent IT 
education with patients 
Stated weakness: no control group without 
regular IT training 
Only allowed in patients who had 
originally received education from their 
clinic- if newly referred excluded- could 
be bias with that 
 
Acute exacerbation excluded- again could 
be bias with those results- their IT may be 






1: Gillette et al. (2016); 2: Rodriguez-Martinez et al. (2017);  3: Alexander et al. (2016); 4: Amirav et al. (1994); 5: Burkhart et al. (2000); 6: Carpenter et al. (2015); 7: 
Kamps et al. (2000); 8: Zivkovic et al. (2008); 9: Bourne (1996); 10: Capanoglu et al. (2015); 11: Carpenter et al. (2016); 12: Chen et al. (2002); 13: Foland et al. (2002); 
14: Janssen et al. (2003); 15: Jones et al. (1995); 16: Levy et al. (2013); 17: Minai et al. (2004); 18: Munzenberger et al. (2007); 19: Sleath et al. (2011); 20: Turkeli et al. 
(2016); 21: Deerojanawong et al. (2009); 22: Walia et al. (2006); 23: Schmier et al. (2007); 24: Manriquez et al. (2015); 25: Reznik et al. (2013); 26: deGroot et al. 
(2014); 27: Duerden, et al. (2001); 28: Pedersen et al. (2010); 29: Price et al. (2013); 30: Morin, 2012 
AC: asthma control; ACT: asthma control test;  AE: asthma education; AQLQ: asthma quality of life questionnaire; AS: asthma severity; AV: after video; BV: before 
video; CC: completely confident; DV: dependent variable; DX: diagnosis; FEV1: forced expiratory volume 1 second;  ER: emergency room; FVC: forced vital 
capacity; GINA: global initiative for asthma; GT: good inhaler technique; HOH: hard of hearing; ICS: inhaled corticosteroid; IMPACT: Improving the Management 
of Patients Asthma and COPD Treatment; IT: inhaler technique; IV: independent variable; MDI: metered dose inhaler; NC: no change; NCC: not completely confident; 
NS: no significance; Obs: observational; PACT: pediatric asthma clinic trial; PE: physical exam; PIF: peak inspiratory flow; PFT: pulmonary function test;  pop: 
population; PP: parental perception RCT: randomized controlled study; RT: respiratory therapist; RTC: return to clinic; SE: self-efficacy; VT: verbal inhaler training; 
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Strength of the Evidence (i.e., level of 













8 pt never cleaned 
device 
5 changed spacer >1 
year 































































-32% ED visit 
Very needed information correlating 
asthma severity to school and ED and 
QOL.  With improved asthma, QOL is 
improved 
1: Gillette et al. (2016); 2: Rodriguez-Martinez et al. (2017);  3: Alexander et al. (2016); 4: Amirav et al. (1994); 5: Burkhart et al. (2000); 6: Carpenter et al. (2015); 7: 
Kamps et al. (2000); 8: Zivkovic et al. (2008); 9: Bourne (1996); 10: Capanoglu et al. (2015); 11: Carpenter et al. (2016); 12: Chen et al. (2002); 13: Foland et al. (2002); 
14: Janssen et al. (2003); 15: Jones et al. (1995); 16: Levy et al. (2013); 17: Minai et al. (2004); 18: Munzenberger et al. (2007); 19: Sleath et al. (2011); 20: Turkeli et al. 
(2016); 21: Deerojanawong et al. (2009); 22: Walia et al. (2006); 23: Schmier et al. (2007); 24: Manriquez et al. (2015); 25: Reznik et al. (2013); 26: deGroot et al. 
(2014); 27: Duerden, et al. (2001); 28: Pedersen et al. (2010); 29: Price et al. (2013); 30: Morin, 2012 
AC: asthma control; ACT: asthma control test;  AE: asthma education; AQLQ: asthma quality of life questionnaire; AS: asthma severity; AV: after video; BV: before 
video; CC: completely confident; DV: dependent variable; DX: diagnosis; FEV1: forced expiratory volume 1 second;  ER: emergency room; FVC: forced vital 
capacity; GINA: global initiative for asthma; GT: good inhaler technique; HOH: hard of hearing; ICS: inhaled corticosteroid; IMPACT: Improving the Management 
of Patients Asthma and COPD Treatment; IT: inhaler technique; IV: independent variable; MDI: metered dose inhaler; NC: no change; NCC: not completely confident; 
NS: no significance; Obs: observational; PACT: pediatric asthma clinic trial; PE: physical exam; PIF: peak inspiratory flow; PFT: pulmonary function test;  pop: 
population; PP: parental perception RCT: randomized controlled study; RT: respiratory therapist; RTC: return to clinic; SE: self-efficacy; VT: verbal inhaler training; 
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131 age 4-11 






















-mean 15.3: 16 
adolescent; 14.6 
younger child 
Adolescent <19 ACT 
increased impairment 







Control asthma: 3.5% 
missed 1 day 
1: Gillette et al. (2016); 2: Rodriguez-Martinez et al. (2017);  3: Alexander et al. (2016); 4: Amirav et al. (1994); 5: Burkhart et al. (2000); 6: Carpenter et al. (2015); 7: 
Kamps et al. (2000); 8: Zivkovic et al. (2008); 9: Bourne (1996); 10: Capanoglu et al. (2015); 11: Carpenter et al. (2016); 12: Chen et al. (2002); 13: Foland et al. (2002); 
14: Janssen et al. (2003); 15: Jones et al. (1995); 16: Levy et al. (2013); 17: Minai et al. (2004); 18: Munzenberger et al. (2007); 19: Sleath et al. (2011); 20: Turkeli et al. 
(2016); 21: Deerojanawong et al. (2009); 22: Walia et al. (2006); 23: Schmier et al. (2007); 24: Manriquez et al. (2015); 25: Reznik et al. (2013); 26: deGroot et al. 
(2014); 27: Duerden, et al. (2001); 28: Pedersen et al. (2010); 29: Price et al. (2013); 30: Morin, 2012 
AC: asthma control; ACT: asthma control test;  AE: asthma education; AQLQ: asthma quality of life questionnaire; AS: asthma severity; AV: after video; BV: before 
video; CC: completely confident; DV: dependent variable; DX: diagnosis; FEV1: forced expiratory volume 1 second;  ER: emergency room; FVC: forced vital 
capacity; GINA: global initiative for asthma; GT: good inhaler technique; HOH: hard of hearing; ICS: inhaled corticosteroid; IMPACT: Improving the Management 
of Patients Asthma and COPD Treatment; IT: inhaler technique; IV: independent variable; MDI: metered dose inhaler; NC: no change; NCC: not completely confident; 
NS: no significance; Obs: observational; PACT: pediatric asthma clinic trial; PE: physical exam; PIF: peak inspiratory flow; PFT: pulmonary function test;  pop: 
population; PP: parental perception RCT: randomized controlled study; RT: respiratory therapist; RTC: return to clinic; SE: self-efficacy; VT: verbal inhaler training; 
























Appraisal of Worth to Practice 
Strength of the Evidence (i.e., level of 





missing 1 day 
(p<0.001) 
Arrive 1 hour late: 
Controlled: 3.5% vs 
uncontrolled 34% 
p<0.001) 
Left school early: 
Controlled 1.8% vs 
uncontrolled 21.3% p 
.003) 
Developed asthma sx 
at school: 
Controlled 29.3% vs 
uncontrolled 76.6% 
p<0.001) 
Parental work:  
Reported more 
missed work days 
with asthma: 
Missed due asthma 
2.5 days vs not 
asthma 1.5 p .08 
1: Gillette et al. (2016); 2: Rodriguez-Martinez et al. (2017);  3: Alexander et al. (2016); 4: Amirav et al. (1994); 5: Burkhart et al. (2000); 6: Carpenter et al. (2015); 7: 
Kamps et al. (2000); 8: Zivkovic et al. (2008); 9: Bourne (1996); 10: Capanoglu et al. (2015); 11: Carpenter et al. (2016); 12: Chen et al. (2002); 13: Foland et al. (2002); 
14: Janssen et al. (2003); 15: Jones et al. (1995); 16: Levy et al. (2013); 17: Minai et al. (2004); 18: Munzenberger et al. (2007); 19: Sleath et al. (2011); 20: Turkeli et al. 
(2016); 21: Deerojanawong et al. (2009); 22: Walia et al. (2006); 23: Schmier et al. (2007); 24: Manriquez et al. (2015); 25: Reznik et al. (2013); 26: deGroot et al. 
(2014); 27: Duerden, et al. (2001); 28: Pedersen et al. (2010); 29: Price et al. (2013); 30: Morin, 2012 
AC: asthma control; ACT: asthma control test;  AE: asthma education; AQLQ: asthma quality of life questionnaire; AS: asthma severity; AV: after video; BV: before 
video; CC: completely confident; DV: dependent variable; DX: diagnosis; FEV1: forced expiratory volume 1 second;  ER: emergency room; FVC: forced vital 
capacity; GINA: global initiative for asthma; GT: good inhaler technique; HOH: hard of hearing; ICS: inhaled corticosteroid; IMPACT: Improving the Management 
of Patients Asthma and COPD Treatment; IT: inhaler technique; IV: independent variable; MDI: metered dose inhaler; NC: no change; NCC: not completely confident; 
NS: no significance; Obs: observational; PACT: pediatric asthma clinic trial; PE: physical exam; PIF: peak inspiratory flow; PFT: pulmonary function test;  pop: 
population; PP: parental perception RCT: randomized controlled study; RT: respiratory therapist; RTC: return to clinic; SE: self-efficacy; VT: verbal inhaler training; 
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-self domain 1.3/2.1 















0.83 vs 0.59 p.001 
ED visits: 
1: Gillette et al. (2016); 2: Rodriguez-Martinez et al. (2017);  3: Alexander et al. (2016); 4: Amirav et al. (1994); 5: Burkhart et al. (2000); 6: Carpenter et al. (2015); 7: 
Kamps et al. (2000); 8: Zivkovic et al. (2008); 9: Bourne (1996); 10: Capanoglu et al. (2015); 11: Carpenter et al. (2016); 12: Chen et al. (2002); 13: Foland et al. (2002); 
14: Janssen et al. (2003); 15: Jones et al. (1995); 16: Levy et al. (2013); 17: Minai et al. (2004); 18: Munzenberger et al. (2007); 19: Sleath et al. (2011); 20: Turkeli et al. 
(2016); 21: Deerojanawong et al. (2009); 22: Walia et al. (2006); 23: Schmier et al. (2007); 24: Manriquez et al. (2015); 25: Reznik et al. (2013); 26: deGroot et al. 
(2014); 27: Duerden, et al. (2001); 28: Pedersen et al. (2010); 29: Price et al. (2013); 30: Morin, 2012 
AC: asthma control; ACT: asthma control test;  AE: asthma education; AQLQ: asthma quality of life questionnaire; AS: asthma severity; AV: after video; BV: before 
video; CC: completely confident; DV: dependent variable; DX: diagnosis; FEV1: forced expiratory volume 1 second;  ER: emergency room; FVC: forced vital 
capacity; GINA: global initiative for asthma; GT: good inhaler technique; HOH: hard of hearing; ICS: inhaled corticosteroid; IMPACT: Improving the Management 
of Patients Asthma and COPD Treatment; IT: inhaler technique; IV: independent variable; MDI: metered dose inhaler; NC: no change; NCC: not completely confident; 
NS: no significance; Obs: observational; PACT: pediatric asthma clinic trial; PE: physical exam; PIF: peak inspiratory flow; PFT: pulmonary function test;  pop: 
population; PP: parental perception RCT: randomized controlled study; RT: respiratory therapist; RTC: return to clinic; SE: self-efficacy; VT: verbal inhaler training; 
























Appraisal of Worth to Practice 
Strength of the Evidence (i.e., level of 
evidence + quality [study strengths and 
weaknesses]) 
RECOMMENDATIONS 
0.50 vs 0.17 p.001 
Overnight hospital: 
0.10 vs 0.03 p .04 
Out of pocket cost 
(2005 dollars): 
$997 expenses & lost 
income 
58% cost OOP 
medication 
Total wages/benefits 
/out of pocket 00lost: 



















































73.4% pedi correct 





Most of pediatric patient had better IT 
compared to adults- however, study did 
not delve into why they may have noted 
(education? Longer time of use with 
poorer IT?) 
Study did not look at IT after further 
education sessions- only 1 week after last 
office visit 
1: Gillette et al. (2016); 2: Rodriguez-Martinez et al. (2017);  3: Alexander et al. (2016); 4: Amirav et al. (1994); 5: Burkhart et al. (2000); 6: Carpenter et al. (2015); 7: 
Kamps et al. (2000); 8: Zivkovic et al. (2008); 9: Bourne (1996); 10: Capanoglu et al. (2015); 11: Carpenter et al. (2016); 12: Chen et al. (2002); 13: Foland et al. (2002); 
14: Janssen et al. (2003); 15: Jones et al. (1995); 16: Levy et al. (2013); 17: Minai et al. (2004); 18: Munzenberger et al. (2007); 19: Sleath et al. (2011); 20: Turkeli et al. 
(2016); 21: Deerojanawong et al. (2009); 22: Walia et al. (2006); 23: Schmier et al. (2007); 24: Manriquez et al. (2015); 25: Reznik et al. (2013); 26: deGroot et al. 
(2014); 27: Duerden, et al. (2001); 28: Pedersen et al. (2010); 29: Price et al. (2013); 30: Morin, 2012 
AC: asthma control; ACT: asthma control test;  AE: asthma education; AQLQ: asthma quality of life questionnaire; AS: asthma severity; AV: after video; BV: before 
video; CC: completely confident; DV: dependent variable; DX: diagnosis; FEV1: forced expiratory volume 1 second;  ER: emergency room; FVC: forced vital 
capacity; GINA: global initiative for asthma; GT: good inhaler technique; HOH: hard of hearing; ICS: inhaled corticosteroid; IMPACT: Improving the Management 
of Patients Asthma and COPD Treatment; IT: inhaler technique; IV: independent variable; MDI: metered dose inhaler; NC: no change; NCC: not completely confident; 
NS: no significance; Obs: observational; PACT: pediatric asthma clinic trial; PE: physical exam; PIF: peak inspiratory flow; PFT: pulmonary function test;  pop: 
population; PP: parental perception RCT: randomized controlled study; RT: respiratory therapist; RTC: return to clinic; SE: self-efficacy; VT: verbal inhaler training; 
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ailment ↓ IT 
P<0.05 
significant 
Most common pedi 
error: 
Fail hold breath 10 
sec: 8.1% 
Fail continue inhale 
after actuation ihaler 
6.1% 
Fail exhale before 
using inhaler: 3.7% 
Error adult: 
Fail exhale before 
using inhaler 53.1% 
Fail hold breath 10 
sec 46% 




























3 pedi practices 
















92/112 87% demo IT 
Attending use 
illustration: 9/37 
(residents 3/55) 24% 
vs 6% p=.01 
Demo IT if asthma 
not controlled: 
Previous study by authors reported 85% 
patients incorrect IT despite previous 
education 
Authors noted use of community health 
worker as possible way to improve 
Limitations: 
Did not assess  providers own knowledge 
of IT 
1: Gillette et al. (2016); 2: Rodriguez-Martinez et al. (2017);  3: Alexander et al. (2016); 4: Amirav et al. (1994); 5: Burkhart et al. (2000); 6: Carpenter et al. (2015); 7: 
Kamps et al. (2000); 8: Zivkovic et al. (2008); 9: Bourne (1996); 10: Capanoglu et al. (2015); 11: Carpenter et al. (2016); 12: Chen et al. (2002); 13: Foland et al. (2002); 
14: Janssen et al. (2003); 15: Jones et al. (1995); 16: Levy et al. (2013); 17: Minai et al. (2004); 18: Munzenberger et al. (2007); 19: Sleath et al. (2011); 20: Turkeli et al. 
(2016); 21: Deerojanawong et al. (2009); 22: Walia et al. (2006); 23: Schmier et al. (2007); 24: Manriquez et al. (2015); 25: Reznik et al. (2013); 26: deGroot et al. 
(2014); 27: Duerden, et al. (2001); 28: Pedersen et al. (2010); 29: Price et al. (2013); 30: Morin, 2012 
AC: asthma control; ACT: asthma control test;  AE: asthma education; AQLQ: asthma quality of life questionnaire; AS: asthma severity; AV: after video; BV: before 
video; CC: completely confident; DV: dependent variable; DX: diagnosis; FEV1: forced expiratory volume 1 second;  ER: emergency room; FVC: forced vital 
capacity; GINA: global initiative for asthma; GT: good inhaler technique; HOH: hard of hearing; ICS: inhaled corticosteroid; IMPACT: Improving the Management 
of Patients Asthma and COPD Treatment; IT: inhaler technique; IV: independent variable; MDI: metered dose inhaler; NC: no change; NCC: not completely confident; 
NS: no significance; Obs: observational; PACT: pediatric asthma clinic trial; PE: physical exam; PIF: peak inspiratory flow; PFT: pulmonary function test;  pop: 
population; PP: parental perception RCT: randomized controlled study; RT: respiratory therapist; RTC: return to clinic; SE: self-efficacy; VT: verbal inhaler training; 
























Appraisal of Worth to Practice 
Strength of the Evidence (i.e., level of 


























Resident: 27/57 47% 
 P=.05 
Pt not bring MDI: 
98/114 86% 
None utilized IUC 
When assess IT: 
-every visit 10/75 
13% 
Common barriers: 
-no MDI: 66% 
-lack of time 50% 
-↓ knowledge IUC 
28% 
-↓ pt/family interest 
1/41 attendings: 
11/72 residents: 2.4% 
vs 15% 
Overcome barriers: 
-provide MDI n=55 
-in inner city clinic- possibly not 
generalizable results 
 
1: Gillette et al. (2016); 2: Rodriguez-Martinez et al. (2017);  3: Alexander et al. (2016); 4: Amirav et al. (1994); 5: Burkhart et al. (2000); 6: Carpenter et al. (2015); 7: 
Kamps et al. (2000); 8: Zivkovic et al. (2008); 9: Bourne (1996); 10: Capanoglu et al. (2015); 11: Carpenter et al. (2016); 12: Chen et al. (2002); 13: Foland et al. (2002); 
14: Janssen et al. (2003); 15: Jones et al. (1995); 16: Levy et al. (2013); 17: Minai et al. (2004); 18: Munzenberger et al. (2007); 19: Sleath et al. (2011); 20: Turkeli et al. 
(2016); 21: Deerojanawong et al. (2009); 22: Walia et al. (2006); 23: Schmier et al. (2007); 24: Manriquez et al. (2015); 25: Reznik et al. (2013); 26: deGroot et al. 
(2014); 27: Duerden, et al. (2001); 28: Pedersen et al. (2010); 29: Price et al. (2013); 30: Morin, 2012 
AC: asthma control; ACT: asthma control test;  AE: asthma education; AQLQ: asthma quality of life questionnaire; AS: asthma severity; AV: after video; BV: before 
video; CC: completely confident; DV: dependent variable; DX: diagnosis; FEV1: forced expiratory volume 1 second;  ER: emergency room; FVC: forced vital 
capacity; GINA: global initiative for asthma; GT: good inhaler technique; HOH: hard of hearing; ICS: inhaled corticosteroid; IMPACT: Improving the Management 
of Patients Asthma and COPD Treatment; IT: inhaler technique; IV: independent variable; MDI: metered dose inhaler; NC: no change; NCC: not completely confident; 
NS: no significance; Obs: observational; PACT: pediatric asthma clinic trial; PE: physical exam; PIF: peak inspiratory flow; PFT: pulmonary function test;  pop: 
population; PP: parental perception RCT: randomized controlled study; RT: respiratory therapist; RTC: return to clinic; SE: self-efficacy; VT: verbal inhaler training; 
























Appraisal of Worth to Practice 
Strength of the Evidence (i.e., level of 
evidence + quality [study strengths and 
weaknesses]) 
RECOMMENDATIONS 
-provide training to 
providers n=13 
-embedded educator 






























































Only 4 patients met 
guidelines for true 
treatment resistant 




Poor IT: 7.8% 
Nonadherence 37% 
Chart review demonstrates multifactorial 
reasons for asthma treatment, compliance 
and severity 
IT a part of asthma control 
1: Gillette et al. (2016); 2: Rodriguez-Martinez et al. (2017);  3: Alexander et al. (2016); 4: Amirav et al. (1994); 5: Burkhart et al. (2000); 6: Carpenter et al. (2015); 7: 
Kamps et al. (2000); 8: Zivkovic et al. (2008); 9: Bourne (1996); 10: Capanoglu et al. (2015); 11: Carpenter et al. (2016); 12: Chen et al. (2002); 13: Foland et al. (2002); 
14: Janssen et al. (2003); 15: Jones et al. (1995); 16: Levy et al. (2013); 17: Minai et al. (2004); 18: Munzenberger et al. (2007); 19: Sleath et al. (2011); 20: Turkeli et al. 
(2016); 21: Deerojanawong et al. (2009); 22: Walia et al. (2006); 23: Schmier et al. (2007); 24: Manriquez et al. (2015); 25: Reznik et al. (2013); 26: deGroot et al. 
(2014); 27: Duerden, et al. (2001); 28: Pedersen et al. (2010); 29: Price et al. (2013); 30: Morin, 2012 
AC: asthma control; ACT: asthma control test;  AE: asthma education; AQLQ: asthma quality of life questionnaire; AS: asthma severity; AV: after video; BV: before 
video; CC: completely confident; DV: dependent variable; DX: diagnosis; FEV1: forced expiratory volume 1 second;  ER: emergency room; FVC: forced vital 
capacity; GINA: global initiative for asthma; GT: good inhaler technique; HOH: hard of hearing; ICS: inhaled corticosteroid; IMPACT: Improving the Management 
of Patients Asthma and COPD Treatment; IT: inhaler technique; IV: independent variable; MDI: metered dose inhaler; NC: no change; NCC: not completely confident; 
NS: no significance; Obs: observational; PACT: pediatric asthma clinic trial; PE: physical exam; PIF: peak inspiratory flow; PFT: pulmonary function test;  pop: 
population; PP: parental perception RCT: randomized controlled study; RT: respiratory therapist; RTC: return to clinic; SE: self-efficacy; VT: verbal inhaler training; 
























Appraisal of Worth to Practice 
Strength of the Evidence (i.e., level of 




















Lit review of 
IT; compliance, 
AK 







-56% accuat6ed MDI 
too early/late 
-79% made errors on 
8 point assessment 
-89% error inhalation 
 
MD/RN poor IT: 
-15%RN correct IT 
-28% MD correct IT 
Role of training IT: 
-communication 
correct IT and 
monitor IT 
-10% correct IT self-




-after 1-2 teaching 
seesion: 
Poor IT assoc w/ poor AC 
Providers do not know how to use inhalers 
and benefit from education and repeat 
education 
1: Gillette et al. (2016); 2: Rodriguez-Martinez et al. (2017);  3: Alexander et al. (2016); 4: Amirav et al. (1994); 5: Burkhart et al. (2000); 6: Carpenter et al. (2015); 7: 
Kamps et al. (2000); 8: Zivkovic et al. (2008); 9: Bourne (1996); 10: Capanoglu et al. (2015); 11: Carpenter et al. (2016); 12: Chen et al. (2002); 13: Foland et al. (2002); 
14: Janssen et al. (2003); 15: Jones et al. (1995); 16: Levy et al. (2013); 17: Minai et al. (2004); 18: Munzenberger et al. (2007); 19: Sleath et al. (2011); 20: Turkeli et al. 
(2016); 21: Deerojanawong et al. (2009); 22: Walia et al. (2006); 23: Schmier et al. (2007); 24: Manriquez et al. (2015); 25: Reznik et al. (2013); 26: deGroot et al. 
(2014); 27: Duerden, et al. (2001); 28: Pedersen et al. (2010); 29: Price et al. (2013); 30: Morin, 2012 
AC: asthma control; ACT: asthma control test;  AE: asthma education; AQLQ: asthma quality of life questionnaire; AS: asthma severity; AV: after video; BV: before 
video; CC: completely confident; DV: dependent variable; DX: diagnosis; FEV1: forced expiratory volume 1 second;  ER: emergency room; FVC: forced vital 
capacity; GINA: global initiative for asthma; GT: good inhaler technique; HOH: hard of hearing; ICS: inhaled corticosteroid; IMPACT: Improving the Management 
of Patients Asthma and COPD Treatment; IT: inhaler technique; IV: independent variable; MDI: metered dose inhaler; NC: no change; NCC: not completely confident; 
NS: no significance; Obs: observational; PACT: pediatric asthma clinic trial; PE: physical exam; PIF: peak inspiratory flow; PFT: pulmonary function test;  pop: 
population; PP: parental perception RCT: randomized controlled study; RT: respiratory therapist; RTC: return to clinic; SE: self-efficacy; VT: verbal inhaler training; 
























Appraisal of Worth to Practice 
Strength of the Evidence (i.e., level of 
evidence + quality [study strengths and 
weaknesses]) 
RECOMMENDATIONS 






















   Inhaled med ↑ work 
at lung, ↓ time 
medication action, ↓ 
systemic effect 
Discussion of droplet 
deposition oral 
pharyx/esophagus: 
larger droplet size=↑ 





50% school aged 
children ↓ benefit 
med d/t incorrect IT 
Spacers ↓ deposition 
in oral pharynx & 
esophagus (80% ↓ 
30%); ↑ IT 
IT needs to be taught; 
teaching each visit 
 
1: Gillette et al. (2016); 2: Rodriguez-Martinez et al. (2017);  3: Alexander et al. (2016); 4: Amirav et al. (1994); 5: Burkhart et al. (2000); 6: Carpenter et al. (2015); 7: 
Kamps et al. (2000); 8: Zivkovic et al. (2008); 9: Bourne (1996); 10: Capanoglu et al. (2015); 11: Carpenter et al. (2016); 12: Chen et al. (2002); 13: Foland et al. (2002); 
14: Janssen et al. (2003); 15: Jones et al. (1995); 16: Levy et al. (2013); 17: Minai et al. (2004); 18: Munzenberger et al. (2007); 19: Sleath et al. (2011); 20: Turkeli et al. 
(2016); 21: Deerojanawong et al. (2009); 22: Walia et al. (2006); 23: Schmier et al. (2007); 24: Manriquez et al. (2015); 25: Reznik et al. (2013); 26: deGroot et al. 
(2014); 27: Duerden, et al. (2001); 28: Pedersen et al. (2010); 29: Price et al. (2013); 30: Morin, 2012 
AC: asthma control; ACT: asthma control test;  AE: asthma education; AQLQ: asthma quality of life questionnaire; AS: asthma severity; AV: after video; BV: before 
video; CC: completely confident; DV: dependent variable; DX: diagnosis; FEV1: forced expiratory volume 1 second;  ER: emergency room; FVC: forced vital 
capacity; GINA: global initiative for asthma; GT: good inhaler technique; HOH: hard of hearing; ICS: inhaled corticosteroid; IMPACT: Improving the Management 
of Patients Asthma and COPD Treatment; IT: inhaler technique; IV: independent variable; MDI: metered dose inhaler; NC: no change; NCC: not completely confident; 
NS: no significance; Obs: observational; PACT: pediatric asthma clinic trial; PE: physical exam; PIF: peak inspiratory flow; PFT: pulmonary function test;  pop: 
population; PP: parental perception RCT: randomized controlled study; RT: respiratory therapist; RTC: return to clinic; SE: self-efficacy; VT: verbal inhaler training; 
























Appraisal of Worth to Practice 
Strength of the Evidence (i.e., level of 
evidence + quality [study strengths and 
weaknesses]) 
RECOMMENDATIONS 
After 3 instructions: 
98% MDI correct IT; 
after 2 instructions 
90% correct MDI IT 
Teaching each visit 























   -inhalers not used 
correctly 14-90% 
time 
VT & hand on 
together ↑ IT 
-multiple factors 
incorrect IT 






provider: does not 
know IT; does not 
teach IT 
Patients do not have correct IT 
Necessary to include healthcare provider 
education for IT and to teach IT 
Each device own IT instructions 
Verbal plus hands on training reinforces 
IT 
1: Gillette et al. (2016); 2: Rodriguez-Martinez et al. (2017);  3: Alexander et al. (2016); 4: Amirav et al. (1994); 5: Burkhart et al. (2000); 6: Carpenter et al. (2015); 7: 
Kamps et al. (2000); 8: Zivkovic et al. (2008); 9: Bourne (1996); 10: Capanoglu et al. (2015); 11: Carpenter et al. (2016); 12: Chen et al. (2002); 13: Foland et al. (2002); 
14: Janssen et al. (2003); 15: Jones et al. (1995); 16: Levy et al. (2013); 17: Minai et al. (2004); 18: Munzenberger et al. (2007); 19: Sleath et al. (2011); 20: Turkeli et al. 
(2016); 21: Deerojanawong et al. (2009); 22: Walia et al. (2006); 23: Schmier et al. (2007); 24: Manriquez et al. (2015); 25: Reznik et al. (2013); 26: deGroot et al. 
(2014); 27: Duerden, et al. (2001); 28: Pedersen et al. (2010); 29: Price et al. (2013); 30: Morin, 2012 
AC: asthma control; ACT: asthma control test;  AE: asthma education; AQLQ: asthma quality of life questionnaire; AS: asthma severity; AV: after video; BV: before 
video; CC: completely confident; DV: dependent variable; DX: diagnosis; FEV1: forced expiratory volume 1 second;  ER: emergency room; FVC: forced vital 
capacity; GINA: global initiative for asthma; GT: good inhaler technique; HOH: hard of hearing; ICS: inhaled corticosteroid; IMPACT: Improving the Management 
of Patients Asthma and COPD Treatment; IT: inhaler technique; IV: independent variable; MDI: metered dose inhaler; NC: no change; NCC: not completely confident; 
NS: no significance; Obs: observational; PACT: pediatric asthma clinic trial; PE: physical exam; PIF: peak inspiratory flow; PFT: pulmonary function test;  pop: 
population; PP: parental perception RCT: randomized controlled study; RT: respiratory therapist; RTC: return to clinic; SE: self-efficacy; VT: verbal inhaler training; 
























Appraisal of Worth to Practice 
Strength of the Evidence (i.e., level of 





IT education increase 
knowledge IT; how 









































7 teaching episodes 
MD 
11% IT correct to 
100% correct post 
education; mean 2.3 
improved steps 
Same city as my DNP scholarly project.  
Not necessarily same socioeconomic 
DNP student higher engagement than 




1: Gillette et al. (2016); 2: Rodriguez-Martinez et al. (2017);  3: Alexander et al. (2016); 4: Amirav et al. (1994); 5: Burkhart et al. (2000); 6: Carpenter et al. (2015); 7: 
Kamps et al. (2000); 8: Zivkovic et al. (2008); 9: Bourne (1996); 10: Capanoglu et al. (2015); 11: Carpenter et al. (2016); 12: Chen et al. (2002); 13: Foland et al. (2002); 
14: Janssen et al. (2003); 15: Jones et al. (1995); 16: Levy et al. (2013); 17: Minai et al. (2004); 18: Munzenberger et al. (2007); 19: Sleath et al. (2011); 20: Turkeli et al. 
(2016); 21: Deerojanawong et al. (2009); 22: Walia et al. (2006); 23: Schmier et al. (2007); 24: Manriquez et al. (2015); 25: Reznik et al. (2013); 26: deGroot et al. 
(2014); 27: Duerden, et al. (2001); 28: Pedersen et al. (2010); 29: Price et al. (2013); 30: Morin, 2012 
AC: asthma control; ACT: asthma control test;  AE: asthma education; AQLQ: asthma quality of life questionnaire; AS: asthma severity; AV: after video; BV: before 
video; CC: completely confident; DV: dependent variable; DX: diagnosis; FEV1: forced expiratory volume 1 second;  ER: emergency room; FVC: forced vital 
capacity; GINA: global initiative for asthma; GT: good inhaler technique; HOH: hard of hearing; ICS: inhaled corticosteroid; IMPACT: Improving the Management 
of Patients Asthma and COPD Treatment; IT: inhaler technique; IV: independent variable; MDI: metered dose inhaler; NC: no change; NCC: not completely confident; 
NS: no significance; Obs: observational; PACT: pediatric asthma clinic trial; PE: physical exam; PIF: peak inspiratory flow; PFT: pulmonary function test;  pop: 
population; PP: parental perception RCT: randomized controlled study; RT: respiratory therapist; RTC: return to clinic; SE: self-efficacy; VT: verbal inhaler training; 
∆ change; ??: questionnaire 
Levels of Evidence 
Table AB2: Levels of Evidence 
Level of Evidence Type of Study Number of Studies 
I Systematic Review 2 
II RCT 6 
III Cohort 1 
IV Observational/Descriptive/Prospective 
Cross Sectional/Retrospective Chart 
Review 
18 
VI Literature Review 3 
VII DNP Scholarly Project 1 
  
1: Gillette et al. (2016); 2: Rodriguez-Martinez et al. (2017);  3: Alexander et al. (2016); 4: Amirav et al. (1994); 5: Burkhart et al. (2000); 6: Carpenter et al. (2015); 7: 
Kamps et al. (2000); 8: Zivkovic et al. (2008); 9: Bourne (1996); 10: Capanoglu et al. (2015); 11: Carpenter et al. (2016); 12: Chen et al. (2002); 13: Foland et al. (2002); 
14: Janssen et al. (2003); 15: Jones et al. (1995); 16: Levy et al. (2013); 17: Minai et al. (2004); 18: Munzenberger et al. (2007); 19: Sleath et al. (2011); 20: Turkeli et al. 
(2016); 21: Deerojanawong et al. (2009); 22: Walia et al. (2006); 23: Schmier et al. (2007); 24: Manriquez et al. (2015); 25: Reznik et al. (2013); 26: deGroot et al. 
(2014); 27: Duerden, et al. (2001); 28: Pedersen et al. (2010); 29: Price et al. (2013); 30: Morin, 2012 
AC: asthma control; ACT: asthma control test;  AE: asthma education; AQLQ: asthma quality of life questionnaire; AS: asthma severity; AV: after video; BV: before 
video; CC: completely confident; DV: dependent variable; DX: diagnosis; FEV1: forced expiratory volume 1 second;  ER: emergency room; FVC: forced vital 
capacity; GINA: global initiative for asthma; GT: good inhaler technique; HOH: hard of hearing; ICS: inhaled corticosteroid; IMPACT: Improving the Management 
of Patients Asthma and COPD Treatment; IT: inhaler technique; IV: independent variable; MDI: metered dose inhaler; NC: no change; NCC: not completely confident; 
NS: no significance; Obs: observational; PACT: pediatric asthma clinic trial; PE: physical exam; PIF: peak inspiratory flow; PFT: pulmonary function test;  pop: 
population; PP: parental perception RCT: randomized controlled study; RT: respiratory therapist; RTC: return to clinic; SE: self-efficacy; VT: verbal inhaler training; 
∆ change; ??: questionnaire 
Verbal inhaler technique/Hands on technique/Return Demonstration with outcomes Synthesis Table 













































1  √ √  √  ↑       
3  √ √  √  ↑       
4  √ √  √  ↑ ↑      
5  √ √  √ √ ↑ ↑    ↓  
6 √ √ √  √  ↑     ↓  
7  √ √  √  ↑ ↑      
8  √ √  √  ↑ ↑ ↑  ↑   
9  √ √  √  ↑       
11 √ √ √  √  ↑       
12  √ √  √  ↑ ↑ ↑     
13  √ √  √  ↑       
14  √ √  √  ↑ ↑      
16  √ √ √ √ √ ↑ ↑      
17  √ √  √ √ ↑ ↑      
18  √ √  √  ↑ ↑      
19  √ √  √  ↑ ↑ ↑     
20  √ √  √  ↑       
21  √ √  √  ↑       
22  √ √  √  =       
24  √ √    ↑       
30  √ √ √ √  ↑       
1: Gillette et al. (2016); 2: Rodriguez-Martinez et al. (2017);  3: Alexander et al. (2016); 4: Amirav et al. (1994); 5: Burkhart et al. (2000); 6: Carpenter et al. (2015); 7: 
Kamps et al. (2000); 8: Zivkovic et al. (2008); 9: Bourne (1996); 10: Capanoglu et al. (2015); 11: Carpenter et al. (2016); 12: Chen et al. (2002); 13: Foland et al. (2002); 
14: Janssen et al. (2003); 15: Jones et al. (1995); 16: Levy et al. (2013); 17: Minai et al. (2004); 18: Munzenberger et al. (2007); 19: Sleath et al. (2011); 20: Turkeli et al. 
(2016); 21: Deerojanawong et al. (2009); 22: Walia et al. (2006); 23: Schmier et al. (2007); 24: Manriquez et al. (2015); 25: Reznik et al. (2013); 26: deGroot et al. 
(2014); 27: Duerden, et al. (2001); 28: Pedersen et al. (2010); 29: Price et al. (2013); 30: Morin, 2012 
AC: asthma control; ACT: asthma control test;  AE: asthma education; AQLQ: asthma quality of life questionnaire; AS: asthma severity; AV: after video; BV: before 
video; CC: completely confident; DV: dependent variable; DX: diagnosis; FEV1: forced expiratory volume 1 second;  ER: emergency room; FVC: forced vital 
capacity; GINA: global initiative for asthma; GT: good inhaler technique; HOH: hard of hearing; ICS: inhaled corticosteroid; IMPACT: Improving the Management 
of Patients Asthma and COPD Treatment; IT: inhaler technique; IV: independent variable; MDI: metered dose inhaler; NC: no change; NCC: not completely confident; 
NS: no significance; Obs: observational; PACT: pediatric asthma clinic trial; PE: physical exam; PIF: peak inspiratory flow; PFT: pulmonary function test;  pop: 
population; PP: parental perception RCT: randomized controlled study; RT: respiratory therapist; RTC: return to clinic; SE: self-efficacy; VT: verbal inhaler training; 
∆ change; ??: questionnaire 
 
Collaborative Team Synthesis Table 
Table AB4: Collaborative Team Synthesis Table 
Article Collaborative Effort 
7 Respiratory Therapy 
13 Pharmacy 
17 Respiratory Therapy 
  
1: Gillette et al. (2016); 2: Rodriguez-Martinez et al. (2017);  3: Alexander et al. (2016); 4: Amirav et al. (1994); 5: Burkhart et al. (2000); 6: Carpenter et al. (2015); 7: 
Kamps et al. (2000); 8: Zivkovic et al. (2008); 9: Bourne (1996); 10: Capanoglu et al. (2015); 11: Carpenter et al. (2016); 12: Chen et al. (2002); 13: Foland et al. (2002); 
14: Janssen et al. (2003); 15: Jones et al. (1995); 16: Levy et al. (2013); 17: Minai et al. (2004); 18: Munzenberger et al. (2007); 19: Sleath et al. (2011); 20: Turkeli et al. 
(2016); 21: Deerojanawong et al. (2009); 22: Walia et al. (2006); 23: Schmier et al. (2007); 24: Manriquez et al. (2015); 25: Reznik et al. (2013); 26: deGroot et al. 
(2014); 27: Duerden, et al. (2001); 28: Pedersen et al. (2010); 29: Price et al. (2013); 30: Morin, 2012 
AC: asthma control; ACT: asthma control test;  AE: asthma education; AQLQ: asthma quality of life questionnaire; AS: asthma severity; AV: after video; BV: before 
video; CC: completely confident; DV: dependent variable; DX: diagnosis; FEV1: forced expiratory volume 1 second;  ER: emergency room; FVC: forced vital 
capacity; GINA: global initiative for asthma; GT: good inhaler technique; HOH: hard of hearing; ICS: inhaled corticosteroid; IMPACT: Improving the Management 
of Patients Asthma and COPD Treatment; IT: inhaler technique; IV: independent variable; MDI: metered dose inhaler; NC: no change; NCC: not completely confident; 
NS: no significance; Obs: observational; PACT: pediatric asthma clinic trial; PE: physical exam; PIF: peak inspiratory flow; PFT: pulmonary function test;  pop: 
population; PP: parental perception RCT: randomized controlled study; RT: respiratory therapist; RTC: return to clinic; SE: self-efficacy; VT: verbal inhaler training; 
∆ change; ??: questionnaire 
Length of Intervention and Sustainability Synthesis Table 
Table AB5: Length of Intervention and Sustainability Synthesis Table 
Article Length of Intervention Sustainability measured 
1 15 months Not measured 
3 5 weeks Not measured 
4 4 months Not measured 
5 4 weeks Not measured 
6 4 weeks Not measured 
7 3 months Not measured 
8 12 months Not measured 
9 4 months Not measured 
10 4 weeks Not measured 
11 4 weeks Not measured 
12 Not stated Not measured 
13 4 months Not measured 
16 3 years 3 years 
17 4 weeks Continuation of PACT study 
18 3 years Not measured 
19 3 months Not measured 
20 2 months Not measured 
21 12 months Not measured 
22 Not measured Not measured 
24 2 months Not measured 
30 11 weeks Not measured 
  
1: Gillette et al. (2016); 2: Rodriguez-Martinez et al. (2017);  3: Alexander et al. (2016); 4: Amirav et al. (1994); 5: Burkhart et al. (2000); 6: Carpenter et al. (2015); 7: 
Kamps et al. (2000); 8: Zivkovic et al. (2008); 9: Bourne (1996); 10: Capanoglu et al. (2015); 11: Carpenter et al. (2016); 12: Chen et al. (2002); 13: Foland et al. (2002); 
14: Janssen et al. (2003); 15: Jones et al. (1995); 16: Levy et al. (2013); 17: Minai et al. (2004); 18: Munzenberger et al. (2007); 19: Sleath et al. (2011); 20: Turkeli et al. 
(2016); 21: Deerojanawong et al. (2009); 22: Walia et al. (2006); 23: Schmier et al. (2007); 24: Manriquez et al. (2015); 25: Reznik et al. (2013); 26: deGroot et al. 
(2014); 27: Duerden, et al. (2001); 28: Pedersen et al. (2010); 29: Price et al. (2013); 30: Morin, 2012 
AC: asthma control; ACT: asthma control test;  AE: asthma education; AQLQ: asthma quality of life questionnaire; AS: asthma severity; AV: after video; BV: before 
video; CC: completely confident; DV: dependent variable; DX: diagnosis; FEV1: forced expiratory volume 1 second;  ER: emergency room; FVC: forced vital 
capacity; GINA: global initiative for asthma; GT: good inhaler technique; HOH: hard of hearing; ICS: inhaled corticosteroid; IMPACT: Improving the Management 
of Patients Asthma and COPD Treatment; IT: inhaler technique; IV: independent variable; MDI: metered dose inhaler; NC: no change; NCC: not completely confident; 
NS: no significance; Obs: observational; PACT: pediatric asthma clinic trial; PE: physical exam; PIF: peak inspiratory flow; PFT: pulmonary function test;  pop: 
population; PP: parental perception RCT: randomized controlled study; RT: respiratory therapist; RTC: return to clinic; SE: self-efficacy; VT: verbal inhaler training; 
∆ change; ??: questionnaire 
Provider Knowledge of Inhaler Technique 
Table AB6: Provider Knowledge of Inhaler Technique Synthesis Table 









1: Gillette et al. (2016); 2: Rodriguez-Martinez et al. (2017);  3: Alexander et al. (2016); 4: Amirav et al. (1994); 5: Burkhart et al. (2000); 6: Carpenter et al. (2015); 7: 
Kamps et al. (2000); 8: Zivkovic et al. (2008); 9: Bourne (1996); 10: Capanoglu et al. (2015); 11: Carpenter et al. (2016); 12: Chen et al. (2002); 13: Foland et al. (2002); 
14: Janssen et al. (2003); 15: Jones et al. (1995); 16: Levy et al. (2013); 17: Minai et al. (2004); 18: Munzenberger et al. (2007); 19: Sleath et al. (2011); 20: Turkeli et al. 
(2016); 21: Deerojanawong et al. (2009); 22: Walia et al. (2006); 23: Schmier et al. (2007); 24: Manriquez et al. (2015); 25: Reznik et al. (2013); 26: deGroot et al. 
(2014); 27: Duerden, et al. (2001); 28: Pedersen et al. (2010); 29: Price et al. (2013); 30: Morin, 2012 
AC: asthma control; ACT: asthma control test;  AE: asthma education; AQLQ: asthma quality of life questionnaire; AS: asthma severity; AV: after video; BV: before 
video; CC: completely confident; DV: dependent variable; DX: diagnosis; FEV1: forced expiratory volume 1 second;  ER: emergency room; FVC: forced vital 
capacity; GINA: global initiative for asthma; GT: good inhaler technique; HOH: hard of hearing; ICS: inhaled corticosteroid; IMPACT: Improving the Management 
of Patients Asthma and COPD Treatment; IT: inhaler technique; IV: independent variable; MDI: metered dose inhaler; NC: no change; NCC: not completely confident; 
NS: no significance; Obs: observational; PACT: pediatric asthma clinic trial; PE: physical exam; PIF: peak inspiratory flow; PFT: pulmonary function test;  pop: 
population; PP: parental perception RCT: randomized controlled study; RT: respiratory therapist; RTC: return to clinic; SE: self-efficacy; VT: verbal inhaler training; 
∆ change; ??: questionnaire 
Tools Utilized During Implementation 
          Table AB7: Tools Utilized During Implementation Synthesis Table 











1      √ 
2 √ √ √ √ √  
4 √ √  √   
6 √ √  √  √ 
7  √    √ 
8  √    √ 
9  √     
10 √      
11  √    √ 
12  √     
13  √  √ √ √ 
14  √     
16  √   √  
17  √  √ √ √ 
19 √ √     
20 √      
21  √     
22  √     
26  √     
30  √     
1: Gillette et al. (2016); 2: Rodriguez-Martinez et al. (2017);  3: Alexander et al. (2016); 4: Amirav et al. (1994); 5: Burkhart et al. (2000); 6: Carpenter et al. (2015); 7: 
Kamps et al. (2000); 8: Zivkovic et al. (2008); 9: Bourne (1996); 10: Capanoglu et al. (2015); 11: Carpenter et al. (2016); 12: Chen et al. (2002); 13: Foland et al. (2002); 
14: Janssen et al. (2003); 15: Jones et al. (1995); 16: Levy et al. (2013); 17: Minai et al. (2004); 18: Munzenberger et al. (2007); 19: Sleath et al. (2011); 20: Turkeli et al. 
(2016); 21: Deerojanawong et al. (2009); 22: Walia et al. (2006); 23: Schmier et al. (2007); 24: Manriquez et al. (2015); 25: Reznik et al. (2013); 26: deGroot et al. 
(2014); 27: Duerden, et al. (2001); 28: Pedersen et al. (2010); 29: Price et al. (2013); 30: Morin, 2012 
AC: asthma control; ACT: asthma control test;  AE: asthma education; AQLQ: asthma quality of life questionnaire; AS: asthma severity; AV: after video; BV: before 
video; CC: completely confident; DV: dependent variable; DX: diagnosis; FEV1: forced expiratory volume 1 second;  ER: emergency room; FVC: forced vital 
capacity; GINA: global initiative for asthma; GT: good inhaler technique; HOH: hard of hearing; ICS: inhaled corticosteroid; IMPACT: Improving the Management 
of Patients Asthma and COPD Treatment; IT: inhaler technique; IV: independent variable; MDI: metered dose inhaler; NC: no change; NCC: not completely confident; 
NS: no significance; Obs: observational; PACT: pediatric asthma clinic trial; PE: physical exam; PIF: peak inspiratory flow; PFT: pulmonary function test;  pop: 
population; PP: parental perception RCT: randomized controlled study; RT: respiratory therapist; RTC: return to clinic; SE: self-efficacy; VT: verbal inhaler training; 
∆ change; ??: questionnaire 
 
Correct Inhaler Technique Steps 




























3  √    √   
6  √ √   √   
7  √  √     
9  √ √   √ √  
10  √    √   
13   √   √  √ 
14  √    √   
19  √    √   
20  √ √      
22 √ √ √ √     





Appendix C: Chapter 3 
Table AC1: Full Implementation Plan 
Intervention Evidence Support Who Where How 
Pre-Implementation Steps 
EBP instruction to staff Clinic staff must know 
difference between 
research and EBP and 
how EBP drives 








BPA MAs  
CHP-BPA 
library 
• Face to face discussion 
• Powerpoint of EBP basics 
• Clinical Scholar EBP model  
• Education provided by PD to clinic staff 
• To discuss each step of EBP; relate to 
practice 
• PDF handouts created for each step in 
EBP model 
• Allowed for time for questions/answers 
Brainstorming session 
with nursing and 
providers 
Brainstorming is a 
quality improvement 
marker (American 











• Face to face discussion 
• Whiteboard 




















• PD met with RT for inhaler training 
•  
• PD met with each nurse individually to 
train for both inhaler technique and well 
as inhaler technique checklist2,4,6,7-9,11-
14,16-17,19,21-22,26,30 












• Acquired from State of Massachusetts 
and American Lung2,4,6,13,17 
 




Intervention Evidence Support Who Where How 
• Obtain Asthma 
Control Test 
(ACT) form 
• Obtain pediatric 
quality of life 
(QOL) form 



























AHRQ: PDSA, 2017 
IHI: PDSA 2017 
Reed & Carol, 2015 
 













• Face: face meeting 
• Whiteboard 
• Journaling by PD 
• Education by PD to nursing and provider 
staff regarding QI/QA process (verbal 
and written) 
• Notebook kept in library for further 
comments, thoughts, reflections from 
staff- encouragement for staff to utilize 
notebook 
First Visit Implementation 
First Vist: 
• ACT 
• Pediatric QOL 




Face to face patient time 
 
• Inhaler Technique 
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Intervention Evidence Support Who Where How 
• Inhaler technique 
eval 
• Inhaler use 
checklist 







• Review of ER 
utilization 
• Review of 
missed 
school/work 
• Schedule 3 








Patient inhaler technique evaluated by 
nurses and recorded on Inhaler Use 
Checklist.  Occured after provider visit.  
• AAP filled out by provider 
• All forms filled out otherwise by 
family/patients 
• All forms brought back to PD desk 
(ownership: self-efficacy for treatment; 
perception of health, perception of 
abilities) 1-31 
 
• Inhaler technique hands-on and verbal 
education provided by nursing to patients 
• Occured after provider visit.   
Education discussed and reviewed per 
protocol checklist 
(ownership: self-efficacy for treatment; 
perception of health, perception of 
abilities) 1-31 
 
• ACT, QOL forms filled out by 
patient/family before patient visit 
Forms placed into project protocol binder 
(ownership: self-efficacy, wellness, 
perception of health, perception of 
abilities)1-31 
 
• ER/urgent care utilization and missed 
school days form reviewed by MA before 
visit 
Patient filled out reported form 
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Intervention Evidence Support Who Where How 
Staff review Meditech reports 
Form was given to provider for review 
then placed into project binder 
(ownership: wellness equates to all areas 
of life- including school and socialization 
and activities of daily living)1-31 
 
• AAP completion 
AAP was given to provider for 
completion at time of patient visit 
AAP copied and scanned into EMR 
Verification form placed into project 
binder 
(ownership: self-efficacy, responsibility, 
wellness) 1-31 
 
• Three month follow up visit tickler alert 
filed 
(Ownership: self-efficacy, responsibility) 
 
 
Subsequent Asthma Visit Implementation Plan 
• ACT 
• Pediatric QOL 
• Inhaler technique 
eval 
• Inhaler use 
checklist 
• Inhaler technique 
education 









• Face to face patient time 
• Outcome metrics as described in outcome 
metric protocol 
 
• Inhaler Technique 
Patient inhaler technique evaluated by 
nurses and recorded on Inhaler Use 
Checklist after provider visit 
Inhaler Use placed into project binder 
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Intervention Evidence Support Who Where How 
• Review AAP: 
new plan 
completed if new 
medications 
• Review of ER 
utilization 














(ownership: self-efficacy for treatment; 
perception of health, perception of 
abilities) 1-26 
 
• Inhaler technique hands-on and verbal 
education provided by nursing to patients 
after provider visit 
Education discussed and reviewed per 
protocol checklist 
(ownership: self-efficacy for treatment; 
perception of health, perception of 
abilities) 1-31 
 
• ACT, QOL forms filled out by 
patient/family before patient visit 
Forms labeled and given to provider for 
review 
Forms placed into project protocol binder 
(ownership: self-efficacy, wellness, 
perception of health, perception of 
abilities) 1-31 
 
• ER/urgent care utilization and missed 
school days form before patient visit 
Patient filled out reported form 
Staff review of Meditech reports 
Form was given to provider for review 
then placed into project binder 
(ownership: wellness equates to all areas 
of life- including school and socialization 
and activities of daily living) 1-31 
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Intervention Evidence Support Who Where How 
 
• AAP completion 
AAP was given to provider for 
completion at time of patient visit 
AAP copied and scanned into Athena 
EMR 
Verification form placed into project 
binder 
(ownership: self-efficacy, responsibility, 
wellness) 1-31 
 
• Three months follow up visit tickler alert 
filed 
(Ownership: self-efficacy, responsibility) 
 
 













AHRQ: PDSA, 2017 
IHI: PDSA 2017 
Reed & Carol, 2015 
 













• Face face meeting 
• Whiteboard 
• Journaling by GMN 
• Notebook kept in library for project 
comments, suggestions for improvement 
 
• Review of QI/QA measures 
• Discuss successes and barriers 
• Sustainability discussion- how to keep 







Implementation Plan: developed through the Clinical Scholar EBP model 
Table AC2: Progress Markers for Implementation of DNP Scholarly Program 
Date Progress 
Marker 





IRB CHP 11/1/17 Face to 
face 
discussion  







Approval CHP  Form 
signature 
Verbal given for 
project 
implementation; 
formal meeting to 










Discussion of roll 








was an ongoing 
process. Final clinic 
approval discussed; 












CHP-BPA  11/13/17 Email 
contact 
Cory from RT was 
contacted.  Have 
met with CMO- 




steps for her.  
 I met with her and 
lead nurse at BMC 
and discussed IT 





Evidence Who? What? Where? When? How? Final Outcome 
EBP minded. I 
contacted Fallon 
ACO for RT 
support; not able to 











Internal data for 
why ER utilized; 
how many ER 
visits occur 











decided by PD and 
CMO not to 
procede. To obtain 
data from Meditech 
12/4/17 Contact 












can be shared or 
if need IRB 
(ownership: 
wellness equates 
to all areas of life- 
including school 
and socialization 
and activities of 
daily living) 











made to not move 
forward; would 
require an IRB.  






















































Copyright not allow 
for import into 




from state of MA 
 
Inhaler use 
checklist: 8 inhaler 
steps with yes/no 
validation typed 
onto single paper 
 
ER/urgent care and 
missed school days 
form: form typed 
by PD for clinic use 
 


















with discussion and 






Evidence Who? What? Where? When? How? Final Outcome 
office 
manager 





month; ending in 
6/18 for pre-
implemenation 





How to acquire 
internal data 
CHP-BPA 
CHP-BPA 1/8/18 Face to 
face 
discussion 
4/18: EMR not able 
to have viable 
asthma patient 
report.  Nursing 
gave PD partial list 
of asthma patients. 
PD adding to every 
day 
 
Will have to hand 
count asthma 








































1/30/18 Face to 
face 
discussion 
6/18: met with RT; 
will not be ethical 





Evidence Who? What? Where? When? How? Final Outcome 
RT training as well.  









since EBP not 
embraced. 
 
PD had inhaler 
training then met 
with each nurse and 
taught.  Providers 
did not attend 
trainings 
4/1/2018 Information 
















with new asthma 










7/18: Met with 
CMO to discuss.  
One general 
introduction to 
asthma care form 
written and added 
to each asthma 
packet. 
 












sign off of project 
Zoom 
session 
4/9/18 Zoom Received approval 
to implement from 
Dr EFO and UT 
Tyler after 6/18 








To discuss project 




CHP-BPA Week of 
4/16 
In person 7/18, 8/18: Met 
with each provider 
individually for 






Evidence Who? What? Where? When? How? Final Outcome 
voiced concerns.  1 
provider opted out 
of program; 1 
provider only 
allowed well care 
visits 
7/5/2018 Launch of 
project 
1-26 All of BPA Launch of EBP 
project at BPA 




















Status review of 
week 1 of roll out 
Barriers 
Facilitators 
First QI/QA eval 
CHP-BPA 
library 

































occurred with full 
















11/1/18 Face to 
face 
discussion 
Face to face 
discussion 
occurred; zoom 
meeting with Dr 

















































presentation (up to 
implementation) at 
Doctors of Nursing 
Practice 
Conference, Palm 






















Appendix D: Forms 
 
THE UNIVERSITY OF TEXAS AT TYLER COLLEGE OF NURSING AND HEALTH SCIENCES 
SCHOOL OF NURSING – DOCTOR OF NURSING PRACTICE PROGRAM. DNP MENTOR AGREEMENT 
I have reviewed the mentor guidelines. I can provide the student with advanced experiences 
that meet the DNP Scholarly Project (EPIP) goals as agreed upon by the student, the faculty 
mentor, and me. I understand that there will be no remuneration for this service. I will 
facilitate and review the student’s learning activities and will submit the required evaluations 
to the DNP Program. 
I   Eve  re_t_t_L_a_m  m_,_M   D_,_F_A  A_P  agree 
to serve as a (name of mentor) 
 
mentor for the DNP student    G_i_n_a_N  ic_k_e_l_s-_N  e_ls_o_n   
(name of student) 
 
 
from  to  (beginning date of 
mentorship) (anticipated end of mentorship) 
 
OR 
I agree to mentor for the following semesters: All Semesters ☐ 
OR 
Specifically:  Fall  Spring  Summer I 
May UTTYLER disclose your contact information for future students seeking mentors? 
 y
es or 
  no 
 
 






For office use only: 
Reviewed by  Date    
 
Approved as a DNP mentor  yes  no 
 
COLLEGE OF NURSING AND HEALTH SCIENCES 
SCHOOL OF NURSING – DOCTOR OF NURSING PRACTICE PROGRAM 
Mentor Biographical Data 
(Please note that an updated resume or curriculum vitae may be submitted as an alternate to 
the completion of this section) 
Name:  E_v_e_r_e_t_t _L_a_m_m   ,_M  D_,_F_A  A_P   Current Agency   C_o_m   
mu_n_it_y_H  e_a_lt_h_P_r_o_g_r_a_m  s_, _In_c_.    Position or Title:  
C_h_ie_f  M_e_d_i_c_a_l _O_f_fi_c_e_r     
Office Address:   4_4_4   S_t_o_c_k_b_ri_d_g_e  R_o_a_d_,_G  re_a_t  B_a_r_ri_n_g_to_n_,_M   A 0_1_2_3_0   
(street) 
 
(city) (state) (zip) 
 
Office phone with area code _4_1_3_-_5_2_8_-_9_3_1_1 x_1_1_4_3 
 
Fax number   
Email (personal or office)   e_l_a_m_m   @   c_h_p_b_e_r_k_s_h_ir_e_s_.o_r_g   
 
Alternate email                                                                                              
Preferred Method of Contact:  Phone      X         Email 
Type of position you currently hold  C_h_i_e_f _M_e_d_i_c_a_l _O_f_fi_c_e_r   Designated 
rural health site?     X   yes  no 













1.  U_n_iv_e_r_s_it_y  o_f _P_e_n_n_s_y_lv_a_n  ia_,_P_h_i_la_d_e  lp_h_ia  , _P_A_,_B  A_/'_9_2                                 
(Name of institution) (City/State) (Degree/Year) 
 
2.   Ha_rv_a_r_d  U_n_iv_e_r_s_it_y_,_C_a_m   b_r_id_g_e_,_M   A_,_P  o_s_t-_B_a_c_c_a_l_a_u_re_a  te  P_r_e_m_e_d_i_c_a_l 
_S_t_udies/'93 (Name of institution) (City/State) (Degree/Year) 
 
Graduate Degree 
1.   Un_iv_e_r_s_it_y_o_f_V  e_rm   o_n_t_C_o_l_le_g_e   o_f_M  e_d_ic_i_n_e_,_B_u_r_li_n_g_to  n_, _V_T_,_M  
D_/_'9_9       (Name of 
institution) (City/State) (Degree/Year) 
Postgraduate Specialty Training 
1._U  n_iv_e_rs_i_ty_o_f_V  e_rm  o_n_t _C_o_ll_e_ge   o_f_M_e_d_i_c_in_e_,_B_u_r_lin_g_t_o_n_,_V_T_,_P_e_d_i_a_tr_ic_R  e_s_id_e_n_c_y_Program 1999-
2002 
(Name of institution) (City/State) (Degree/Year) 
2.  (Name of 
institution) (City/State) (Degree/Year) 
 
License Information (*Must provide State verification/proof of licensure and 
certification when applicable) 
 
Professional License Number/State _2_6_9_0_2_4_/_M_a_s_s_a_c_h_u  
se  tt_s   Board Certification:     X yes  no 
Certifying Board (if applicable): 
1._A  m_e_r_ic_a_n   B_o_a_r_d  o_f _P_e_d_ia  tr_ic_s  Date  2_0_0_3   
 
2.  Date   
 
 
Employment Last Five Years (most recent first) 
 




1.   C_o_m   m  u_n_it_y_H  e_a_lt_h_P_r_o_g_r_a_m  s,  In_c_.  G_r_e_a_t_B_a_r_r_in_g_t_o_n_,_M  
A_9_/_2_0_1_6_-_P_r_e_s_e_n_t 2.   Co_re   P_h_y_s_i_c_ia_n_s_,_L_L_C  , _E_x_e_t_e_r,_N  H  8_/2_0_0_9_-
_8_/_2_0_1_6   
3.   
4.   
 
Student Signature:   Gina M Nickels-Nelson  
 
Date submitted:  9-6-2017  








CHP Berkshire Pediatrics is introducing a new asthma care program for your 
child/teen.  Your child’s health, especially caring for asthma, is extremely 
important to us.  So, over the next few months we will begin implementing 
additional care measures at our office that you will notice. 
At your visits, there will be new paperwork we are requesting you to fill out 
regarding how asthma is affecting your life at home.  Asthma not only causes 
breathing issues, but can also cause your child to miss school and for you to 
miss work.  By filling out these questions, we will better be able to address these 
issues. 
We are also going to have your child show us how they use their inhaler at home.  
Please bring your medication and spacer to the office for each visit.  Even though 
most people believe they use their medication correctly, unfortunately only about 
40% of patients use their inhaler appropriately.  This is usually as a result of not 
getting the proper training when the diagnosis is made.  If your child is not using 
their medication correctly, then they are not getting the medication to their lungs 
to help manage their asthma effectively. 
These are the first steps to improving your child’s care.  We look forward to 
seeing you and your child in our office every 6 (six) months to make sure your 
child is doing well and not suffering as a result of having asthma.   






















MDI Inhaler Use Checklist Evaluation Form 
 
 
Name of Patient: 
 








Remove Cap 1   
Shake inhaler/place 
into spacer 
1   
Exhale completely 1   
Place mouthpiece 
in mouth between 
lips 
1   
Press canister down 
once 
1   
Inhale slowly and 
deeply; hold breath 
10 seconds 
1   
Breathe out gently 1   
Wait 30 seconds 
before next dose 
1   
Form AD6: Inhaler Technique Checklist 
 
